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Abstract
Leukemia is a cancer of blood, which originates from malignant transformation of 
hematopoietic progenitor cells. Acute myeloid leukemia (AML), acute lymphocytic 
leukemia (ALL), chronic myeloid leukemia (CML) and chronic lymphocytic leukemia 
(CLL) are four major types of leukemia. A number of genetic, life-style, therapeutic 
and environmental factors have been linked to an increased risk of leukemia. 
However, the evidence to date is inconsistent on majority of these factors. The aim 
of this study was to evaluate associations between various occupational exposures 
and adult leukemia.
This study was based on the Nordic Occupational Cancer Studies (NOCCA). 
The NOCCA study includes 14.9 million persons from Denmark, Finland, Iceland, 
Norway and Sweden. These persons were 30-64 years old when they participated in 
one or more computerized censuses, which took place in 1990 or before in the 
Nordic countries. Census records provided information on age, gender, marital 
status, education, occupation and industry. These records were linked to national 
cancer registries for information on leukemia. The linkage was done by using unique 
personal identity codes.
In Study I, all cases of AML (n=18,811), CLL (n=20,462), and all other non­
specified leukemia (“Other leukemia”) (n=15,570) diagnosed between 1961 and 
2005 in the Nordic countries were grouped into 53 occupational categories and one 
group of economically inactive persons. Study II included 15,332 incident cases of 
AML and 76,660 controls matched for year of birth, sex and country. Study III 
consisted of 13,435 AML cases and 67,175 matched controls. Finally, Study IV 
included 5,022 airline workers (1,535 cockpit crew and 3,487 cabin crew members) 
from Finland.
The exposure estimates for solvents in Study II were obtained by using NOCCA 
job-exposure matrix (NOCCA-JEM). The estimates for extremely low-frequency 
magnetic fields (ELF-MF) and electrical shocks in Study III were obtained by using 
ELF-MF and electrical shock job exposure matrices (JEM). In Study IV, NOCCA- 
JEM  based cosmic radiation exposure estimates were compared against individual 
dose estimates from Radiation and Nuclear Safety Authority, Finland (STUK). 
Individual doses were estimated by using the software package CARI-6 and 
European Program Package for the Calculation of Aviation Route Doses 
(EPCARD) computer programs.
In Study I, the relative incidences of AML, CLL and “Other leukemia” were 
described by standardized incidence ratios (SIR). In Studies II and III, hazard ratios 
(HR) and 95% confidence intervals (95% CI) were estimated by using conditional 
logistic regression models. In Study IV, intraclass correlation coefficient (ICC) and 
Bland-Altman plot were used for continuous exposures, and proportion of 
agreement (PA) and kappa statistics (both Cohen’s kappa and weighted kappa) were 
used for categorical exposures as agreement measures.
Study I showed that leukemia incidence in some occupational groups was slightly 
elevated compared to the incidence in the overall study population. AML risk was 
increased among drivers (SIR=1.16, 95% CI 1.07-1.26) and food workers (SIR=1.13, 
95% CI 1.01-1.27). CLL risk was elevated among farmers (SIR=1.09, 95% CI 1.04­
1.14) and clerical workers (SIR=1.07, 95% CI 1.01-1.14). Risk of “Other leukemia” 
was increased among seamen, other health workers, chemical process workers, and 
sales agents. In some occupational groups significantly reduced risk of leukemia was 
observed. For example, forestry workers had reduced risk of AML, seamen had 
reduced risk of both AML and CLL, and fishermen had reduced risk of other non­
specified leukemia. No evidence o f increased AML risk was observed for 
occupational exposure to solvents, ELF-MF, electrical shock and working in 
electric/electronic occupation in Studies II and III. Study IV demonstrated large 
disagreement between cosmic radiation estimates from NOCCA-JEM and STUK. 
The Bland-Altman plot showed that NOCCA-JEM underestimated true cosmic 
radiation exposure on average by about 9 mSv, and NOCCA-JEM estimates could 
be about 28 millisievert (mSv) below and 10 mSv above true dose estimates. A low 
correlation was observed (intraclass correlation (ICC) 0.37, 95% CI 0.01-0.61) for 
continuous measures of radiation exposure, while the agreement between categorical 
exposure estimates was moderate (Cohen’s kappa statistic 0.46 and weighted kappa 
0.43).
In conclusion, the observed small leukemia excess in some occupational 
categories may be associated with exposure to specific occupational chemical and 
non-chemical agents. However, our studies on solvents, ELF-MF, and electrical 
shocks did not demonstrate any associations with adult leukemia. Study IV showed 
substantial disagreement between NOCCA-JEM based and individual cosmic 
radiation exposure estimates among airline workers suggesting that NOCCA-JEM 
can lead to exposure misclassification of cosmic radiation exposure in NOCCA 
studies.
Tiivistelmä
Leukemia (kreik. vaikoverisyys) on verisyöpä, veren valkosolujen syöpä. Sen neljä 
yleisintä muotoa ovat akuutti myelooinen leukemia (engl. lyhenne AML), akuutti 
lymfaattinen leukemia (ALL), krooninen myelooinen leukemia (CML) ja krooninen 
lymfaattinen leukemia (CLL). Vaikka monilla geneettisillä ja elintapoihin ja — 
ympäristöön liittyvillä tekijöillä on arvioitu olevan yhteyttä leukemian riskiin, 
useimmissa tapauksissa näyttö on epäyhtenäistä. Tutkimukseni tavoitteena on 
arvioida eräiden ammattialtistusten yhteyttä aikuisten leukemiariskiin.
Tutkimus pohjautuu pohjoismaisen ammattisyöpätutkimussarjan (Nordic 
Occupational Cancer Studies, NOCCA) yhteensä 14,9 miljoonan islantilaisen, 
norjalaisen, ruotsalaisen, suomalaisen ja tanskalaisen henkilön aineistoon. Näiden 
henkilöiden ammattitiedot 30-64 vuoden iässä löytyvät digitalisoiduista 
väestölaskentatiedostoista vuosilta 1960-1990 (vaihtelevasti maasta riippuen). 
Tutkimushenkilöille haettiin henkilötunnuksen avulla syöpätiedot vuoteen 2003­
2005 asti kansallisista syöpärekistereistä.
Tutkimuksen I aineistona olivat kaikki AML-tapaukset (n=18 811), CLL- 
tapaukset (n=20 462), ja kolmantena ryhmänä kaikki loput leukemiatapaukset 
(n=15 570), jotka oli todettu Pohjoismaissa ensimmäisen käytettävissä olevan 
väestölaskentatiedon jälkeen ja viimeistään vuonna 2005. Syövät luokiteltiin 53 
ammattiluokkaan ja erilliseen ammatissa toimimattomien ryhmään. Tutkimukseen II 
ei voitu ottaa mukaan Tanskan aineistoa, jolloin siihen jäi 15 332 AML-tapausta. 
Heille haettiin yhteensä 76 660 syntymävuosi-, sukupuoli- ja maakaltaistettua 
verrokkia. Tutkimuksessa III oli 13 435 AML-tapausta ja 67 175 verrokkia. Tutkimus 
IV rajautui suomalaiseen lentohenkilöstöön, joista 1 535 oli lentäjiä ja 3 487 
matkustamohenkilökuntaa.
Tutkimuksessa II käytetyt liuotinaltistusarviot perustuivat NOCCA- 
tutkimuksessa kehitettyyn ammattialtistusmatriisiin (NOCCA-JEM). Tutkimuksessa 
III käytetyt erittäin matalataajuuksisen magneettikenttäaltistuksen (ELF-MF) ja 
sähköaltistuspiikkien määräarvioiden pohjaksi räätälöitiin Hollannissa erillinen 
ammattialtistusmatriisi (JEM). Tutkimuksessa IV verrattiin NOCCA-JEM-pohjaisia 
kosmiselle säteilylle altistumisen arvioita yksilökohtaisiin säteilymittaustietoihin, joita 
oli saatavissa Säteilyturvakeskuksesta (STUK). Yksilöannokset estimoitiin CARI-6 ja 
EPCARD (European Program Package for the Calculation of Aviation Route 
Doses) -ohjelmistoilla.
Tutkimuksessa I AML:n, CLL:n ja muun leukemian riskiä kuvattiin vakioidulla 
ilmaantuvuussuhteella (standardized incidence ratio, SIR). Tutkimuksissa II ja III 
määritettiin riskitiheyssuhteet (hazard ratio, HR) 95 %:n luottamusväleineen (95% 
CI) ehdollisten logististen regressiomallien avulla. Tutkimuksessa IV käytettiin 
(kahden käytetyn altistumisen arviointimenetelmän yhtäpitävyyden mittareina) 
luokansisäisiä korrelaatiokertoimia (intraclass correlation coefficient, ICC) ja Bland- 
Altmanin kuvaajia jatkuville altistusmuuttujille, sekä yhtäpitävyyden suhteellisia 
osuuksia (proportion of agreement, PA) ja kappakerrointa (sekä Cohenin kappa että 
painotettu kappa) luokitelluille altistusmuuttujille.
Tutkimus I osoitti leukemian ilmaantuvuuden olevan hieman väestökeskiarvoa 
suurempi eräissä ammattiluokissa. AML:n riski oli koholla autonkuljettajilla 
(SIR=1,16, 95% CI 1,07-1,26) ja elintarviketyöntekijöillä (SIR=1,13, 95% CI 1,01­
1,27) ja CLL:n riski maanviljelijöillä (SIR=1,09, 95% CI 1,04-1,14) ja 
konttorityöntekijöillä (SIR=1,07, 95% CI 1,01-1,14). Muiden leukemiatyyppien riski 
oli suurentunut merimiehillä, kemian prosessityöntekijöillä ja myyntiedustajilla. 
Metsureilla AML:n riski, merimiehillä AML:n ja CLL:n riskit, sekä kalastajilla muiden 
leukemiatyyppien riski, olivat tilastollisesti merkitsevästi tavanomaista pienempiä. 
AML:n riski ei liittynyt liuotinaltistuksiin (tutkimus II) eikä magneettikenttä- tai 
sähköaltistuksiin (tutkimus III).
Tutkimus IV osoitti, että kosmisen säteilyn altistusestimaatit poikkeavat selvästi 
toisistaan riippuen siitä, onko arvion lähteenä NOCCA-JEM (ryhmätason 
ammattialtistumatriisi) vai Säteilyturvakeskuksen mittausaineisto (yksilökohtaiset 
säteilymittaustiedot). Bland-Altman kuvaajat osoittivat, että NOCCA-JEM:iin 
perustuvat altistusarviot olivat keskimäärin 9 mSv alhaisempia kuin yksilöllisiin 
mittaustietoihin perustuvat arviot. NOCCA-JEM:iin perustuvat arviot saattoivat olla 
noin 28 mSv matalampia ja 10 mSv korkeampia kuin yksilöllisiin mittaustietoihin 
perustuvat arviot. Jatkuvien altistusmuuttujien välinen korrelaatio oli matala (ICC 
0,37, 95% CI 0,01-0,61), kun taas yhtäpitävyys luokiteltujen altistusmuuttujien välillä 
oli kohtalainen (Cohenin kappa 0,46 ja painotettu kappa 0,43).
Tutkimuksessa havaitut vaihtelut ammattialakohtaisessa leukemiailmaantu- 
vuudessa olivat melko pieniä ja voisivat johtua työhön liittyvistä kemikaali- tai muista 
altistuksista. Havaintojemme mukaan ilmiön selittäjiä eivät ole liuotinaltistukset, 
magneettikentät eivätkä sähköaltistukset. Arvioitaessa lentohenkilökunnan 
altistumista kosmiselle säteilylle altistusarvioissa havaittiin selviä eroja NOCCA- 
JEM:n ja yksilöllisiin mittaustietoihin perustuvien arvioiden välillä. NOCCA-JEM 
saattaa siksi johtaa kosmista säteilyä koskevan altistustiedon virheluokitteluun.
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1 Introduction
Leukemia is a cancer of blood, which originates from malignant transformation of 
hematopoietic progenitor cells (Linet, Devesa, & Morgan, 2006). It may develop 
from either myeloid or lymphoid progenitor cells. The four major types of leukemia 
are acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute 
lymphocytic leukemia (ALL), and chronic lymphocytic leukemia (CLL) (Linet et al., 
2006).
Leukemia is characterized by accumulation of malignant blood cells in bone 
marrow and infiltration into other organs, thereby replacing healthy tissues (Miller 
& Grodman, 2001). This results in suppression of hematopoietic and immune 
systems, and manifestation of typical symptoms such as fatigue, fever, malaise and 
bruising.
In the Nordic countries in 2013, the highest incidence of AML adjusted for world 
standard population was observed in Denmark for males (3.5 per 100,000), and in 
Iceland for females (3.9 per 100,000) (Engholm et al., 2015). The incidence of CLL 
was the highest in Norway (5.7 per 100,000) and Denmark (5.6 per 100,000) for 
males, and in Denmark for females (3.1 per 100,000). The incidences of ALL and 
CML were substantially lower in all Nordic countries (Engholm et al., 2015).
Leukemia caused 9.3 million disability-adjusted life years (DALY) in the world 
(GBD, 2015a). 78% of this occurred in developing and only 22% in developed 
countries. Leukemia ranked tenth for cancer incidence and ninth for cancer deaths 
in the world in 2013 (GBD, 2015a). Studies investigating economic burden of 
leukemia are sparse, and low incidence and the fact that it mainly affects patients 
older 60 years of age may have contributed to sparse attention to this disease 
(Redaelli, Botteman, Stephens, Brandt, & Pashos, 2004). The economic burden of 
leukemia is primarily from inpatient and pharmaceutical costs, and costs due to 
productivity losses (Redaelli et al., 2004). The economic burden of CLL in Germany 
was about 201 million euros per year for the sickness funds and 322 million for 
society (Blankart et al., 2013). Also the burden of AML on society is significant 
despite its low incidence (Redaelli et al., 2004). According to Blankart et al (2013), 
the economic burden of CLL is considerably lower compared to common diseases
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(e.g. diabetes, chronic obstructive pulmonary disease). However, the treatment costs 
per CLL case are approximately twice higher than the treatment costs per case with 
common diseases. It is expected that the economic and societal burden of leukemia 
will continue to grow with the aging population and increasing incidence of leukemia 
(Blankart et al., 2013).
The causes of leukemia remain largely unknown. Previous studies have linked 
some genetic and life-style factors, various drugs and diagnostic procedures, viruses, 
and environmental factors with increased risk of adult leukemia.
Occupational exposures constitute a major part of environmental exposures. 
Among occupational exposures, benzene (BENZ) and ionizing radiation (IRAD) are 
the most widely accepted risk factors of adult leukemia. Occupational exposure to 
BENZ has mainly been linked to acute non-lymphocytic leukemia (ANLL) (Divine 
& Hartman, 2000; Guenel, Imbernon, Chevalier, Crinquand-Calastreng, & 
Goldberg, 2002; Hayes et al., 1997), but some studies also demonstrated associations 
with other leukemia subtypes (Glass et al., 2003; Hayes et al., 1997; Huebner, Wojcik, 
Rosamilia, Jorgensen, & Milano, 2004). The leukemogenic effect of occupational 
ionizing radiation exposure has been demonstrated in studies of radiologists and X- 
ray technicians (Smith & Doll, 1981), airline pilots (Gundestrup & Storm, 1999) and 
military servicemen exposed to atomic bomb tests (Caldwell, Kelley, Zack, Falk, & 
Heath, 1983; Darby et al., 1988). Formaldehyde, electromagnetic field and solvents 
are among other occupational exposures suspected as a risk factor of adult leukemia 
(Hauptman et al, 2003; Strom, Oum, Gbito, Garcia-Manero, & Yamamura, 2012; 
Theriault et al., 1994).
The main objective of this study was to assess associations between various 
occupational exposures and adult leukemia. The study population was an 
occupational cohort from four Nordic countries. The cohort members were 
employed between 1920s and 2000s and leukemia cases were diagnosed between 
1961 and 2005. Data from various registries such as census records, cancer registries 
and population registries, were used to collect information on sex, date of birth, 
death and emigration; date of diagnosis; education; and occupation.
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2 Review of literature
The purpose of literature review was to collect background information on adult 
leukemia and risk factors with main focus on occupational factors. The Medline 
database search engine was accessed via Ovid and used to search the literature. 
Leukemia, occupation, environmental exposure, pollutant, chemical, radiation, 
benzene, solvent, formaldehyde among others were used as keywords for extracting 
relevant papers from the database. Reference lists of articles selected from Medline 
database were further examined for additional literature relevant to the current 
research. Papers were restricted to English language and adult leukemia. The review 
was performed from July 2015 to October 2015.
2.1 Classification and overview of leukemia
Leukemias are subdivided into acute and chronic types (Miller & Grodman, 2001). 
Acute leukemias are characterised by rapid proliferation of leukemic cells with 
impaired maturation and chronic leukemias are characterized by expanded 
population of cells that proliferate but retain their ability to differentiate. Leukemias 
are also divided into myeloid and lymphocytic types depending on which cell type is 
affected (Linet et al., 2006). Myeloid leukemia type originates in myeloid progenitor 
cells that give rise to platelets, monocytes, erythrocytes and granulocytes, and 
lymphocytic type develops in lymphoid progenitor cells that differentiate into 
lymphocytes.
The latest version (10th revision, volume 2) of international classification of 
diseases (ICD) has grouped leukemia into lymphoid leukemia (C91), myeloid 
leukemia (C92), monocytic leukemia (C93), other leukemia of specified cell type 
(C94) and other leukemia of unspecified cell type (C95) (WHO, 2010).
The clinical manifestation of leukemias is a result of accumulation of leukemic 
cells in bone marrow, and infiltration into bloodstream and other organs (Miller & 
Grodman, 2001). In acute leukemias, rapid accumulation of malignant cells in bone 
marrow results in suppression of hematopoiesis, anemia, thrombocytopenia and
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neutropenia. In chronic leukemias, proliferated leukemic cells gradually replace 
healthy tissue in bone marrow, spleen and lymph nodes. Fatigue, malaise, fever, 
bruising are some of the typical symptoms of leukemia and clinical presentation 
varies across subtypes (Miller & Grodman, 2001).
The poorest prognosis is observed for AML compared to other leukemia 
subtypes. 5-year relative survival of AML in the United States significantly improved 
from 6.2 % in 1975-1977 to 26.8% in 2006-2012 according to U.S. SEER program 
(Howlader et al., 2016). Survival of CML improved from 21.8% to 65.9%, and of 
ALL from 40.6% to 70.7% during the same period. A modest improvement of CLL 
survival (from 67.1% to 85.1%) was also observed. In general, survival of all leukemia 
subtypes among younger patients is considerably better compared to older patients 
(Howlader et al., 2016). Better survival among younger patients is attributed to their 
having more chemo-sensitive disease (Hills & Burnett, 2011), intense induction 
treatment, better management of short-term toxicity and a reduction in relapse rates 
(Andersson et al., 2010). Older patients are more likely to be offered palliative care 
rather than intensive curative therapy because of differences in the biology of their 
disease and co-morbidities (Burnett et al., 2009, Burnett et al., 2010).
Leukemia survival has substantially improved also in the Nordic countries during 
the last few decades (Engholm et al., 2015) (Figure 1). The poorest 5-year survival 
was observed for AML and the highest survival was observed for lymphoid leukemia 
types (Figure 1).
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Figure 1. Five-year age standardized relative survival of acute myeloid leukemia (AML), acute 
lymphocytic leukemia (ALL), chronic myeloid leukemia (CML), chronic lymphocytic 
leukemia (CLL) in the Nordic countries (Engholm et al, 2015).
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2.2 Epidemiology of leukemia
Geographical patterns. There were 414,000 incident cases and 265,100 deaths of 
leukemia worldwide in 2013 (GBD, 2015a; GBD, 2015b). Age-standardized 
incidence rates and deaths rates (per 100,000) were higher in developed countries 
than developing countries (age-standardized incidence rates 8.15 vs 5.09; deaths rates 
4.78 vs 3.46) (GBD, 2015a). In 2013, the lowest incidence rate due to leukemia was 
reported for sub-Saharan Africa and the highest for North America, Australia and 
Western Europe (GBD, 2015a).
Incidence rates of AML vary about three-fold internationally and are the highest 
in white populations in North America, Oceania, northern and western Europe, and 
in Hispanics in Los Angeles (Douer et al., 1996; Tomas & Fernandez-Ranada, 1996). 
The lowest AML rate is observed in Asians, particularly Chinese (Shanghai) and 
Indians (Bombay). The highest CML rates are observed among Italian males, 
Australians, African Americans, Los Angeles Hispanics and the lowest rates are 
among Asians (Parkin, Whelan, Ferlay, & Teppo, 2002). The rates of ALL are the 
highest among Hispanics in Los Angeles, Spain, northern Italy and in whites in New 
Zealand (Parkin et al., 2002). The lowest ALL incidences are observed among Israeli 
Jews, Japanese, Indians (Bombay) and Chinese (Shanghai). International variation of 
incidence rates is the highest for CLL among all leukemia subtypes (Parkin et al., 
2002). The highest CLL rates are observed in whites in New Zealand, Italy, North 
America and the lowest rates are observed in Japan, China (Shanghai), India 
(Bombay).
In the Nordic countries, the AML incidence rate in 2013 among males was the 
highest in Faroe Islands and Denmark, and among females in Denmark (Engholm 
et al., 2015) (Figure 2). Incidence of CML was the highest in Iceland and Denmark 
for males, and in Denmark and Norway for females. The highest rates for CLL were 
observed in Norway, Denmark and Iceland for males, and in Denmark and Norway 
for females. The incidence of ALL was the highest in Iceland and Greenland in 
females, and Faroe Islands for males (Figure 2).
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Figure 2. Incidence (per 100 000 person-years) of acute myeloid leukemia (AML), chronic myeloid 
leukemia (CML), chronic lymphocytic leukemia (CLL) and acute lymphocytic leukemia 
(ALL) by country and sex in the Nordic countries in 2004-2013 (No Rd c A n data). 
Adjusted for world standard population (Engholm et al, 2015).
Time-trend. Age-standardized mortality rate of overall leukemia has decreased by 
about 20% from 5.2 in 1990 to 4.1 in 2013 (GBD, 2015b). However, overall deaths 
due to leukemia increased from 223,800 in 1990 to 265,100 in 2013, and 
corresponding incidence rates increased from 297,000 to 414,000, mainly because of 
global population growth and aging during the past decades (GBD, 2015a; GBD, 
2015b).
Age-standardized AML incidence rates in both sexes were higher among whites 
compared to African Americans in all periods from 1970s to 1990s (Ries et al., 2003). 
The rate of AML in all groups slightly increased through 1994-2000 compared to 
previous years. CML rates were uniquely increased in African Americans in both 
sexes compared to white Americans (Ries et al., 2003). CML rates among African 
Americans increased from 1973-1979 and 1987-1993 for males and between 1973­
1979 and 1980-1986 for females, then declined for both sexes. The rate of ALL has 
increased over time for all four race-sex groups with the higher rates observed for 
white Americans. The rate of CLL was higher for whites than African Americans 
and very small increase was observed during 1973-1979 and 1987-1993, which 
followed by a decline in 1987-1993 and 1994-2000 (Ries et al., 2003).
The incidence of AML for both sexes has been the highest in Denmark and 
decreased in all Nordic countries from 1980 to 2013 (Engholm et al., 2015) (Figure 
3). CML rate increased in Norway and Denmark, but decreased in other Nordic
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countries among females. Among males, CML rate increased in Iceland, but 
decreased in Finland and Denmark. Incidence of CLL increased in Denmark, 
Iceland, and Norway, and decreased in Finland in both sexes. Small increases of ALL 
rates were observed among females in Norway and Denmark, among males in 
Norway and Iceland. ALL rate decreased in Finland for both sexes (Figure 3).
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Figure 3. Five-year average incidence (per 100 000 person-years) of acute myeloid leukemia 
(AML), chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL) and acute 
lymphocytic leukemia (ALL) by country, sex and time period (1980-2013) in Nordic 
countries (NORDCAN data). Adjusted for world standard population (dashed lines show 
trends) (Engholm et al, 2015).
Age-specific patterns. In the US, myeloid leukemias account for about 45% of all 
leukemias (Ries et al., 2003). AML incidence rapidly increases after the age 40 years. 
There are no sex-specific differences in AML rates among middle-aged white and 
African Americans, while among elderly persons, higher rates among whites 
compared to African Americans are observed. The rates of CML exponentially 
increase in both races and sexes throughout life. Generally, the rate of CML is higher 
among African Americans than white Americans for both sexes. Lymphoid 
leukemias constitute about 47% of all leukemias in the U.S. (Ries et al., 2003). Over 
70% of all childhood leukemias are lymphocytic, predominantly ALL. Among 
persons aged >65 years, about 46% of leukemias are lymphocytic, most of which is 
CLL. ALL incidence rate has two distinct age-specific peaks. The first peak 
corresponds to the age 2-4 years followed by sharp decline during adolescence and 
early adulthood. The second peak occurs at older ages, which is lower than the first 
peak. CLL is very uncommon before the age 30 years and the difference in incidence 
between white and African Americans is very small among middle-age persons. The
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rate increases exponentially between ages 30 and 60 years and then a small increase 
is observed in older ages (Ries et al., 2003).
Figure 4 shows age-specific pattern o f leukemia incidences in adult populations 
(age 20+ years) of the Nordic countries during 2004-2013. Incidences of all leukemia 
types seem to rapidly increase from age 60-65 years for both sexes (Engholm et al., 
2015) (Figure 4).
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Figure 4. Incidence (per 100 000 person-years) of acute myeloid leukemia (AML), chronic myeloid 
leukemia (CML), chronic lymphocytic leukemia (CLL) and acute lymphocytic leukemia 
(ALL) by country, sex and age in 2004-2013 in Nordic countries (NORDCAN data) 
(Engholm et al, 2015).
2.3 Risk factors of leukemia
A broad range of factors linked to adult leukemia can be grouped into genetic, life­
style, therapy-related and environmental factors (Zeeb & Blettner, 1998). Some of 
these factors can be included in more than one group. For example, exposure to 
ionizing radiation may be included in environment, occupation, and 
therapy/diagnostics (Table 1).
Table 1. Potential risk factors of adult leukemia.
Group Examples
G enetic Down syndrom e, K linefe lter syndrom e, 
P h ilade lph ia  chrom osom e etc.
Life-style Sm oking, diet, body m ass index etc.
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Group Examples
Therapy-re la ted R adio therapy, chem otherapy, d iagnostic  
rad io logy etc.
Environm enta l O ccupation, chem ical and non-chem ical 
agents.
2.3.1 Genetic factors
The genetic predisposition to leukemia is supported by evidence from family history 
studies and studies of genetic abnormalities. In a Texas case-control study, family 
history of lymphoma, multiple myeloma, myelodysplastic syndrome and leukemia in 
the first-degree relatives significantly increased the risk of AML both among women 
(OR=2.75, 95% confidence interval [95% CI] 1.20-6.32) and men (OR=3.06, 95% 
CI 1.47-6.37) (Strom et al., 2012).
Down syndrome, Philadelphia chromosome, Fanconi anemia, and Klinefelter 
syndrome are among genetic abnormalities that have been studied in relation to 
leukemia. The risk of leukemia was 10-fold among persons with Down syndrome in 
a Finnish cohort study (Patja, Pukkala, Sund, Livanainen, & Kaski, 2006). Although 
the risk was more obvious in younger ages, it remained elevated throughout life. In 
another study of persons with Down syndrome, significant rate ratios of 18.9 (95% 
CI 10.4-31.5) for leukemia, 22.2 (95% CI 10.9-40.6) for lymphoid leukemia and 17.2 
(95% CI 5.5-40.9) for myeloid leukemia were observed (Goldacre, Wotton, 
Seagroatt, & Yeates, 2004). In a mortality study between 1988 and 1999 among 
14,781 persons with Down syndrome, a SMR=17 (95% CI 11-25) was observed for 
leukemia (Day, Strauss, Shavelle, & Reynolds, 2005). Philadelphia chromosome 
(usually translocation 9/22) was found in the majority of CML cases. It was 
suggested that its presence alone may not lead to CML, but it induces an early step 
in leukemia development (Greaves, 1997, as cited in Zeeb & Blettner, 1998). An 
association between Klinefelter syndrome and leukemia was suggested in some case 
reports (Keung, Buss, Chauvenet, & Pettenati, 2002; Mamunes, 1961), but it was not 
confirmed in larger studies (Horsman, Pantzar, Dill, & Kalousek, 1987; Price, 
Clayton, Wilson, Collyer, & De Mey, 1985). In a prospective Danish cohort study, 
696 men with Klinefelter syndrome were followed-up from 1943 to 1991 and no 
excess leukemia risk was observed (Hasle, Mellemgaard, Nielsen, & Hansen, 1995). 
An excess incidence of leukemia was observed among 279 patients with ataxia 
telangiectasia compared to general population in a French cohort study (Suarez et
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al., 2015). In a retrospective cohort of North American patients with Fanconi 
anemia, the ratio of observed to expected cases was 785 (observed=9) for leukemia 
(Rosenberg, Green, & Alter, 2003).
2.3.2 Life-style factors
Cigarette smoking, alcohol intake, obesity, dietary intake are among life-style related 
factors, which have been studied in relation to adult leukemia.
In a Texas case-control study, statistically significantly increased risk of AML was 
observed for being a current smoker (men: OR=1.60, 95% CI 1.08-2.38; women: 
OR=1.93, 95% CI 1.26-2.97) (Strom et al., 2012). Similarly, current smoking was 
significantly associated with AML (OR=1.4, 95% CI 1.1-1.8) in a Canadian 
population based case-control study, but no increased risk was observed for other 
leukemia subtypes (Kasim, Levallois, Abdous, Auger, & Johnson, 2005). In an 
analysis by the number of cigarette packs smoked per year, leukemia risk remained 
elevated with positive dose-response relationship in both studies (Kasim et al., 2005; 
Strom et al., 2012). The risk of AML decreased by increasing number of years since 
quitting smoking and no association with AML was reported for those quitting 
smoking for >28 years before the date of interview (Kasim et al., 2005). Second hand 
smoking was not associated with AML risk in a study by Strom et al. (2012). The risk 
of smoking-related AML was restricted to a subgroup with t(8;21) (q22;q22) 
translocation but not to other groups in a study by cytogenetic groups, suggesting 
that AML risk due to smoking may vary by chromosomal abnormalities (Moorman, 
Roman, Cartwright, & Morgan, 2002). In 2004, the IARC concluded that there is a 
sufficient evidence for the causality between active smoking and AML (IARC, 2004).
Obesity was statistically significantly associated with increased risk of leukemia in 
a Canadian case-control study (Kasim et al., 2005). Odds ratio for all leukemias was
1.3 (95% CI 1.1-1.5) for body mass index (BMI) =25-30 kg/m3, and 1.6 (95% CI 
1.3-1.9) for BMIT30 kg/m3 compared to BMI<25 kg/m3. Analysis by leukemia cell- 
types showed that the risk of AML, CML, ALL and CLL were increasing with BMI 
with a significant trend (Kasim et al., 2005). The risk of CML was also reported to 
increase with BMI in a study by Strom, Yamamura, Kantarijian, & Cortes-Franco 
(2009). In this study, the risk remained elevated for both males and females and 
different age groups in a detailed analysis. Weight gain was also consistently 
associated with increased CML risk and the strongest association was observed for 
gaining >1 kg/year between 25 and 40 years of age (OR=3.63, 95% CI 1.46-9.04) 
(Strom et al., 2009). Strom et al. (2012) observed significantly increased risk of AML
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for BMIA30 kg/m3 among women (OR—1.62, 95% CI 1.06-2.47) but not men 
(OR=1.24, 95% CI 0.91-1.79).
In a Texas case-control study, overall AML risk was significantly decreased 
among those who consumed dark-green vegetables, seafood, and nuts/seeds; and it 
was significantly increased among greatest consumers of red meat (Yamamura, Oum, 
Gbito, Garcia-Manero, & Strom, 2013). Among men, AML risk was the lowest 
among those whose consumption was in the highest quartile for fruits (OR—0.25, 
95% CI 0.10-0.69), poultry (OR—0.28, 95% CI 0.10-0.78), and seafood (OR—0.39, 
95% CI 0.16-0.96) compared to those in the lowest quartile. Among women, risk 
was the lowest among those whose consumption was in the highest quartile of dark- 
green vegetables (OR—0.28, 95% CI 0.12-0.68), orange vegetables (OR—0.40, 95% 
CI 0.17-0.96), and nuts/beans (OR—0.26, 95% CI 0.11-0.60) (Yamamura et al., 
2013). Vegetable intake was also associated with decreased risk of adult leukemia 
(OR—0.30, 95% CI 0.18-0.50) in a Chinese multicenter case-control study (Liu, 
Holman, Jin, & Zhang, 2015a). In this study, intakes of fruit, red meat and poultry 
was not associated with leukemia risk. Dietary fiber, carotenoids, vitamins B1, B2, 
and C, niacin, and folate were significantly associated with reduced risk. Dietary 
intake of animal fat, deep-fried and smoked foods was associated with elevated 
leukemia risk (Liu et al., 2015a). Fruit or vegetable intake was not associated with 
leukemia in a study by Kasim et al. (2005), and none of the selected dietary factors 
(red and processed meat, poultry, offal, fish, dairy products, vegetables, and 
seeds/nuts) was associated with leukemia risk in a European Prospective 
Investigation into Cancer and Nutrition study (Saberi et al., 2014). In a Chinese 
multicenter case-control study, significantly decreased leukemia risk was observed 
among those who consumed green tea (Liu, Zhang, Xie, Jin  & Holman, 2015b). 
Compared with non-tea drinkers, the adjusted odds ratios were 0.50 (95% CI 0.27­
0.93), 0.31 (95% CI 0.17-0.55) and 0.53 (95% CI 0.29-0.99) for those, who, 
respectively, consumed green tea >20 years, >2 cups daily and dried tea leaves >1000 
g annually (Liu et al., 2015b).
The effect of alcohol intake on development of AML was not supported in 
previous studies (Brown, Gibson, Burmeister, Schuman, Everett, & Blair, 1992; 
Hinds, Kolonel, Lee, & Hirohata, 1980; Williams & Horm, 1977). In an Italian 
multicenter case-control study, a non-significant increased risk of all leukemias, 
AML, CLL and ALL was observed for the highest quartile (>31 g/day) of alcohol 
intake (Gorini et al., 2007). In this study, the risk of CML was significantly increased 
in the highest quartile (>27.7 g/day) of wine intake (2.13, 95% CI 1.01-4.50).
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However, a recent systematic review and meta-analysis did not support increased 
leukemia risk among alcohol drinkers (Rota et al., 2014).
2.3.3 Therapy related factors
Adult leukemia sometimes occurs following a primary neoplasm. The most 
frequently reported primary cancers preceding secondary leukemia are lymphomas 
and breast cancer (Fianchi et al., 2015; Howard et al., 2007). However, there is 
evidence also for other cancer types such as testicular cancer and prostate carcinoma 
(Travis et al., 2000).
In a number of studies, this phenomenon has been linked to certain types of 
chemotherapy drugs and radiotherapy administered to patients treated for primary 
cancers (Boivin, 1990; Kyle, 1982). However, it is often difficult to attribute an 
observed risk of secondary leukemia to a particular therapy-related factor, because 
various chemotherapeutic drugs are usually administered in combination with 
radiotherapy (Kröger et al., 2003). Alkylating agents, platinum-containing anti-cancer 
drugs, topoisomerase II-inhibitors, anti-tumor antibiotics are among 
chemotherapeutic drugs that have been linked to secondary leukemia.
Alkylating agents have been linked to AML but not ALL in an Italian multi-center 
(GIMEMA) study (Pagano et al., 2000). In a case-control study nested in an 
international cohort of 18,567 one-year survivors of testicular cancer, a significantly 
increased risk of secondary leukemia (OR=3.2, 95% CI 1.5-8.4) was observed among 
patients receiving cisplatin for cumulative dose of 650 mg (Travis et al., 2000). Larger 
cumulative doses of cisplatin (1000 mg) were linked to significantly increased 6-fold 
risk in that study. However, no increased leukemia risk was observed for other 
chemotherapeutic agents such as etoposide and bleomycin (Travis et al., 2000). 
Mitoxantrone administered breast cancer patients had significantly increased risk of 
secondary AML and myelodysplastic syndrome (MDS) (RR=10.1, 95% CI 3.5-16.7) 
and AML alone (RR=14.1, 95% CI 2.8-25.4) compared to the general population in 
a study by Saso et al. (2000). Kröger et al. (2003) also observed secondary AML cases 
emerging after about 57 months of follow-up in a group of 305 breast cancer patients 
who received mitoxantrone-based high dose chemotherapy. Some of topoisomerase 
II-inhibitor drugs (e.g. anthracyclines) were linked to increased risk of secondary 
acute promyelocytic leukemia (APL) following 3-years treatment of breast carcinoma 
(Beaumont et al., 2003). The lag-time following treatment with topoisomerase II- 
inhibitors is about 2 years and MDS usually does not precede secondary leukemia 
(LeBeau et al., 1986; Felix, 1998).
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The evidence for radiation therapy of cancer seems to be weaker than that for 
chemotherapy. In an Italian cohort study of breast cancer patients undergoing 
radiotherapy with either tele-cobalt unit or linear accelerator, an elevated risk of 
secondary leukemia (RR=6.67, 95% CI 0.76-58.00) was observed during two or 
more years following the treatment (Zhang, Becciolini, Biggeri, Pacini, & Muirhead, 
2011). In another cohort study (Kaplan, Malmgren, & Atwood, 2011), breast cancer 
patients receiving both combination of radiotherapy and chemotherapy, and 
radiotherapy alone were at increased risk of AML and MDS/AML compared to 
population incidence data. In that study, the risk of AML seemed to be restricted in 
women younger 65 years (RR=5.32, 95% CI 1.31-14.04) than women older 65 years 
(RR=2.38, 95% CI 0.73-5.61). In a cohort study based on data from eight national 
cancer registries from North America and Europe, the risk of leukemia was 3-fold 
among patients receiving radiotherapy (mean dose 12.6 Gy) to pelvis, abdomen and 
chest and the risk significantly increased by administered dose (Travis et al., 2000). 
However, no increased leukemia risk was observed among thyroid cancer patients 
following iodine-131 therapy (De Vathaire et al., 1997). Radiotherapy for diseases 
other than cancer has also been linked to elevated leukemia risk. For example, 
enhanced rate of leukemia was observed among patients injected radium-224 for the 
treatment of ankylosing spondylitis (Wick, Nekolla, Gaubitz, & Schulte, 2008; Wick, 
Atkinson, & Nekolla, 2009). Median lag-time after radiotherapy was reported to be 
longer than that following chemotherapy in an Italian study (Fianchi et al., 2015).
Patients undergoing radiation diagnostics may also be at risk of subsequent 
leukemia, however, the evidence is weaker than that for radiation therapy. Diagnostic 
radiation involves radiation doses lower than that received during radiation therapy. 
Assessment of exposure to diagnostic radiation maybe challenging as it heavily relies 
on patient’s memory that may span for a long time. Diagnostic X-ray has been linked 
to leukemia risk in small case-control studies (Flodin, Fredriksson, Persson, & 
Axelson, 1990; Preston Martin, Thomas, Yu, & Henderson, 1989). Conversely, no 
leukemia risk was observed in a larger study of tuberculosis patients who repeatedly 
received fluoroscopy (Davis, Boice, Hrubec, & Monson, 1989). Among radioactive 
contrast agents, thorotrast, is a well-known leukemia risk factor. It is an alpha- 
emitting contrast that was widely used in the world between 1920 and 1950 for 
various diagnostic procedures (Ron, 2003). Epidemiologic follow-up studies of 
patients receiving thorotrast consistenly showed an increased leukemia risk (Dos 
Santos Silva, Jones, Malveiro, & Swerdlow, 1999; Mori et al., 1999; Nyberg et al., 
2002; Van Kaick et al., 1999).
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2.3.4 Environmental factors
Environmental risk factors have received widespread attention in epidemiological 
studies of adult leukemia (Zeeb & Blettner, 1998). These factors include various 
chemical and non-chemical agents, and exposure to these factors is common in 
occupational settings. Because occupational groups are commonly used as a proxy 
for specific occupational exposures, they are also discussed in this chapter.
2.3.4.1 O ccupational groups
Increased incidence and mortality o f adult leukemia has been observed in various 
occupational groups. Farming and farming related jobs, rubber industry workers, 
shoe workers, and petroleum workers are the occupational groups most commonly 
linked to excess leukemia incidence and mortality.
Excess leukemia (ANLL and ALL) risk was reported among meat industry 
workers (abattoir and butchers) in New-Zealand (Bethwaite, McLean, Kennedy, & 
Pearce, 2001). The risk among abattoir workers was confined to those working more 
than two years (OR=4.9, 95% CI 1.5-15.6) and having direct contact with animals 
or animal products (OR=5.2, 95% CI 1.2-22.2). The risk among butchers was 
observed among butchers working in abattoir (OR=4.8, 95% CI 1.1-20.0) but not 
among retail/wholesale butchers and meatpackers (OR=1.2, 95% CI 0.4-3.6) 
(Bethwaite et al., 2001). In a Canadian population based case-control study, subjects 
occupationally exposed to beef cattle were at significant leukemia risk (OR=2.0, 95% 
CI 1.2-3.3) and the risk was confined to a group of workers with duration of working 
with beef cattle for more than 30 years (OR=3.0, 95% CI 1.4-6.3). Other animal- 
related occupations (e.g. dairy cattle, poultry, horses, pigs, and fish) were not linked 
with excess leukemia risk in this study (Fritschi, Johnson, Kliewer, Fry, & the 
Canadian Cancer Registries Epidemiology Research Group, 2002). The risk of ALL, 
CLL and AML was elevated among farmers in Ireland (Kelleher et al., 1998) and the 
risk of CLL was increased among animal breeding farmers in Italy (Amadori et al.,
1995).
Excess deaths due to leukemia (SMR=219, 95% CI 109-392) were observed 
among rubber industry workers in Germany. The risk was confined to workers hired 
during 1950-1959 and having work experience for more than 10 years (Straif et al., 
1998). Rubber workers were at increased leukemia risk also in an Italian multi-center 
case-control study (Costantini et al., 2001). Non-significantly increased risk of overall 
leukemia and AML among petroleum workers was restricted to workers hired before
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1950 (Raabe, Collingwood, & Wong, 1998). In this study, the risk peaked during 
1960s and no more elevation was observed after 1980. The risk of leukemia among 
shoe workers (SMR=536, 95% CI 111-1566) was restricted to shoe workers first 
hired between 1950 and 1959 when benzene exposure was substantial (Fu et al., 
1996). Restriction of leukemia risk to earlier but not recent periods may be due to 
reduction of level of some carcinogenic agents at work places over time as a result 
o f strict regulations of exposure limits (Wong, Harris, & Smith, 1993).
Increased leukemia risk was also observed among painters, material handlers, 
metal processors, printers (OR=3.20, 95% CI 1.5-9.77), management, business and 
finance workers, sales managers, engineers, radiological technologists, automobile 
manufacture workers (OR=2.50, 95% CI 1.17-5.34), food and beverage industry 
(OR=1.61, 95% CI 1.02-2.56), airline workers (Band et al., 1996; Robinson et al., 
2015; Wong, Harris, Armstrong, & Hua, 2010; Yoshinaga, Aoyama, Yoshimoto, & 
Sugahara, 1999).
It is difficult to attribute an excess leukemia risk in an occupational group to 
particular agent because workers in the same occupation are usually exposed to a 
diverse group of chemical and non-chemical factors simultaneously. For example, 
farmers and farmworkers may be occupationally exposed to pesticides and various 
biological agents from animals. Petroleum, rubber industry workers, painters, 
printers and shoe makers may be exposed to benzene and other solvents. For some 
other occupations such as sales managers, business and finance workers there are no 
known chemical and non-chemical factors.
In many studies of occupational groups (e.g. airline pilots, shoe manufacturing 
workers, petroleum refinery workers), statistically significant decreased overall 
mortality, compared to general population, was reported (Band et al., 1996; Fu et al., 
1996; Raabe et al., 1998). In some studies, reduced mortality was observed for some 
specific cancers (e.g. cancer of liver, rectum, buccal cavity and pharynx) (Raabe et 
al., 1998). Decreased mortality in these studies is believed to result from the healthy 
worker effect because comparisons were usually made with the general population. 
This suggests that if  expected cases were estimated from a comparable population 
(e.g. employed population), the risk estimates would have probably been larger. In 
fact, a cancer mortality study among radiological technologists in Japan showed no 
increased risks for leukemia when expected cases were estimated using the general 
population of Japan. However, when professional and technical workers were used 
as a standard population, leukemia risk reached a statistically significant level 
(SMR=1.75, 95% CI 1.07-2.71) (Yoshinaga et al., 1999).
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2.3.4 .2  C hem ica l facto rs
Benzene. Benzene is used in the manufacture of other chemicals (e.g. cyclohexane, 
cumene, phenol, aniline, and styrene) and as a component of dyes, rubber, 
detergents, pesticides, gasoline etc. (ATSDR, 2007; IARC, 2012; Williams, Panko, 
Unice, Brown, & Paustenbach, 2008). Occupational exposure to benzene occurs via 
inhalation or dermal absorption of solvents in rubber and paint manufacturing 
industries; during crude oil refining and chemical manufacturing (IARC, 2012). The 
level of benzene exposure may differ across occupational categories. For example, 
in rubber, shoe and paint manufacturing it is higher than in oil industry (IARC, 2012).
Benzene exposure may also occur in a non-occupational setting from gasoline 
filling-stations, tobacco smoke, air contaminated with benzene (from industrial 
sources, heavy traffic areas etc.) (ATSDR, 1997). Compared to occupational 
exposure, non-occupational benzene exposure is generally very low. For example, 
outdoor air concentrations of benzene in the U.S. was 0.02 parts per billion (ppb) 
(0.06 microgram (pg)/m3) in rural area, and 112 ppb (356 pg/m3) in an urban area 
(ATSDR, 1997). In an urban area exposure was the highest around gasoline filling- 
stations and heavy motor-vehicle traffic. Amount of benzene per cigarette ranged 
from 5.9 to 75 pg in mainstream smoke and from 345 to 653 pg in sidestream smoke 
(ATSDR, 1997). Average airborne benzene exposure ranges from 3.7 to 41 pg/m3 
in the UK (Duarte-Davidson, Courage, Rushton, & Levy, 2001). Residential 
exposure to benzene may also occur from drinking contaminated water or eating 
contaminated food (IARC, 2012). The level of benzene intake via ingestion is 
considerably lower than intake from ambient air (ATSDR, 1997).
In high concentrations, benzene can suppress bone marrow cell proliferation and 
lead to hematologic disorders (IARC, 2012). In 1982, IARC classified benzene as 
Group-1 carcinogen (IARC, 2012).
The first suggestion of leukemogenic effect of benzene exposure came from a 
case report in 1928 (Delore & Borgomano, 1928) and was followed by other case 
reports (Aksoy, Din Col, Erdem & Din Col, 1972; Aksoy, Erdem & Din Col, 1974; 
Vigliani, 1976). These studies were followed by a large number of industry- and 
population-based cohort and case-control studies. In this summary, characteristics 
and results from industry-based studies found through the literature review are 
presented and discussed (Table 2).
The strongest epidemiologic evidence was observed for an association between 
high benzene exposure levels and non-lymphocytic leukemia (ANLL) (Divine & 
Hartman, 2000; Glass et al., 2003; Guenel et al., 2002; Hayes et al., 1997). There is 
also some evidence for other leukemia subtypes (Glass et al., 2003; Hayes et al., 1997;
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Huebner et al., 2004). In an Italian case-control study, benzene exposure was 
associated with CLL, but not with AML (Costantini et al., 2008).
Excess leukemia risk was reported for various benzene exposure levels. Evidence 
seems to be stronger for high exposure levels, but for low levels the results are 
inconsistent. For example, Collins, Ireland, Buckley, and Shepperly (2003) observed 
increased risk of leukemia and ANLL for peak levels >100 parts per million (ppm), 
Aksoy et al., (1972) for average exposure >25 ppm. In a Chinese multi-industrial 
cohort, risk of leukemia subtypes was elevated at average levels <10 ppm, and 
increased by increasing exposure level and duration of exposure (Hayes et al., 1997). 
Leukemia risk was evident among gas- and electric-utility workers with cumulative 
exposures >16.8 ppm-years and average intensity of <1ppm (Guenel et al., 2002). 
In a Pliofilm cohort study, workers exposed to benzene levels >200 ppm-years were 
at increased AML risk (Wong, 1995). In a study of Australian, Canadian and UK 
petroleum workers with cumulative exposure 10 ppm-years equivalent to average 
exposure intensities of 0.2-0.3 ppm, no evidence of leukemia risk was observed 
(Schnatter, Glass, Tang, Irons, & Rushton, 2012). Cancer incidence between 1971 
and 1994 was studied in a cohort of Finnish oil refinery workers, and no increased 
risk of leukemia was observed (SIR=1.02, 95% CI 0.47-1.93) (Pukkala, 1998). 
Rushton and Romaniuk (1997) observed a weak association between myeloid 
leukemia and cumulative benzene exposure levels <45 ppm-years in a study of 
petroleum marketing and distribution workers in the UK. In a large Texas cohort o f 
oil refinery workers, an increased SMR (259.6, 95% CI 112.1-511.5) was observed 
for ALL but not for other leukemia cell-types (Satin et al., 1996).
The temporal pattern o f risk suggested that the risk o f leukemia from benzene 
exposure was higher in earlier periods and increased by duration o f exposure. 
Sathiakumar et al. (1995) reported increased risk of AML for oil and gas production 
workers (OR=2.8, 95% CI 1.1-7.3). This risk was restricted to employees hired for 
over 32 years (highest tertile o f employment duration) (OR=8.7, 95% CI 2.0-37) and 
there was a consistent trend of ORs with increasing duration of employment 
(Sathiakumar et al., 1995). In Texaco crude oil workers, risk of AML was higher 
among those first employed before 1940 (Divine & Hartman, 2000) and in a multi­
industrial cohort in China, workers hired before 1972 had higher ANLL risk (Hayes 
et al., 1997). Similarly, significantly increased mortality from ANLL and ALL was 
observed in Baton Rouge workers (ExxonMobil refinery/petrochemical workers) 
before and during World War II, but not after (Huebner et al., 2004). Authors 
suggested two possible explanations: first, wartime exposures and production 
processes might have been different than during later periods; second those worked
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at plant might have had poorer health than those who were recruited to active 
military service (Huebner et al., 2004). Among Norwegian offshore workers the risk 
of leukemia and AML was more evident for the first exposure during 1981-1985 
compared to 1986-2003 (Kirkeleit, Riise, Bratveit, & Moen, 2008). Among gas and 
electric utility workers, the risk seemed to be restricted to persons first exposed 
before 1960 (Guenel et al., 2002). In a Texas cohort study of petroleum workers, 
leukemia risk seemed to be restricted to those hired before 1950 (Wong, Harris, 
Rosamilla, & Raabe, 2001). The temporal pattern of leukemia risk among benzene 
exposed workers can be related to strict regulation of exposure limits in some 
countries. For example, in the US, 8-hour daily time-weighted average benzene 
exposures were reduced from 100 ppm to 50 ppm in 1947, and from 50 ppm further 
down to 35 ppm in 1948 (Wong et al., 1993).
Lag-time analyses in some studies indicated that relatively recent but not too 
distant benzene exposures were related to adult leukemia. In a study of gas and 
electric utility workers (Guenel et al., 2002) the risk was observed for 2, 5 and 10 
years lag-time. In a recent cohort study of rubber hydrochloride workers, RR of 
leukemia was the highest in the 10 years immediately after exposure and risk 
gradually decreased to background levels in 20 years and more after exposure 
(Richardson, 2008). In a Chinese multi-industrial cohort, exposures occurring less 
than 10 years before diagnosis were more strongly related to the leukemia risk (Hayes 
et al., 1997).
Despite being based on similar occupational group (e.g. petroleum workers), 
some studies reported an increased risk of leukemia (Divine & Hartman, 2000; Glass 
et al., 2003; Kirkeleit et al., 2008), while others did not (Lewis et al., 2003; Rushton, 
1993, Rushton & Romaniuk, 1997). Inconsistent results were observed even in 
studies based on the same cohort. For example, strong evidence for ANLL and CLL 
was reported in a case-control study nested in Australian Health Watch cohort (1981­
1996) (Glass et al., 2003). However, in an updated follow-up of the same cohort 
through 31 December 2001 no evidence was observed (Gun, Pratt, Ryan, & Roder, 
2006). In an updated follow-up (1970- 1997) of ExxonMobil refinery/petrochemical 
workers, significantly increased risk of ANLL was observed, which was not evident 
in previous update (1970-1992) (Huebner et al., 2004). Potential explanations for 
inconsistencies include accuracy of disease status ascertainment and exposure 
measurement, differences in study designs, study populations and exposure metrics.
Although the results of individual studies did not provide strong evidence, the 
most recent reviews supported an association between occupational benzene 
exposure and AML, CLL, CML and ALL (Vlaanderen, Lan, Kromhout, Rothman,
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& Vermeulen, 2011; Vlaanderen, Lan, Kromhout, Rothman, & Vermeulen, 2012). 
One of explanations for this discrepancy is the fact that these review studies 
provided only pooled risk estimates for “any occupational benzene exposure” vs 
“background benzene exposure”, and overall estimates could have been influenced 
by large estimates from single studies. The authors selected this general approach 
because they wanted to also include studies that did not provide stratum-specific risk 
estimates but only overall estimates. However, it seems that more detailed analysis 
could have been performed in many cases. For example, Vlaanderen et al. (2011) 
reported a summary meta-RR of 2.32 (95% CI 1.55-3.47) for AML based on six 
studies, which authors classified as studies with the best quality of exposure 
assessment (Group A studies). Among these studies, a statistically significant overall 
risk estimate (SMR=5.03, 95% CI 1.84-10.97) based on only six observed cases was 
observed only in a Pliofilm cohort study (Wong, 1995). All of the remaining studies 
reported non-significantly increased overall AML risk (Bloemen et al., 2004; Collins 
et al., 2003; Glass et al., 2003; Hayes et al., 1997; Rushton & Romaniuk, 1997). It is 
possible that the overall pooled risk estimate in this analysis could have been 
influenced by a single estimate from Wong (1995). All of these six studies provided 
stratum-specific risk estimates for various exposure levels, and pooled estimates for 
various exposure levels in this specific analysis would probably be more informative 
than overall pooled estimate.
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Table 2. Cohort and case-control studies of occupational benzene exposure and adult leukemia (AML -  acute myeloid leukemia; CML -  chronic myeloid 
leukemia; ALL -  acute lymphocytic leukemia; CLL -  chronic lymphocytic leukemia; ANLL -  acute non-lymphocytic leukemia; CMML - chronic 
myelomonocytic leukemia; OR -  odds ratio; SMR -  standardized mortality ratio; RR -  relative risk; ppm -  parts per million).
Reference Country,
fo llow -upa
Study population/Industry Outcomes Exposure
a ss es sm e n t
Main findings
Case-control study
Sathiakumar et 
al., 1995
USA, 1976­
1990
69 leukemia cases and 284 
matched controls selected 
from employees at large 
petroleum company.
Leukemia,
AML
Qualitative The association with AML was observed for 
oil and gas production workers (OR=2.8, 95% 
CI 1.1-7.3). It was restricted for workers hired 
for more than 32 years (highest tertile of 
employment duration) (OR=8.7, 95% CI 2.0­
37). Also significantly increasing risk trend 
was observed for employment duration in oil 
and gas production.
Schnatter et al., 
1996
Canada,
1964-1983
16 leukemia cases 64 
controls nested in petroleum 
distribution workers.
Leukemia Semi-quantitative No evidence of leukemia risk (OR=1.002).
Rushton & 
Romaniuk, 1997
UK,
-1991
91 cases and 364 controls 
nested in petroleum 
marketing and distribution 
workers cohort.
Leukemia, 
AML, ALL, 
CML, CLL
Semi-quantitative Non-significantly increased risk of AML 
without a clear trend was observed for 
cumulative exposures <45 ppm-years. The 
risk of AML also seemed to increase from 
zero 10 year lag-time. The job history data 
was incomplete and sometimes it had to be
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Reference Country,
fo llow -upa
Study population/industry Outcomes Exposure
a ss es sm e n t
Main findings
supplemented from other sources, such as 
medical and pension records, and interviews.
Guenel et al., 
2002
France,
1978-1989
72 cases and 285 controls 
nested in gas- and electric- 
utility workers.
Leukemia, 
AML, CML, 
ALL, CLL
Semi-quantitative OR=3.6 (95% CI 1.1-11.7) for leukemia at 
cumulative exposure >16.8 ppm-years. For 
some of subtypes non-significantly increased 
risk observed.
Glass et al., 
2003
Australia,
1981-1994
79 cases and 395 controls 
nested in Australian 
petroleum workers (Health 
Watch Cohort).
Leukemia, 
CLL, CML, 
ALL, ANLL
Semi-quantitative OR=7.17 (95% CI 1.27-40.4) for ANLL and 
OR=4.52 (95% CI 0.89-22.9) for CLL at 
cumulative lifetime exposure >8 ppm-years. 
No association for cumulative lifetime 
exposures <8 ppm-years. The number of 
exposed cases were small.
Costantini et al., 
2008
Italy,
1991-1993
586 cases and 1,278 controls 
from 11 provinces in Italy.
Leukemia, 
AML, CLL
Qualitative Non-significant risk for CLL (OR=1.8, 95% CI 
0.9-3.9), and no evidence for AML (OR=0.9) 
for medium/high exposure.
Gross et al., 
2012
China,
2003-2007
36 cases and 72 controls 
selected from 28 hospitals
CMML Semi-quantitative No evidence of increased risk.
Schnatter et al., 
2012
Australia, 
Canada, UK, 
-2006
370 cases and 1587 controls 
nested within Australia, 
Canada and UK petroleum 
workers cohorts.
AML, CML, 
ALL
Semi-quantitative Non-significantly increased risk estimates 
were observed for some exposure metrics.
Cohort study
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Reference Country,
fo llow -upa
Study population/Industry Outcomes Exposure
assessm ent13
Main findings
McCraw et al., 
1985
USA, 1973­
1982
All white male employees at 
the Wood River Refinery.
AML, CML, 
ALL, CLL
Qualitative SMR=394 (95% CI 172-788) for AML, for 
other cell-types no increased risk was 
observed.
Rushton, 1993 UK,
1950-1975
34,569 oil refinery and 34,781 
distribution workers (males).
AML, ALL,
CLL, CML,
monocytic
leukemia,
other
leukemia
Qualitative All SMR estimates were non-significant, 
except for other leukemia (SMR=678, 95% CI 
273-1397) based on 7 cases.
Wong et al., 
1993
USA,
1946-1985
18,135 petroleum distribution 
workers (land-based terminal 
and marine workers).
Leukemia, 
AML, CML, 
ALL, CLL
Semi- quantitative No evidence of leukemia by various exposure 
metrics. Only non-significantly increased risk 
for AML (SMR=1.5, p-value>0.05).
Wong, 1995 USA, 1940­
1987
Cohort of workers employed 
at two Goodyear plants in 
Ohio in the manufacture of 
Pliofilm (rubber 
hydrochloride).
AML Semi-quantitative SMR=27.21 (95% CI 3.29-98.24) for 
cumulative exposure levels 200-400 ppm- 
years, SMR=98.37 (95% CI 20.28-287.65) for 
levels >400 ppm-years. Overall SMR=5.03 
(95% CI 1.84-10.97). There were only 2 
observed cases in the category 200-400 
ppm-years and 3 cases in the category >400 
ppm-years.
Wong & Raabe, 
1995
USA, UK, 
1937-1989
208,000 petroleum workers 
from US and UK.
AML, ALL, 
CML, CLL
Qualitative No evidence of leukemia risk. SMR=0.96 
(95% CI 0.81-1.13) for AML; SMR=0.89 (95%
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Reference Country,
fo llow -upa
Study population/Industry Outcomes Exposure
a ss es sm e n t
Main findings
CI 0.68-1.15) for CML; SMR=1.16 (95% CI 
0.81-1.61) for ALL. Authors attributed the lack 
of association to low levels of benzene 
exposure in study population.
Satin et al., 
1996
USA., 1937­
1987
17,844 employees of a large 
Texas refinery cohort.
Leukemia, 
AML, CML, 
ALL, CLL
Qualitative SMR=259.6 (95% CI 112.1-511.5) for ALL 
was observed. For other cell-types no 
increased risk reported. SMR for AML was 
62.7 (95% CI 30.1-115.3). Analyses stratified 
by sex and employment duration did not 
show any significantly increased risk for 
leukemia.
Yin et al., 1996 China,
1972-1987
74,828 exposed and 35,805 
unexposed subjects.
Leukemia, 
AML, CLL, 
CML, ALL
Qualitative RR=2.6 (95% CI 1.3-5.7) for leukemia; 
RR=3.1 (95% CI 1.2-10.7) for AML.
Hayes et al., 
1997
China,
1972-1987
74,828 exposed and 35,805 
unexposed workers (multi­
industrial cohort).
Leukemia, 
ANLL, other 
leukemia
Semi-quantitative RR=3.0 (95% CI 1.0-8.9) for ANLL; the risk 
seemed to be restricted among those hired 
before 1972 but not evident in later periods. 
ANLL risk was statistically significantly 
increased for average exposure 10-24 ppm 
(RR=5.8), but not for <10 ppm (RR=3.2) and 
>25 ppm (RR=4.1); for exposure duration 
<10 years (RR=4.3) but not >10 years
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Reference Country,
fo llow -upa
Study population/industry Outcomes Exposure
a ss es sm e n t
Main findings
(RR=2.8); and for cumulative exposures >40 
ppm-years. No significant trend of increasing 
ANLL risk was observed and the number of 
cases was less than 15 in all stratified 
analyses.
Divine et al., 
1999
USA, 1947­
1993
28 840 workers of Texaco 
mortality study
Leukemia, 
AML, CLL, 
CML, ALL
Qualitative Mortality of leukemia and cell-types was not 
increased in the cohort. SMR=155 (95% CI 
93-243) for AML for those employed before 
1950 and SMR=30 (95% CI 0-168) for those 
employed after 1950.
Divine & 
Hartman, 2000
USA,
1946-1994
24,124 crude oil production 
workers (Texaco cohort).
Leukemia, 
AML, CLL, 
CML, ALL
Qualitative SMR=1.92 (95% CI 1.10-3.13) for AML and 
the risk was restricted among those first 
employed before 1940 and worked >20 
years.
Wong et al., 
2001a
USA,
1945-1996
7,543 Beaumont, Texas 
petroleum refinery workers.
Leukemia, 
AML, CLL, 
CML, ALL
Qualitative Overall results did not show association 
(leukemia SMR=1.39, 95% CI 0.99-1.90).
Wong et al., 
2001b
USA, 1959­
1997
3,328 workers who were 
employed at the Mobil (now 
ExxonMobil) Torrance, 
California.
AML, CML, 
ALL, CLL
Qualitative SMR=74.4 (95% 1.9-414.3) for CLL; 
SMR=45.4 (95% 1.1-252.8) for AML; 
SMR=195.6 (95% CI 23.7-706.6) for CML. 
For ALL there were 0 observed cases and 
SMR was not estimated. No risk pattern was
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Reference Country,
fo llow -upa
Study population/industry Outcomes Exposure
a ss es sm e n t
Main findings
observed by time since hire or employment 
duration.
Collins et al., 
2003
USA,
1940-1997
4,172 male and 245 female 
workers of chemical plant in 
Illinois.
Leukemia, 
ANLL, CLL
Semi-quantitative No significantly increased risk was observed 
for leukemia. SMR for ANLL was 4.1 (95% CI 
95% CI 0.5-14.9) for >40 days exposure to 
peak exposure levels (>100 ppm). No 
significantly increased ANLL risk was 
observed for cumulative exposures <1 ppm- 
years (SMR=1.4, 95% CI 0.1-5.1); 1-6 ppm- 
years (SMR=2.7, 95% CI 0.3-9.9), >6 ppm- 
years (SMR=2.2, 95% CI 0.3-8.1). The 
number of observed cases were small (<5) in 
all ANLL analyses and there was a limited 
exposure information for 1940s and 1950s.
Lewis et al., 
2003
Canada,
1964-1994
25,292 petroleum workers. Leukemia, 
ANLL, CLL, 
ALL, AML
Qualitative No evidence of leukemia risk.
Bloemen et al., 
2004
USA,
1940-1996
2,266 chemical workers from 
Michigan.
Leukemia Semi-quantitative SMR for leukemia was 1.14 (95% CI 0.59­
1.99), for ANLL 1.11 (95% CI 0.30-2.83), for 
CLL 0.42 (95% CI 0.01-2.36). There was no 
significantly increased SMR for ANLL in the 
analyses of duration, cumulative exposure
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Reference Country,
fo llow -upa
Study population/Industry Outcomes Exposure
a ss es sm e n t
Main findings
and average intensity and the number of 
exposed cases was mainly <5 in all stratified 
analyses.
Huebner et al., 
2004
USA,
1970-1997
7,637 Baton Rouge (Illinois) 
and 7,007 Baytown (Texas) 
workers of two ExxonMobil 
refinery/petrochemical 
workers.
Leukemia, 
ANLL, CLL, 
ALL, CML
Qualitative Risk of ANLL seemed to be increased in 
Baytown cohort (SMR=2.13, 95% CI 1.10­
3.73) but not in Baton Rouge; the risk of CLL 
was increased in Baton Rouge (SMR=2.42, 
95% CI 1.16-4.45) but not Baytown cohort.
Gun et al., 2006 Australia,
1980-2001
16,547 males and 1,356 
females (Australian Health 
Watch cohort).
Leukemia, 
AML, CLL, 
ALL, CML
Semi-quantitative No evidence of increased risk of leukemia 
subtypes.
Kirkeleit et al., 
2008
Norway,
1981-2003
27,919 offshore petroleum 
workers and 366,114 referent 
group from general 
population.
Leukemia, 
AML, ALL, 
CML, CLL
Qualitative RR=2.89 (95% CI 1.25-6.67) for AML among 
upstream offshore workers, for other job 
categories no risk was observed.
Richardson,
2008
USA,
1940-1965
1,845 rubber hydrochloride 
workers.
leukemia Semi-quantitative Leukemia risk seemed to be increased 
(RR=1.19, 95% CI1.10-1.29) at 10 ppm for 
about 10 years duration and showed 
decreasing tendency for duration >10 years. 
Benzene exposures accrued at age >45 
years seemed to be more strongly associated
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Reference Country,
fo llow -upa
Study population/industry Outcomes Exposure
a ss es sm e n t
Main findings
with leukemia than exposures accrued at 
younger ages.
a Follow-up period corresponds either to the time period of exposure assessment or case diagnosis in case-control studies.
b Semi-quantitative exposure measurement was based on job-history data that were converted to numeric exposure either by using job-exposure matrix or 
expertise of industrial hygienist; qualitative measurements grouped subjects into exposed and unexposed and did not provide numeric exposure estimates.
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Formaldehyde. Formaldehyde has a large number of industrial uses and is found in 
many consumer products (NTP, 2010). Its primary use in industry is in production 
of resins. Occupational exposure to formaldehyde may occur among manufacture 
workers of resins, furniture, plastics, fiberglass, histologists and pathologists, 
embalmers, foundry and construction workers and many other occupational groups. 
The main source of exposure is through inhalation of formaldehyde gases present 
indoors (NTP, 2010). Non-occupational exposure may occur from many home 
products such as furniture, carpets, fiberglass products, latex paints, fingernail 
hardeners, grocery bags, paper towels etc. (ATSDR, 2010). Based on sufficient 
evidence for nasopharyngeal cancer, formaldehyde has been classified as a Group 1 
carcinogen (IARC, 2006). In 2009, the IARC working group reaffirmed 
carcinogenicity of formaldehyde for humans and concluded that evidence for 
leukemia, particularly myeloid type, is sufficient (Baan et al., 2009).
Studies of occupational formaldehyde exposure and leukemia were mainly cohort 
studies based on either professional groups (e.g. embalmers, pathologists, and 
anatomists) or industrial workers. These studies are summarized in Table 3.
The strongest evidence was observed in a cohort study of U.S. formaldehyde 
industry workers (RR=3.46, 95% CL 1.27-9.23) (Hauptmann, Lubin, Stewart, Hayes, 
& Blair, 2003) and a case-control study of U.S. embalmers (OR=11.2, 95% CL 1.3­
95.6) (Hauptman et al., 2009). In a cohort study of industrial workers, the risk of 
leukemia and myeloid leukemia was statistically significantly increased for peak 
exposures >2 ppm, non-significantly increased for average intensity >0.5 ppm and 
duration of exposure >15 years. Cumulative exposure was not associated with 
leukemia risk (Hauptmann et al., 2003). In a case-control study of embalmers, the 
risk of myeloid leukemia and AML increased by duration of working in jobs with 
embalming (>20 years), cumulative formaldehyde exposures greater than 9253 ppm- 
hours, and number of embalming (>1422). Also average intensity and peak exposure 
seemed to predict increased risk (Hauptmann et al., 2009). Little evidence for 
lymphatic leukemia was observed in both studies. Association between 
formaldehyde exposure and leukemia was also suggested in mortality studies of 
embalmers, garment workers (Hayes, Blair, Stewart, Herrick, & Mahar, 1990; 
Walrath & Fraumeni, 1984). However, Coggon, Ntani, Harris, and Palmer (2014) 
and Pira, Romano, Verga, and La Vecchia (2014) did not observe any evidence of 
increased risk of leukemia from formaldehyde exposure in cohorts of British 
chemical workers and Italian laminated plastic factory workers respectively.
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Beane Freeman et al. (2009) updated a cohort study of industrial workers 
(Hauptmann et al., 2003) with additional 10 years follow-up. In this update, risk 
estimates for leukemia and myeloid leukemia diminished and became non­
significant. This could reflect either increased precision o f risk estimates due to 
accrual o f additional cases or relatively short induction period following 
formaldehyde exposure (Beane Freeman et al., 2009). Diminished risk of leukemia 
was also observed in an update of 11,098 U.S. formaldehyde exposed garment 
workers (Meyers, Pinkerton, & Hein, 2013). In this study, risk was elevated only 
among workers first hired before 1963, but not after. Also the risk was restricted to 
longer time since first exposure (>20 years) and duration (>10 years).
One of major limitations in studies of formaldehyde was an accuracy of exposure 
measurement. Because no data on exposure measurement were available, exposure 
estimates were derived merely based on the knowledge of industrial hygienist in 
some studies (Beane Freeman et al., 2009; Hauptmann et al., 2003). In a case-control 
study of embalmers, exposure was estimated using predictive models based on 
duration, year of exposure, availability and type of ventilation at work place and other 
predictors of exposure (Hauptman et al., 2009). The latter was collected through 
interviewing next of kin of deceased subjects and there was a likely recall bias. 
Despite having individual measurements for some years, some studies did not derive 
numeric exposure estimates (Meyers et al., 2013; Pinkerton, Hein, & Stayner, 2004).
Bosetti, McLaughlin, Tarone, Pira, and La Veccia (2008) reviewed cohort studies 
of formaldehyde through 2006, and found a pooled relative risk of 1.39 (1.15-1.68) 
for leukemia. Schwilk, Zhang, Smith, Smith, & Steinmaus (2010) also observed 
increased risk for leukemia (RR=1.53, 1.11-2.21) and for AML (RR=2.47, 1.42-4.27) 
in a review study of formaldehyde exposure. However, another review concluded 
that evidence for an association between formaldehyde and lymhpohematopoietic 
malignancies including AML was inconsistent across studies and there was little 
evidence for a dose-response relationship (Checkoway, Boffetta, Mundt, & Mundt, 
2012).
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Table 3. Cohort and case-control studies of occupational formaldehyde exposure and adult leukemia (AML -  acute myeloid leukemia; CLL -  chronic 
lymphocytic leukemia; RR -  relative risk; SMR -  standardized mortality ratio; PMR -  proportional mortality ratio; CI -  confidence interval).
Reference Country,
Follow-upa
Study population/industry Outcom e Exposure
a ss es sm e n t
Main findings
Case-control study
Hauptman et 
al., 2009
USA,
1960-1986
168 lympho-hematopoietic 
cases and 265 matched 
controls from embalmer 
cohort.
Myeloid
leukemia
Semi­
quantitative
Evidence was the strongest for myeloid leukemia, 
significantly increasing trend by duration of 
employment was observed. Cumulative exposure 
and number of embalming were also predictors of 
the risk.
Cohort study
Walrath & 
Fraumeni, 1984
California, 
US, 1916­
1978
1,046 male and 63 female 
embalmers.
Leukemia Qualitative Overall PMR was 175 (p<0.05). When the duration 
of exposure was estimated by length of licensure, 
PMR was 221 (p<0.05) for duration of more than 20 
years. For duration less than 20 years PMR was 
124 (p>0.05).
Hauptman et 
al., 2003
USA,
1966-1994
25,619 workers from 10 
plants.
Leukemia,
myeloid
leukemia
Semi­
quantitative
The risk of leukemia, particularly myeloid leukemia, 
increased by peak exposures and average intensity 
of exposure, but not cumulative exposure 
categorized by 60th and 80th percentile cut-points.
Pinkerton et al., 
2004
USA,
1955-1998
11,039 garment workers/2 
plants from Georgia and 1 
from Pennsylvania
Leukemia,
myeloid
leukemia
Qualitative SMR for leukemia and myeloid leukemia was non­
significantly elevated. The risk seemed to be 
restricted in a category of duration >10 years, time
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Reference Country,
Follow-upa
Study population/Industry Outcom e Exposure
a ss es sm e n t
Main findings
since first exposure >20 years, first exposure before 
1963.
Beane Freeman 
et al., 2009
USA,
-2004
25,619 workers employed in 
10 plants producing or 
using formaldehyde
Myeloid
leukemia
Semi­
quantitative
Peak exposures >4 ppm seemed to increase the 
risk of all leukemia and AML.
Meyers et al., 
2013
USA,
1955-2008
11,098 garment workers 
from Georgia and 
Pennsylvania
Leukemia, 
myeloid 
leukemia, 
AML, CLL
Qualitative Non-significantly increased risk of leukemia, 
myeloid leukemia and AML was observed in this 
study. The risk was restricted to year of first 
employment before 1963, time since first exposure 
>20 years, duration of exposure >10 years, and 
exposure windows (exposures from 2 to 20 years 
accrued at any age).
Coggon et al., 
2014
England 
and Wales, 
1941-2012
14,008 chemical workers at 
six factories
Leukemia,
myeloid
leukemia
Semi­
quantitative
This study did not provide evidence for leukemia or 
myeloid leukemia.
Pira et al., 2014 Italy,
1947-2011
2,750 laminated plastic 
workers (2,227 men and 
523 women)
Leukemia Qualitative No evidence of leukemia overall. Many exposure 
metrics were used in this study and no clear pattern 
of the risk was observed.
a Follow-up period corresponds either to the time period of exposure assessment or case diagnosis in case-control studies.
b Semi-quantitative exposure measurement was based on job-history data that were converted to numeric exposure either by using job-exposure matrix or 
expertise of industrial hygienist; qualitative measurements grouped subjects into exposed and unexposed and did not provide numeric exposure estimates.
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Pesticides. Pesticides are widely used to protect crops from insects, plants and 
molds. Farmers are among a group of occupations with the highest occupational 
pesticide exposure. However, because of wide use of pesticides, exposure to these 
agents is also ubiquitous in a general population, with a major exposure route being 
through ingestion of food contaminated with pesticides (Barr et al., 2005; Barr et al.,
2010). Despite consisting of diverse group of chemicals, only some of specific 
pesticides were classified as probably carcinogenic (Group 2A: captafol, nonarsenical 
insecticides, 4,4-Dichlorodiphenyltrichloroethane (DDT), glyphosate etc.) or 
possibly carcinogenic (Group 2B:, chlordane, dichlorvos, heptachlor etc) to humans 
(IARC, 1991; IARC, 2016).
The link between exposure to pesticides and leukemia has been studied among 
farmers, agricultural workers and pesticide manufacturers (Adegoke et al., 2003; 
Brown et al., 1990). Overall, there appears to be weak evidence for an association 
between pesticide exposures and leukemia. Brown et al. (1990) observed significantly 
elevated leukemia risks for exposure to specific animal insecticides including the 
organophosphates crotoxyphos (OR=11.1, 95% CI 2.2-55.0), dichlorvos (OR=2.0, 
95% CI 1.2-3.5), and famphur (OR=2.2, 95% CI 1.0-5.0), and the pyrethrins 
(OR=3.7, 95% CI 1.3-10.6), nicotine (OR=1.6, 95% CI 1.0-2.6) the organochlorines 
methoxychlor (OR=2.2, 95% CI 1.0-5.0), and DDT (OR=1.3, 95% CI 1.0-1.8).
A major limitation of the pesticide studies was the inability to evaluate specific 
groups of pesticides and leukemia subtypes due to scarcity of data. Some studies 
grouped the study population into exposed vs unexposed (Acquavella, Delzell, 
Cheng, Lynch, & Johnson, 2004; Adegoke et al., 2003), while others provided 
numeric exposure estimates based on a job-exposure matrix (Steenland, Piacitelli, 
Deddens, Fingerhut, & Chang, 1999).
In a cohort study of alachlor manufacturers, an increased risk (SMR=1165, 95% 
CI 141-4210) was observed for CML (Acquavella et al., 2004). In a population-based 
case-control study of agricultural workers, increased risk of leukemia (OR=1.2, 95% 
CI 1.0-1.5) and CLL (OR=1.4, 95% CI 1.1-1.9 was observed for farmers compared 
to non-farmers (Brown et al., 1990). Analysis of specific group of pesticides 
suggested that the risk may be restricted to specific animal insecticides (e.g. 
organophosphates, chlorinated hydrocarbons), but not herbicides, fungicides or 
crop insecticides (Brown et al., 1990). In an Italian multi-center case-control study, 
an increased risk of leukemia was observed for women exposed to nitro-derivatives 
(OR=5.6, 95% CI 1.2-29.5), dinocap (OR=8.5, 95% CI 1.7-62.7) and 
phosphoroamidon (5.4, 95% CI 1.4-30.4), and for men exposure to insecticide oils 
(OR=11.7, 95% CI 2.8-79.5) (Miligi et al., 2003). Differences in perception of the
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risk and in attitudes towards using protective equipment, different exposure patterns 
in different cultivation situations were suggested as potential explanations for sex- 
specific differences in risk estimates, though the role of chance could not be 
excluded. A recent cohort study of chemical manufacturers and pesticide sprayers in 
UK did not find any evidence of risk associated with exposure to phenoxy herbicies 
and leukemia (Coggon, Ntani, Harris, Jayakody, & Palmer, 2015).
A review of cohort studies of pesticide manufacturing workers yielded a pooled 
relative risk of leukemia (pooled-RR=1.60, 95% CI 1.02-2.52) and myeloid leukemia 
(pooled-RR=6.99, 95% CI 1.96-24.90) for ever exposure to phenoxy herbicides 
unlikely to have been contaminated with dioxins and furans (Van Maele-Fabry, 
Duhayon, Mertens, & Lison, 2008). Merhi et al. (2007) reviewed case-control studies 
of hematopoietic cancers in pesticide related occupations and observed overall 
leukemia risk (pooled-OR=1.35, 95% CI 0.91-2.0) in pesticide related occupations.
Other chemicals. Ethylene-oxide, butadiene, styrene, cadmium, polyvinyl chloride, 
and solvents are other chemicals that have been studied in relation to leukemia. A 
positive association between ethylene-oxide exposure and lymphoid leukemia was 
observed in a cohort study of ethylene-oxide workers (Stayner et al., 1993). However, 
a review based on 10 cohort studies with 29,800 workers did not show evidence of 
such association (summary SMR=1.06, 0.73-1.48) (Shore, Gardner, & Pannett, 
1993).
In an updated cohort study of US synthetic rubber industry workers, potentially 
exposed to styrene-butadiene, increased mortality due to leukemia was observed 
among a specific group of workers (polymerization, coagulation, laboratory work 
and maintenance labor) (Sathiakumar et al., 2005). The length of employment and 
time since hire also seemed to be related to the risk in that study. However, in a 
mortality cohort study of styrene exposed reinforced plastic boatbuilding industry 
workers, no excess leukemia deaths was found (Ruder, Ward, Dong, Okun, & Davis­
King, 2004).
In a cancer mortality cohort study based on the Third National Health and 
Nutrition Examination Survey (NHANES III), suggestive evidence of increased 
risks from cadmium exposure were observed (Adams, Passarelli, & Newcomb,
2011). Increased mortality due to leukemia was observed among polyvinyl chloride 
workers in Taiwan (Hsieh et al., 2011).
In a case-referent study, about 6-fold increased risk of leukemia associated with 
solvent exposure was reported (Flodin et al., 1981). Also in a Texas case-control 
study, occupational solvent exposure was statistically significantly linked to increased 
AML risk with dose response relationship in women (OR=4.18, 95% CI 2.28-7.64)
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and in men (OR=4.26, 95% CI 3.00-6.04) for medium/high exposures (Strom et al., 
2012). In a population-based case-control study in Shanghai, toluene exposure was 
associated with increased risk of adult leukemia. Dose-response relationship with 
increasing exposure duration was also observed (OR=2.9, 95% CI 1.3-6.7 for >15 
years duration, p for trend=0.02) (Adegoke et al., 2003). However, these findings for 
solvent exposure are inconsistent with findings from other studies (Clavel et al., 
1998; Lehman & Hein, 2006).
2.3.4 .3  N on-chem ica l facto rs
Two major types of non-chemical factors, which has been linked to adult leukemia 
are ionizing radiation and electromagnetic fields (EMF).
Ionizing radiation. Ionizing radiation (IRAD) carries sufficient energy to ionize 
atoms in the human body and induce chemical changes that maybe harmful for the 
functioning of cells (IARC, 2000). Until the end of nineteenth century, humans were 
exposed only to radiation from natural sources (e.g. y-radiation, a-emitting radon). 
y-radiation may originate from outer space (also known as cosmic radiation) or from 
radioactive atoms (radionuclides) present in earth. Man-made radiation was 
introduced by discovery of X-rays by Wilhelm Röntgen in 1895, and many new 
sources of radiation have been discovered since then (IARC, 2000). Man-made 
radiation has found its application in diagnostics and treatment of diseases, 
production of weapons and electricity from nuclear power plants. The general 
population can be exposed to man-made radiation as a result of fallout from facilities 
where radionuclides are used or when they are subject to the treatment and diagnosis 
involving ionizing radiation. Persons working in such facilities are occupationally 
exposed to IRAD, usually in low doses (IARC, 2000).
Effect of IRAD on leukemia has been studied extensively. High-dose radiation 
exposure has been studied in the context of Hiroshima-Nagasaki atomic bomb 
survivors and Chernobyl accident emergency and clean-up workers. In a Life Span 
Study (LSS) of atomic bomb survivors followed up from 1950 to 1990, excess 
relative risk (ERR) of leukemia per Sievert (Sv) was 4.62 (95% CI 3.28-6.40) and 
attributable risk was 53.7% (Pierce, Shimizu, Preston, Vaeth, & Mabuchi, 1996). In 
an evaluation of hematopoietic cancer incidence among Hiroshima-Nagasaki atomic 
bomb survivors during 1950-1987, about 50% of all leukemia was attributable to 
radiation (Preston et al., 1994). Both studies concluded that there was a strong 
evidence for association between IRAD and all leukemia subtypes except adult T-
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cell leukemia. Risk of radiation-induced leukemia among Chernobyl emergency 
workers of Russian cohort was similar to atomic bomb survivors (Ivanov et al.,
2012). In that study, average ERR of leukemia was 4.98 per Gray (Gr) during the 
period 1986-1997, that is about 7-10 years since the exposure onset of cohort 
members. No statistically significant risk was observed for CLL and for leukemia 
during the years 1998-2007. The main conclusion was that leukemia-induced risk 
was limited on time after exposure (Ivanov et al., 2012).
The evidence for low dose radiation exposure is less consistent than that for high 
doses. Effect of low-dose radiation on leukemia has been studied among nuclear 
industry workers, uranium miners, medical personnel, airline workers and military 
servicemen. Increased leukemia risk among radiologists and X-ray technicians 
employed during the first half of the 20th century was reported in studies of British 
(Smith & Doll, 1981) and US radiologists (Matanoski, Sartwell, Elliot, Tonascia, & 
Sternberg, 1984). Leukemia mortality was also elevated among US (RR=1.64, 0.42­
6.31) and Japanese (SMR=1.75, 1.07-2.71) radiologic technologists first employed 
before 1950 and 1960 but not later periods (Mohan et al., 2003; Yoshinaga et al., 
1999). Richardson & Wing (2007b) observed a positive association between IRAD 
and leukemia mortality in a study of Savannah River Site nuclear weapon industry 
workers. Although individual studies among nuclear industry workers by Boice et al. 
(2006) and Matanoski et al. (2008) did not produce statistically significantly increased 
risk, a combined analysis of cohorts of nuclear workers yielded a small risk elevation 
(Cardis et al., 1995; Muirhead et al., 1999). Significantly increased incidence of AML 
(SIR=5.1, 1.03-14.91) was reported among Danish male jet cockpit crew members 
flying more than 5,000 hours but not among those flying less than 5,000 hours 
(Gundestrup & Storm, 1999). Excess risk of myeloid and overall leukemia was also 
observed in studies of military servicemen exposed to atomic weapon tests (Caldwell 
et al., 1983; Darby et al., 1988). However, low-dose ionizing radiation was not linked 
to adult leukemia among medical and research laboratory personnel, workers 
handling uranium and military personnel in some recent studies (Ahn, Park & Koh, 
2008; Lie, Kjaerheim, & Tynes, 2008; Mohner, Gellissen, Marsh, & Gregoratto, 
2010). Some studies observed increased risk with borderline significance (Mohner, 
Lindtner, Otten, & Gille, 2006; Richardson, Wing, & Wolf, 2007 a).
Non-ionizing radiation. Exposure to electromagnetic fields (EMF) may occur both 
occupationally and residentially (IARC, 2002). The main sources of residential 
exposure to EMF are multiple grounded current-carrying plumbing and/or electrical 
circuits, appliances and nearby powerlines, including lines supplying electricity to 
individual homes (IARC, 2002). Exposure to EMF at workplace greatly varies across
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occupations. Floderus et al. (1993) measured EMF at 1015 different workplaces by 
using personal dosimeters and average exposure exceeding 1 micro-Tesla (pT) was 
very rare. Occupations with the highest EMF exposure included train (railroad) 
drivers, lineman, sewing machine users, logging workers, welders, electricians, power 
station operators and sheet metal workers (Floderus et al., 1993).
Occupational or residential exposure to EMF has been considered as a risk factor 
for leukemia since 1979, when association between household wiring and childhood 
leukemia was observed (Wertheimer & Leeper, 1979). Since then, there have been 
many studies of both residential and occupational exposure to EMF with highly 
inconsistent results. In an industrial cohort study, statistically significantly increased 
risk of leukemia and acute leukemia (PMR=136 and PMR=162) was observed 
(Milham, 1985). In a case-control study nested within three cohorts of electric utility 
workers (1 from France, 2 from Canada), occupational exposure to 50-60 Hertz (Hz) 
magnetic fields was significantly associated with AML (Theriault et al., 1994). In a 
Swedish case-control study, occupational but not residential exposure to magnetic 
fields (at levels >0.2 pT) has been linked to acute myeloid and chronic lymphocytic 
leukemia (Feychting, Forssen, & Floderus, 1997). These findings were further 
supported by findings for exposure to extremely low-frequency magnetic fields 
(ELF-MF) (Kheifets, Monroe, Vergara, Mezei, & Afifi, 2008; Roosli et al., 2007). 
Significantly elevated risk (HR=2.15, 95% CI 1.06-4.35) with dose-response was 
observed for AML following occupational exposure to ELF-MF in a prospective 
Netherlands Cohort Study (Koeman et al., 2014). There have also been a number of 
studies in which no evidence was observed (Floderus et al., 1993; Kheifets, London, 
& Peters, 1997; Kheifets et al., 1999; Willet, McKinney, Fear, Cartwright, & Roman, 
2003).
In summary, the current literature review suggests that evidence for a 
leukemogenic effect of occupational exposure agents is mainly inconsistent. The 
strongest evidence seems to have accumulated for benzene, while for other exposure 
agents there have been limited studies. Exposure estimation in most of previous 
studies seems to have been a major challenge. Some of these studies could not 
estimate exposure quantitatively and merely grouped subjects into exposed and 
unexposed. The quality of exposure data was variable within the studies that 
provided quantitative exposure estimates, because numeric exposure values by job 
title and employment years was limited in most of the studies. Finally, the quality of 
leukemia data across studies was also variable because diverse sources of information 
such as health insurances, deaths certificates, medical/pathology records, pension 
benefits were used.
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2.4 Exposure measurement in occupational studies
In epidemiology, the term exposure denotes any of subject’s attributes or any agent 
with which he/she may come in contact that may be relevant to his or her health 
(Armstrong, White & Saracci, 1992). The objective of exposure measurement is to 
characterize the nature, dose (amount) and temporal pattern of exposure (Armstrong 
et al., 1992). The nature of exposure variable should be as specific as possible, 
isolating components of a broader class of exposure. Dose can reflect a total 
accumulated dose (cumulative exposure), rate (e.g. number of exposure episodes per 
day), peak exposure (the highest exposure level), and average exposure (cumulative 
exposure divided by duration of exposure). The most common exposure metrics 
used in studies included in this review were cumulative exposure, average exposure, 
peak exposure, duration of exposure, and start date of exposure/employment 
(Collins et al., 2013; Glass et al., 2003; Hayes et al., 1997). According to its 
relationship to exposed subjects, exposure dose can be described as available, 
administered, absorbed, or active dose (Armstrong et al., 1992). Available dose is 
measured in the external subject’s environment. Administered dose or intake is the 
actual amount of agent coming into contact with the subject’s body. How much of 
available dose becomes administered dose, depends on subject’s physiology and 
behavior. From a biological point of view, administered dose can only be a surrogate 
for absorbed dose or uptake, which is an amount o f agent that actually enters the 
body. Absorbed dose in its turn, is a surrogate for active or biologically effective 
dose at the sites in the body (e.g. organs, tissues, cells, molecules), which are the 
specific targets of agents (Armstrong et al., 1992).
Each exposure should also be characterized as to when it first began and ended, 
and how it was distributed over time (e.g. continuous, periodic). Characterizing 
temporal patterns of exposure is essential, because duration of exposure determines 
cumulative exposure and a critical time window (etiologically relevant exposure 
period) for many diseases. Inclusion of exposures outside of critical time window 
into exposure variable may lead to misclassification of exposure (Rothman, 1981).
Exposure measurement methods range from objective measurement methods on 
human attributes or environment (e.g. blood, urine, ambient air) to methods that 
may depend on subject’s capacity to recall information or accuracy of recorded data. 
The latter is the most commonly used method in occupational studies, because 
objective measurements on past exposures are rarely available. For example, in most 
studies included in this review, exposure information was based on the work history 
of subjects. Work history information was obtained through employment records,
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labor organizations, social security administration or self-report. In some mortality 
cohort studies, exposure could not be estimated quantitatively. Instead, subjects were 
categorized to exposed and unexposed (Yin et al., 1996; Divine & Hartman, 2000; 
Huebner et al., 2004). In other studies, quantitative exposure estimates for each study 
participant were derived from work history information either by using job-exposure 
matrices (JEMs) or an occupational hygiene specialist assigned exposure values. The 
quality of exposure information was also variable within studies with quantitative 
exposure estimates. For example, in a study by Bloemen et al. (2004), data on 
ambient benzene concentrations were available for each department in a plant. In a 
study by Collins et al. (2003), such information was limited only to some 
departments. In a Chinese multi-industrial cohort, ambient air measurements were 
further categorized into various time periods (e.g. 1949-59, 1960-64, 1965-69, 1970­
74, 1975-79, 1980-84 and 1985+) to account for time variation of benzene exposure 
(Hayes et al, 1997). In an Italian multi-center case-control study, no ambient benzene 
estimates were available, and exposure estimates were assigned by industrial 
hygienists based on only work history information (Costantini et al., 2008).
Exposure measurement error is a difference between measured exposure variable 
and the true exposure. It is one of the major sources of bias in epidemiological 
studies and can lead to spurious conclusions about the relationship between 
exposure and disease (Armstrong et al., 1992). Exposure measurement error can 
result from a number of reasons including differential recollection of exposure 
history by subjects (recall bias) and data collector’s knowledge of the subject’s disease 
status (interviewer bias). Validity and reliability measures are often used as a 
benchmark for evaluation of the degree of exposure measurement error. Validity 
refers to the capacity of an exposure variable to measure the true exposure in a 
population of interest. Reliability generally refers to the reproducibility of a measure, 
that is, how consistently a measurement can be repeated on the same subjects. 
Intramethod reliability is a measure of reproducibility of an instrument, either 
applied in the same manner to the same subjects in two or more different times (test- 
retest reliability) or applied by two or more data collectors to the same subjects (inter­
rater reliability). Intermethod reliability is a measure of ability of two different 
instruments, which measure the same exposure, to yield similar results on the same 
subjects (Armstrong et al., 1992). There are various measures of reliability, and the 
choice of the measure depends on type of exposure variables (continuous or 
categorical) and study design (intramethod or intermethod reliability). The most 
common reliability measures used for continuous variables are Pearson and 
Spearman correlation coefficients, intraclass correlation coefficient (ICC), Bland-
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Altman plot, and reliability measures for categorical variables include the proportion 
of agreement (PA), Cohen’s kappa and weighted kappa. The most common validity 
measures are sensitivity and specificity.
Intermethod reliability is quite often used in occupational studies to compare 
exposure measurement instrument under the study to a more accurate method, and 
the studies of this type are sometimes also called validity or intermethod agreement 
studies (Armstrong et al., 1992). For example, validity of JEM  for estimation of 
occupational exposure to iron, lead and copper was assessed in a case-control study 
of association between neurologic disease and occupational metal exposure (Rybicki, 
Johnson, Peterson, Kortsha, & Gorell, 1997). In this study, JEM  estimates were 
compared against individual estimates derived by an industrial hygienist from the 
work history of each participant. In an Australian community-based case-control 
study of the association of medical conditions, family and reproductive history, diet 
and occupational exposures with glioma, FINJEM estimates were compared with 
estimates assigned by industrial hygiene panel (Benke et al., 2001). In a retrospective 
Netherlands Cohort Study, validity of three various JEMs (asbestos JEM, 
DOMJEM, FINJEM) was assessed for the estimation of asbestos, welding fumes 
and polycyclic aromatic hydrocarbons (PAHs) exposure by comparisons with case- 
by-case expert assessment (Offermans et al., 2012). In a study by Grajewski, Atkins, 
and Whelan (2004), self-reported flight hours were compared with airline company 
records to assess validity of self-reporting.
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3 Aims of the study
The overall aim of the current study was to examine a variation of adult leukemia by 
occupational groups, to assess associations between specific occupational agents and 
adult leukemia, and to assess a reliability of the Nordic Occupational Cancer Studies 
Job-Exposure Matrix (NOCCA-JEM). The specific aims were as follows:
1. To describe occupational variation of AML, CLL and all other non-specified 
leukemia incidences in Denmark, Finland, Iceland, Norway and Sweden 
(Study I).
2. To assess associations between solvents, ELF-MF, electrical shocks and 
electric/electronic occupations and adult leukemia in employed populations 
of Finland, Iceland, Norway and Sweden (Studies II and III).
3. To assess an agreement between NOCCA-JEM and individual dose 
measurements for estimation of occupational cosmic radiation exposure 
among the Finnish airline personnel (Study IV).
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4 Materials and methods
4.1 Study population
4.1.1 Nordic Occupational Cancer Studies (NOCCA) cohort
The Nordic Occupational Cancer Study (NOCCA) cohort was a source population 
from which individual study populations in Studies I, II and III were drawn. A 
detailed description of NOCCA cohort can be found in Pukkala et al. (2009). A 
summary of that description is provided in this chapter.
The NOCCA cohort consists o f 14.9 million persons from five Nordic countries: 
2 million from Denmark, 3.4 million from Finland, 100,000 from Iceland, 2.6 million 
from Norway and 6.8 million from Sweden.
All of these persons participated in computerized censuses, which took place in 
1990 or before in the Nordic countries. Computerized censuses occurred on 9 
November 1970 in Denmark; 31 December 1970, 1980 and 1990 in Finland; 31
January 1981 in Iceland; and 1 November 1960, 1970 and 1980 in Norway. In
Sweden the 1960, 1970 and 1990 censuses took place on 1 November and the 1980 
census on 15 September.
Information on personal identity code, name, address, marital status, education, 
economic activity, occupation, and industry was collected by means of self­
administered questionnaires for each person in NOCCA cohort during censuses. In 
Iceland, all persons born in 1964 or before had to fill out self-administered 
questionnaire personally, whereas in other Nordic countries, the heads o f 
households filled it out on behalf of all members of household and dwelling.
4.1.2 Individual study populations
The Study I was an occupational cohort study. A sampling unit in this study was a 
number of observed and expected cases of AML, CLL and all other non-specified 
leukemia types defined as “Other leukemia” in categories of:
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- country (Finland, Denmark, Iceland, Norway and Sweden)
- sex (male and female)
- occupational groups (53 groups and one group of economically inactive 
persons)
- period (9 five-year periods from 1961 to 2005)
- age (12 five-year age groups from age 30 years)
In total, 18,811 AML, 20,462 CLL and 15,570 “Other leukemia” cases diagnosed 
from 1961 to 2005 in NOCCA cohort were included into the Study I. AML cases 
were from Finland, Denmark, Iceland, Norway and Sweden. CLL and “Other 
leukemia” cases were from Finland, Iceland, Norway and Sweden. Because the 
categories of CLL and “Other leukemia” in Denmark could not be defined, the cases 
from this country were not included.
The Study II employed a case-control design nested in NOCCA cohort. It 
included all incident cases of AML that occurred between 1961 and 2005 in the 
Nordic countries. Five controls per each case were randomly selected from NOCCA 
cohort. Cases and controls were individually matched by year of birth, sex and 
country. Cases could have a previous history of any type of cancer before developing 
AML and controls could have any type of cancer other than AML. In total, 15,332 
AML cases and 76,660 controls were selected from NOCCA cohort. Out of these, 
350 cases (2.3%) and 2,155 (2.8%) controls were excluded because they were either 
younger than 20 years old or did not have any occupational record.
Study III employed the same study design as Study II. The only difference was 
that in Study III, cases and controls who did not have a previous history of any 
cancer were included. As a result, 13,435 AML cases and 67,175 controls were 
selected for this study. Because of large exposure uncertainty before the World War 
II, only those persons who started their employment career in 1945 and later periods 
were included in the main analysis. This resulted in inclusion of 5,409 AML cases 
and 27,045 controls into the main analysis.
The Study IV was an intermethod agreement study, which included all 5,022 
airline workers (1,535 cockpit crew and 3,487 cabin crew members) from Finland. 
The other occupational groups potentially exposed to cosmic radiation were miners 
and health workers (e.g. radiologists). Miners were not included because individual 
data on radiation exposure for this occupational group were limited. Health workers 
were not included because NOCCA-JEM assigns a zero value to this group due to a 
low prevalence (<10%) of radiation exposure among health workers.
The data used for Studies I through III were linkage-based. Therefore, no ethical 
statement was required for the implementation of these studies. Ethical statement
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was not also required for Study IV because direct contact with study participants was 
not needed and personal identification numbers were not used. Therefore, 
information used in Study IV could not be linked to any particular person. In 
addition, the Study IV did not deal with health outcome, but with exposure 
information. Obtaining personal consent from each study participant would be very 
laborious due to a large number of subjects, and furthermore, consent could not be 
obtained from persons who were already deceased.
4.2 Information on outcome
Information on leukemia status was obtained by linking census records of each 
study participant to cancer registries of the Nordic countries by using personal 
identity numbers. Personal identity numbers were given to all persons in Sweden in 
1947, in Iceland in 1953, in Norway in 1964, in Finland in 1967 and in Denmark in 
1968 (Pukkala et al., 2009).
Cancer registries in the Nordic countries was described in Pukkala et al. (2009) 
and summarized below. Cancer registry in Denmark is the oldest in the Nordic 
countries and was established in 1942. Notification of Danish cancer cases come 
from hospital departments, and are supplemented by reports from practicing 
specialists and autopsy reports. Cancer registry in Finland was established in 1953 
and reporting of cancer cases has been compulsory since 1961. Finnish cancer cases 
were registered based on reports from clinical and pathological departments, private 
clinics, general practitioners and death registry records. Cancer registry in Iceland 
started in 1955, and case notification was based on reports from pathology 
laboratories complemented by information from cytology and hematology 
laboratories, hospitals, health centers, and deaths certificates. Registration of cancer 
in Norway was established in 1953 and reports of cancer cases came from the same 
sources as in Finland and Iceland. In Sweden, reporting of cancer cases during the 
period 1958-1982 was based on reports from hospitals and pathologists. Private 
practitioners were required to report cancer cases since 1983. Unlike other Nordic 
countries, Sweden does not use death certificates information for cancer registry.
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4.3 Information on exposure
4.3.1 Occupational groups
Study participants are classified into more than 300 specific occupations in NOCCA 
cohort. These occupations are coded according to national adaptations o f the Nordic 
Occupational Classification (NYK) (Arbeidsdirektoratet, 1958) in Finland, Norway 
and Sweden. NYK is based on the International Standard Classification of 
Occupations (ISCO) from 1958 (ILO, 1962). The first digit of NYK code indicates 
the major occupational category, two-digit level indicates about 70 minor 
occupations and three-digit level more than 300 specific occupations (Pukkala et al., 
2009). The national NYK codes are different across the Nordic countries, however, 
the principle of coding is similar. A national adaptation of ISCO-68 (ILO, 1968) was 
used in Iceland for occupational coding, while Denmark used a special Danish 
nomenclature (Pukkala et al., 2009). Validity studies in the Nordic countries indicated 
reasonable accuracy of occupational classification based on census records (OECD, 
1997; Schmidt, 2004; Terlinden, 2005).
In the Study I, more than 300 specific occupational groups in NOCCA cohort 
were combined into 53 broader job titles and a group o f economically inactive 
persons. The definition for economic activity varied across countries. Persons who 
were gainfully employed at the time of census or were temporarily absent from work 
due to illness or military service were classified as economically active in Denmark 
and Sweden. In Finland, persons who were gainfully employed or employed at least 
half of industry’s normal working hours or were temporarily absent were classified 
as economically active. In Iceland, persons who were gainfully employed the week 
before 1981 census or temporarily absent due to vacation or illness were classified 
as economically active. In Norway, economically active persons had to be gainfully 
employed for at least 100 hours during 1970 and 1980 censuses, and for 1960 census 
they were defined based on having an occupation (Pukkala et al., 2009). 
Occupational classification was based on the first census record a person participated 
in when s/he was aged 30-64 years old. The reason for combining specific 
occupations into broader groups was to avoid small numbers o f cancer cases in 
categories o f occupation.
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4.3.2 Nordic Occupational Cancer Studies Job-Exposure Matrix
JEMs were developed for estimating occupational exposure agents in occupational 
epidemiology studies. They are commonly used when occupational history data are 
available but individual exposure estimates cannot be obtained for each study 
participant.
NOCCA-JEM was used in Studies II, III and IV to convert job titles of study 
participants to specific occupational agents. NOCCA-JEM is based on the Finnish 
job-exposure matrix (FINJEM) (Kauppinen et al., 2009). FINJEM was constructed 
for occupational epidemiology studies in Finland in 1990s (Kauppinen, Toikkanen, 
& Pukkala, 1998). It has three dimensions: agent, occupation and period. The agent­
dimension of FINJEM includes over 80 chemical, physical, microbiological, 
ergonomic and psychosocial factors. The occupation-dimension includes all 311 
occupations used for occupational classification in the Finnish census records. 
Finally, time-dimension consists of periods: 1945-59, 1960-84, 1985-94, 1995-97, 
1998-2000 and 2001-03 (Kauppinen et al., 1998). Each cell in FINJEM characterizes 
exposure agent by proportion of exposed workers (P) and mean exposure intensity 
(L). The latter is expressed as the annual mean exposure concentration during 
working-hours in workroom air. Both P and L are based on FINJEM exposure 
measurement data, which includes over 4,000 measurements based on tens of 
thousands of samples (Kauppinen et al., 1998). The minimum level of L for chemical 
agent in FINJEM is defined as occupational inhalatory level exceeding background 
levels originating from non-occupational exposure (Kauppinen et al., 1998).
Two exposure experts from Finland, two from Norway, and one from each 
Sweden, Denmark and Iceland were recruited to create NOCCA-JEM by modifying 
FINJEM (Kauppinen et al., 2009). Information on exposed occupations and 
exposure prevalence (P) in NOCCA-JEM is based on the knowledge of those 
experts and FINJEM prevalence estimates. NOCCA-JEM exposure intensity (L) was 
derived from FINJEM intensity estimates and exposure measurement data from the 
Nordic countries (Kauppinen et al., 2009).
FINJEM estimates were directly adopted for Norway, Iceland, Sweden and 
Denmark if the difference between country-specific P and L values from these 
countries was within 50% and 150% of corresponding FINJEM values (Kauppinen 
et al., 2009). Otherwise, FINJEM values had to be modified for each country. If 
prevalence of chemical agent was less than 5% and prevalence of non-chemical agent 
was less than 10% for all periods, such agents were not included in NOCCA-JEM. 
The values for non-chemical agents were available only for the period 1985-94, 
because no reliable data were available for other periods (Kauppinen et al., 2009).
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FINJEM period 1960-84 was split into two NOCCA-JEM periods because it was 
believed that exposure levels and agents may have changed in 1970s. FINJEM 
periods after 1995 was not assessed because their relevance in cancer studies may be 
small due to long latency period required for the development of cancer after 
exposure (Kauppinen et al., 2009).
Consequently, the adoption procedure resulted in a new three-dimensional matrix 
NOCCA-JEM (Kauppinen et al., 2009). NOCCA-JEM provides values for 28 
chemical and non-chemical factors. It covers 4 periods: 1945-59, 1960-74, 1975-84, 
and 1985-94 for chemical and only 1985-94 period for non-chemical agents. Finally, 
NOCCA-JEM includes 492 occupational categories for men and 447 for women in 
Denmark, 311 in Finland, 374 in Iceland, 322 in Norway, and 296 in Sweden 
(Kauppinen et al., 2009).
4.3.3 Solvent exposure
In Study II, occupational solvent exposure was estimated by linking occupational 
titles to NOCCA-JEM. Exposure estimation based on NOCCA-JEM offers various 
exposure metric options. For example, average life-time exposure can be derived 
from annual exposures (L) over entire working career and duration of exposure. It 
is also possible to estimate peak exposure by selecting the highest L value that a 
subject was exposed during working career. Such estimates are commonly used in 
studies of acute conditions. However, in studies of chronic conditions with long 
latency periods (e.g. cancer), cumulative exposure is the recommended exposure 
metric (Kauppinen et al., 2009). Cumulative exposures to solvents as well as other 
covariates were estimated by first assigning P and L values of the exposure to the 
occupation held by an individual and then multiplying it to the duration (T) during 
which individual worked in that occupation. If a given subject had more than one 
occupation during working career, it was assumed that he/she changed an 
occupation in the middle between two available census records. It was also assumed 
that working career started at the age 20 and ended at the age 65 years in this study. 
Codes for missing occupational records were imputed from the nearest available 
census records. The imputation procedure used in this study is explained in detail in 
Appendix 1.
In the analyses, cumulative exposures were categorized into background, low, 
moderate and high exposure levels. Background level corresponded to zero 
exposure, low level to exposure values between zero and 50th percentile, moderate
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level to exposure values between 50th and 90th percentile, and high level to exposure 
values above 90th percentile o f exposure distribution among exposed cases/controls.
Altogether, this procedure was repeated for the following solvents: BENZ, 
toluene (TOLU), perchloroethylene (PER), methylene chloride (MCH), 
trichloroethylene (TRI) and 1,1,1-trichloroethane (TCE) as individual solvents; and 
aliphatic and alicyclic hydrocarbon solvents (ALHC), aromatic hydrocarbon solvents 
(ARHC) and chlorinated hydrocarbon solvents (CHC) and other organic solvents 
(OSOL) as grouped solvents.
4.3.4 Extremely low-frequency magnetic fields
Occupational exposure values to ELF-MF were obtained by linking job titles of 
subjects to ELF-MF job-exposure matrix (ELF-MF JEM). ELF-MF JEM  is a 
modified version o f job-exposure matrix developed by Bowman, Touchstone, and 
Yost (2007, as cited in Koeman et al., 2013). The latter provides time-weighted 
intensity in |aT of low-frequency magnetic field exposure by occupation based on 
available measurement data. However, it does not take into account the proportion 
of exposure by job. To incorporate proportion of exposure into job-exposure matrix, 
Koeman et al. (2013) first categorized exposure intensities into background (i.e. very 
low), low and high levels by using distributional cut-off points 0.15 |aT and 0.30 |aT. 
These levels were then up- or downgraded by two industrial hygienists based on the 
estimated probability of exposure per job. The resulting levels were classified as 
background, low and high (Koeman et al., 2013).
The following exposure metrics were used for ELF-MF exposure:
1. Ever exposure to low and high levels versus background levels. Because 
some study participants changed occupation during working career, they 
could be in more than one ELF-MF exposure level. Such persons were 
grouped into their highest possible exposure level. For example, if  a person 
had a job with low ELF-MF exposure for some years and then moved to the 
one with high exposure levels, he/she was classified into high exposure level.
2. Exposure duration of ever low or high and ever high ELF-MF levels 
expressed in years. Risk associated with each 10-year increase in exposure 
duration was estimated.
3. Cumulative exposure. Weights reflecting the multiplicative nature of 
exposure distribution were assigned to each ELF-MF exposure level: 0 for 
background, 1 for low, and 4 for high levels. These weights were then
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multiplied by duration of exposure to the corresponding level. Finally, all 
multiplications were summed up for the entire working career to estimate 
cumulative ELF-MF exposure for each subject. The working career in Study 
III was assumed to start at the age 20 years and end at the age 60 years. In 
the analyses, cumulative exposure to ELF-MF was categorized into four 
levels by using tertiles of exposure distribution among exposed controls. The 
first level corresponded to zero exposures; the second level included 
exposure values between zero and the first tertile; the third level included 
values between the first and the second tertiles; and the fourth level 
corresponded to values higher than the second tertile.
BENZ, TOLU, TRI, MCH, ALHC, TCE, formaldehyde and ionizing radiation 
were used as co-factors in the Study III. All co-factors were estimated by using the 
NOCCA-JEM. The list of occupations with high levels of ELF-MF exposure in the 
NOCCA cohort is described in Table 4.
Table 4. Occupations with high level of extremely low-frequency magnetic field (ELF-MF) exposure 
and high risk of electrical shocks in the Nordic Occupational Cancer Studies (NOCCA) 
cohort.
Occupation ELF-MF Electrical shock
Airline pilots etc. + -
Assisting construction workers - +
Bench carpenters - +
Bricklayers, plasterers and tile setters - +
Building occupations - +
Cabinetmakers and joiners etc. - +
Cold- and hot-rolling metal workers + -
Concrete shutterers and finishers - +
Construction carpenters - +
Cookers and furnacemen (chemical processes) + -
Crane operators + -
Deck crew - +
Electric machine fitters (high voltage) + +
Electric machine operators + -
Electrical and electronic equipment assemblers - +
Electricians + +
Electronics and telecommunications workmen - +
Fitter-assemblers etc. - +
Forestry supervisors + -
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Occupation ELF-MF Electrical shock
Forestry workers and lumberjacks + -
Foundry workers + +
Glaziers - +
Heat treaters, hardeners, temperers etc. + -
Insulation workers - +
Lighthouse keepers - +
Machine and engine mechanics - +
Machine setter operators (not in textile industry) 
riggers
+ +
Maintenance crews and supervisors - +
Metal plating and coating work + -
Metal smelting furnacemen + -
Occupations in smelting, metallurgical and foundry 
workers
+ -
Plumbers - +
Radio and TV transmitter, other electrical work - +
Railway engine drivers, steam engine firemen + -
Reinforced concrete layers, stonemasons etc. - +
Rod layers - +
Sheet metal workers - +
Smiths + -
Stone cutters + -
Telegraphists, radio communications operators 
etc.
+ -
Telephone installation crew, linemen and cable 
jointers
- +
Welders and flame cutters + +
Wire and pipe drawers + -
Wooden boat builders, coach-body builders etc. - +
4.3.5 Electrical shock
Electrical shock exposure was estimated by linking occupational history to electrical 
shock JEM. Huss, Vermeulen, Bowman, Kheifets, & Kromhout (2013) developed 
electrical shock JEM  based on electrical injury risk by occupation in five European 
countries. In that study, electrical injury data were obtained from various registries
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in Germany, United Kingdom (UK), Austria, Switzerland and Netherlands. In 
Germany, data were obtained from Social Accident Insurance on electrical injuries 
at work for the years 2005-2008 and occupational data are based on 4-digit ISCO- 
88 classification (Standke, 2007). Electrical injury data in the UK was provided by 
the Health and Safety Executive for the years 2007-2009 and accidents were coded 
in the British Standard Occupational Classification (SOC) 2000 (Huss et al., 2013). 
This was translated to ISCO-88 by using translation available online (Lambert, 2005) 
and by hand checking the assigned occupations. Huss et al. (2013) retrieved injury 
data in Austria from the Austrian Workers’ Compensation Board database, which 
included data for the period 2005-2009. In this database, occupations were classified 
based on ISCO-08, which were translated to ISCO-88 using the correspondence 
table provided by International Labor Organization (ILO) (ILO). The Swiss 
Accident Insurance provided electrical injury data for the period 2003-2008 and 
occupations were classified according to ISCO-88. Data from Netherlands were 
from the Dutch Labor Inspectorate. This provided injury data for the years 1998­
2004, names of job titles and industry that were translated into ISCO-88 (Huss et al.,
2013). Huss et al. (2013) found minor differences in definition of electrical injury 
between the countries and most of them followed the definition of the European 
Statistics on Accidents at Work, which defines electrical injury as an accident 
resulting in at least three consecutive days of inability to work (excluding the day of 
the accident) or death (EUROSTAT). The denominator data consisted o f the 
number of workers per ISCO-88 job category and country, which was retrieved from 
the European Statistics for the year 2001 (EUROSTAT). Because the denominator 
data was in 3-digit level occupational codes, the numerator data was also collapsed 
into 3-digit level ISCO-88 occupations. Consequently, electrical injury rates and 95% 
confidence intervals were calculated by occupation for each country and year (Huss 
et al., 2013). These rates were then pooled to estimate summary rates for each 
occupation by using random effect models. The resulting rates were categorized into 
background, low and high categories by using 75th and 90th percentile values of the 
distribution of electrical injury rates as cut-points. Finally, electrical injury had to be 
reported from at least two countries in low category, and from at least three countries 
in high category (Huss et al., 2013).
Both ELF-MF JEM  and electrical shock JEM  were developed for job titles based 
on ISCO-88 classification. Because job titles in NOCCA cohort are based on NYK 
codes, ISCO-88 based ELF-MF and electrical shock JEMs had to be translated to 
NYK codes. This was achieved by using existing automated crosswalk (Van 
Tongeren et al., 2013). These translations did not lead to large inconsistencies in
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exposure values due to one-to-many and many-to-one code translations because the 
coding systems are very similar in classifications (Koeman et al., 2013).
The list of occupations with high risk of electrical shock in the NOCCA cohort 
is described in Table 4.
4.3.6 Electric and electronic occupations
In Study III, study subjects were also grouped into electric/electronic occupations 
by using two classifications used in previous epidemiological studies (Deapen & 
Henderson, 1986; Feychting, Jonsson, Pedersen, & Ahlbom, 2003).
Deapen and Henderson (1986) used electrical/electronic occupation 
classification to study the link between trauma induced by electrical shocks and 
amyotrophic lateral sclerosis. They classified occupation as electrically related if 
occupation was likely to expose the worker to electricity. This work was performed 
in consultation with an occupational medicine physician familiar with job duties. 
Occupations selected as electrically related were: electrical and electronic engineers; 
electrical and electronic engineering technicians; electricians; electrician apprentices; 
electric power linemen and cablemen; air conditioning, heating and refrigeration 
repairmen; data processing machine repairmen; household appliance and accessory 
installers and mechanics; office machine repairmen; radio and television repairmen; 
power station operators; telephone installers and repairmen; telephone linemen and 
splicers; welders and flame cutters; conductors and motormen, urban rail transit; and 
assemblers (Deapen & Henderson, 1986).
Feychting et al. (2003) studied association between occupational magnetic field 
exposure and neurodegenerative diseases. In that study, occupations defined as 
electrical/electronic were: railway engine drivers; glass, pottery, tile work; welders; 
forest workers and log-drivers; electricians; radio and television assemblers and 
repairmen; telephone and telegraph installers and repairmen.
The list of electrical and electronic occupations in the NOCCA cohort is shown 
in Table 5. Two exposure metrics were used for electric/electronic occupations: 1) 
ever versus never exposed; 2) duration of ever exposed in years.
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Table 5. Electrical/electronic occupations in the Nordic Occupational Cancer Studies (NOCCA) 
cohort.
Occupation
Classification
DM Deapen et ala M Feychting et alb
Canal, harbor and ferry watchmen + -
Electric machine fitters (high voltage) + +
Electric machine operators + +
Electrical and electronic equipment assemblers + +
Electrical engineering technicians + -
Electrical engineers + -
Electricians + +
Electronics and telecommunications workmen + +
Radio and TV transmitter, other electrical work + -
Railway engine drivers, steam engine firemen + -
Technicians in mechanical engineering + -
Telegraphists, radio communications operators etc. + +
Telephone installation crew, linemen and cable jointers + +
Welders and flame cutters + -
aDeapen DM, Henderson BE (1986) A case-control study of amyotropic lateral sclerosis. Am J Epidemiol 
123(5):790-799.
bFeychting M, Jonsson F, Pedersen NL, Ahlbom A (2003) Occupational magnetic field exposure and 
neurodegenerative disease. Epidemiol 14(4):412-419.
4.3.7 Cosmic radiation exposure
In the Study IV, reliability of NOCCA-JEM was assessed for estimation of cosmic 
radiation exposure among Finnish aircrew members by using individual dose 
estimates from STUK as a reference. STUK was established in 1958 with a task of 
inspecting radiation facilities in hospitals (STUK). Nowadays, STUK regulates the 
use of radiation in nuclear power plants, health care, industry, research and training. 
Operation of STUK is strictly controlled by the Finnish legislation and safety 
guidelines (STUK).
STUK individual dose estimates were derived from flight profile of each study 
participant. Airline companies must estimate annual cosmic radiation dose for each 
airline worker and report it to STUK (STUK, 2013). Estimation of individual cosmic 
radiation dose for airline workers has been compulsory in Finland since 2001. 
Therefore, individual dose estimates were available from 2001 to 2014. Airline
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companies currently estimate individual doses by using CARI-6 software, but in 
earlier periods European Program Package for the Calculation o f Aviation Route 
Doses (EPCARD) software was also used by some companies. CARI-6 was 
developed by the US Federal Aviation Authority (CARI-6) and is based on the LUIN 
radiation transport program (Friedberg et al., 1992; O’Brien et al., 1992). EPCARD 
was developed by Helmholtz Zentrum Munchen and approved by Civil Aviation 
Authority in Germany (Bottollier-Depois, 2012). CARI-6 and EPCARD computer 
programs calculate effective dose of cosmic radiation received by an individual 
during a flight. Effective dose is estimated as a function of flight route, aircraft type, 
altitude and latitude, and calendar period. Based on the time of the flight, programs 
take into account effect of changes in earth’s magnetic and solar activity. If flight 
information is available, programs can estimate cosmic radiation effective dose from 
earlier periods. For example, CARI-6 can estimate effective dose from January 1958 
(CARI-6). NOCCA-JEM based cosmic radiation estimates were derived by linking 
occupational information of study participants to NOCCA-JEM. The procedure was 
similar to the one that was used in Study II for estimation of solvent exposure, and 
it is described in Section 4.2.3.
Continuous and categorical dose estimates were used in Study IV. Continuous 
estimates were expressed as cumulative exposure, which was estimated as a sum of 
annual doses during the follow-up 2001-2014. Categorical doses were obtained by 
categorizing continuous estimates by using tertile based cut-points. In this study 
tertiles of NOCCA-JEM based dose estimates were used as cut-points for both 
NOCCA-JEM and STUK estimates. The resulting exposure categories were: <6 
mSv for low, 6-12 for medium and >12 mSv for high levels.
4.4 Statistical analysis
4.4.1 Descriptive statistics
Descriptive statistics included estimates o f frequencies o f study participants by 
demographic indicators and exposures o f interest (solvents in Study II; ELF-MF, 
electrical shock and electrical/electronic occupations in Study III; cosmic radiation 
exposure among Finnish aircrew members in Study IV).
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4.4.2 Standardized incidence ratios
In Study I, incidences of AML, CLL and “Other leukemia” in 53 occupational 
categories and a group of economically inactive persons were compared with 
corresponding incidences in entire national study populations. Observed number of 
AML, CLL and “Other leukemia” cases and person-years were stratified into 5-year 
age groups and 5-year calendar periods by categories of occupation, country and 
gender. Expected number of cases in each of these strata were derived from stratum- 
specific incidence rates in the entire study population and corresponding person- 
years. Standardized incidence ratios (SIR) were estimated for each occupation as a 
ratio of observed to expected number of cases, and 95% CIs by assuming Poisson 
distribution of observed cases. Analyses stratified by age groups, calendar periods, 
countries, time since first hired and duration of employment were performed to 
evaluate consistency of the main results. Poisson trend test (Breslow & Day, 1987) 
was performed to assess statistical significance of observed trends across subgroup 
levels in stratified analyses.
4.4.3 Conditional logistic regression models
Hazard ratios (HR) and 95% CIs were estimated for exposures of interest by fitting 
conditional logistic regression models in Studies II and III. Covariates were selected 
by using a “purposeful variable selection” method for categorical variables (Hosmer 
& Lemeshow, 2013). According to this procedure, several steps of variable selection 
were followed to arrive at final effect models. In the first step, each covariate was 
examined through univariate analyses and selected variables with likelihood-ratio test 
p-value less than 0.25. In the next steps, variables selected in Step 1 and clinically 
significant variables were included into multivariate analyses. Consequently, 
contribution of each variable into full model was evaluated by comparing reduced 
model (model without variable of interest) with full model by using a partial 
likelihood-ratio test. These steps resulted in the decision to include formaldehyde 
(FORM) and ionizing radiation into the final effect models as co-variates. To avoid 
multicollinearity, highly correlated variables were included into separate models. 
Using the purposeful variable selection method described, resulted in two final main 
effect models in Study II:
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1. All covariates except for ARHC were included in the final main effect 
model
(Model1=BENZ+TOLU+ALHC+TRI+TCE+MCH+PER+OSOL+IRA
D+FORM).
2. All covariates except for BENZ and TOLU were included 
(Model2=ARHC+ALHC+TRI+TCE+MCH+PER+OSOL+IRAD+FO 
RM).
Age and sex-specific stratified analyses were conducted in Study II to evaluate 
effect modification of the main results with age and sex.
The main exposures of interest in Study III were ELF-MF, electrical shock and 
electrical/electronic occupation. Final main-effect models were defined separately 
for each of these exposures. All models were adjusted for BENZ, TOLU, ALHC, 
TRI, TCE, MCH, PER, OSOL, IRAD and FORM. Adjusting variables were selected 
based on the same procedure used in Study II.
To assess the robustness of the main results, a series of sensitivity analyses were 
conducted in Studies II and III. Analyses with various exposure lag-time 
assumptions were the main sensitivity analyses. In this approach, it was assumed that 
there is a latency period between exposure and leukemia, and exposures occurring 
during this period were unlikely to have an effect on leukemia risk. Analyses with 0, 
3, 5, 7, 10, 20 years lag-time in Study II, and analyses with 0, 10 and 20 years lag-time 
in Study III were conducted. Results from analysis with 10 years lag-time in Study 
II, and from analyses with 0 years (no lag-time) in Study III were used as the main 
results.
Other sensitivity analyses included, analyses with various onset and end of 
working career (e.g. from age 20 to 65 years in Study III), estimation of exposure by 
using only average intensities (L) (Study II). Because Icelandic data included 
occupational information only from one census (1981 census), sensitivity analysis by 
excluding Icelandic data (n=684, 0.85%) was also conducted (Study III). Finally, 
analysis by excluding economically inactive persons was conducted (n=4931, 6.1%) 
(Study III).
4.4.4 Agreement indices
Spearman correlation, Bland-Altman plot and intraclass correlation coefficient (ICC) 
were used for the assessment of reliability of continuous NOCCA-JEM dose 
estimates. Bland-Altman plot illustrates differences of measurements against their
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mean (Bland & Altman, 1999). It is a more powerful graphical tool than simple 
correlation plot because it shows magnitude of difference, systematic differences and 
whether there is any trend of differences. ICC estimates proportions of total 
variation due to true differences between estimates and due to measurement error, 
and it is based on mean squares obtained by applying analysis of variance (ANOVA) 
models (Deyo, Diehr, & Patrick, 1991).
For categorical exposures, proportion of agreement (PA) and kappa statistic were 
estimated. PA was estimated by dividing a sum of frequencies in agreement cells by 
total number of observations. It provides an estimate of proportion of exact 
concordance between two measurements across all measurements (Fleiss, Levin, & 
Paik, 2003). However, it cannot take into account chance agreement between the 
measurements (Szklo & Nieto, 2014). Therefore, kappa statistic and weighted kappa 
were also estimated. Kappa statistic is a proportion of observed agreement not due 
to chance in relation to the maximum non-chance agreement (Cohen, 1960). 
Weighted kappa is used for ordered categorical data (Szklo & Nieto, 2014). It is based 
on assigning weights to different levels o f disagreement. In Study IV, medians of 
NOCCA-JEM dose categories were used as weights. Hence, the weights 
corresponded to median values of 3 mSv for low level, 9 mSv for medium, and 14 
mSv for high levels.
Subgroup analyses separately for cockpit and cabin crew members, males and 
females, persons younger and older 50 years were also conducted.
All analyses (Studies I through IV) were conducted by using R statistical software 
(various releases from 2.11 to 3.2.0).
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5 Results
5.1 Characteristics of study populations
The majority of AML and CLL cases in Study I were from Sweden (35.9% and 
57.4%) and Norway (24.7% and 21.2%). Males constituted 60.2% and females 39.8% 
of CLL cases. There were no substantial sex-specific differences for AML cases 
(51.5% males vs 48.5% females). The majority of AML (76.0%) and CLL (82.6%) 
cases were older than 60 years.
Studies II and III included all AML cases diagnosed in four Nordic countries 
between 1961 and 2005, and their matched controls. Demographic characteristics of 
study populations in Studies II and III are shown in Table 6. Removing secondary 
AML cases from dataset did not result in large differences in demographic 
characteristics of study populations in Studies II and III. The majority of cases were 
from Sweden (~45%) and Norway (~31%), a smaller proportion from Finland 
(~23%) and only less than 1% from Iceland (Table 6). In both studies, over 60% of 
AML cases were 60 years old or older at index date, and more than 85% of study 
participants were born before 1941. The proportion of male AML cases was slightly 
greater than the proportion of female cases in both studies.
Occupational solvent exposure was very rare in a study population of Study II 
(Table 7). The prevalence of low and moderate solvent exposure was less than 4% 
whereas the prevalence of high exposure levels was less than 1%. Solvent exposure 
was more common among males than females.
About 40% of subjects were ever exposed to low ELF-MF exposure levels and 
about 7% to high levels. Approximately, 18% of case/controls were at low risk and 
15% at high risk of electrical shocks at workplace. Overall less than 6% of 
participants worked in electrical/electronic occupations. Sex-specific analyses 
showed that mainly men constituted high exposure levels. There were about 12% of 
males in high ELF-MF exposure category compared to only about 1% females, and 
about 26% of men were at high risk of electrical shocks compared to only about 2% 
females. A similar pattern was observed for electrical/electronic occupations where 
about 7% of men were ever employed in electrical/electronic job compared to only 
1.5% women (Table 8).
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The study population in Study IV consisted of 1,535 cockpit and 3,487 cabin crew 
members. Over 60% of study participants were 30-50 years old and the mean age at 
the end of follow-up was 44 years old. 94.9% of cockpit crew were males and 86.7% 
of cabin crew were females. The median cumulative cosmic radiation exposure 
according to STUK was 18.5 mSv among cockpit crew members and 14.5 mSv 
among cabin crew members. The respective median NOCCA-JEM dose estimates 
were 9.0 mSv and 8.0 mSv. 61.1% of cockpit crew had cumulative individual dose 
greater than 12 mSv compared to 54.8% of cabin crew members. Individual doses 
were set to zero for 2% of study population because they had annual doses below 
0.1 mSv due to few or no flights.
Table 6. Demographic characteristics of study populations (AML cases and controls) in Studies II 
and III.
Characteristic
Study II Study III
Case Control Case Control
n % n % n % n %
Sex
male 7751 51.7 38642 51.9 6967 51.9 34835 51.9
female 7231 48.3 35863 48.1 6468 48.1 32340 48.1
Country
Finland 3484 23.3 17419 23.4 3099 23.1 15494 23.1
Iceland 109 0.7 479 0.6 114 0.8 570 0.8
Norway 4606 30.7 22928 30.8 4277 31.8 21385 31.8
Sweden 6783 45.3 33679 45.2 5945 44.3 29725 44.3
Age at indexa
20-29 139 0.9 690 0.9 163 1.2 832 1.2
30-39 458 3.1 2271 3.1 529 3.9 2612 3.9
40-49 1163 7.8 5758 7.7 1200 8.9 6018 8.9
50-59 1991 13.3 9881 13.3 1980 14.7 9902 14.7
60-69 3558 23.8 17687 23.7 3427 25.5 17188 25.5
70-79 4836 32.3 24089 32.3 4068 30.3 20281 30.3
>80 2837 18.9 14129 18.9 2068 15.4 10342 15.4
Year o f birth
<1910 3350 22.4 16682 22.4 3058 22.8 15290 22.8
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Characteristic
Study II Study III
Case Control Case Control
n % n % n % n %
1911-1920 4042 26.9 20138 27.0 3524 26.2 17620 26.2
1921-1930 3677 24.5 18293 24.6 3257 24.2 16285 24.2
1931-1940 2000 13.4 9926 13.3 1809 13.5 9045 13.5
1941-1950 1406 9.4 69.75 9.4 1310 9.8 6550 9.8
1951-1960 507 3.4 24.91 3.3 477 3.6 2385 3.6
Total 14982 100.0 74505 100.0 13435 100.0 67175 100.0
a index date is defined as a date of case diagnosis
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Table 7. Distribution of occupational solvent exposure among acute myeloid leukemia (AML) cases and controls (Study II) (ppm -  parts per million).
Agenta (ppm/year)
Male Female Total
Case Control Case Control Case Control
n % n % n % n % n % n %
Aliphatic and alicyclic hydrocarbon solvents
background 7154 92.3 35651 92.3 7138 98.7 35352 98.6 14292 95.4 71003 95.3
<17.5 320 4.1 1572 4.1 33 0.5 171 0.5 353 2.4 1743 2.3
17.5-300 227 2.9 1075 2.8 56 0.8 318 0.9 283 1.9 1393 1.9
>300 50 0.6 344 0.9 4 0.1 22 0.1 54 0.4 366 0.5
Aromatic hydrocarbon solvents
background 7237 93.4 36164 93.6 7064 97.7 34976 97.5 14301 95.5 71140 95.5
<9.3 265 3.4 1182 3.1 97 1.3 479 1.3 362 2.4 1661 2.2
9.3-275 197 2.5 1000 2.6 59 0.8 362 1.0 256 1.7 1362 1.8
>275 52 0.7 296 0.8 11 0.2 46 0.1 63 0.4 342 0.5
Benzene
background 7074 91.3 35308 91.4 7100 98.2 35147 98.0 14174 94.6 70455 94.6
<3.7 350 4.5 1513 3.9 80 1.1 486 1.4 430 2.9 1999 2.7
3.7-13.6 264 3.4 1420 3.7 46 0.6 213 0.6 310 2.1 1633 2.2
>13.6 63 0.8 401 1.0 5 0.1 17 0.0 68 0.5 418 0.6
Toluene
background 7037 90.8 35129 90.9 7149 98.9 35420 98.8 14186 94.7 70549 94.7
<42.4 366 4.7 1653 4.3 58 0.8 301 0.8 424 2.8 1954 2.6
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Agenta (ppm/year)
Male Female Total
Case Control Case Control Case Control
n % n % n % n % n % n %
42.4-612 277 3.6 1477 3.8 19 0.3 125 0.3 296 2.0 1602 2.2
>612 71 0.9 383 1.0 5 0.1 17 0.0 76 0.5 400 0.5
Trichloroethylene
background 7238 93.4 35883 92.9 7099 98.2 35144 98.0 14337 95.7 71027 95.3
<16.2 239 3.1 1400 3.6 63 0.9 360 1.0 302 2.0 1760 2.4
16.2-121 225 2.9 1115 2.9 50 0.7 258 0.7 275 1.8 1373 1.8
>121 49 0.6 244 0.6 19 0.3 101 0.3 68 0.5 345 0.5
1,1,1-trichloroethane
background 6977 90.0 34555 89.4 7109 98.3 35165 98.1 14086 94.0 69720 93.6
<5.6 489 6.3 2528 6.5 77 1.1 458 1.3 566 3.8 2986 4.0
5.6-12.7 211 2.7 1131 2.9 33 0.5 186 0.5 244 1.6 1317 1.8
>12.7 74 1.0 428 1.1 12 0.2 54 0.2 86 0.6 482 0.6
Methylene chloride
background 7180 92.6 35764 92.6 7168 99.1 35508 99.0 14348 95.8 71272 95.7
<9.9 285 3.7 1429 3.7 41 0.6 209 0.6 326 2.2 1638 2.2
9.9-64.6 228 2.9 1123 2.9 21 0.3 144 0.4 249 1.7 1267 1.7
>64.6 58 0.7 326 0.8 1 0.0 2 0.0 59 0.4 328 0.4
Perchloroethylene
background 7648 98.7 38110 98.6 7162 99.0 35446 98.8 14810 98.9 73556 98.7
<12.1 60 0.8 313 0.8 29 0.4 159 0.4 89 0.6 472 0.6
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Agenta (ppm/year)
Male Female Total
Case Control Case Control Case Control
n % n % n % n % n % n %
12.1-106 41 0.5 206 0.5 26 0.4 175 0.5 67 0.4 381 0.5
>106 2 0.0 13 0.0 14 0.2 83 0.2 16 0.1 96 0.1
Other organic solvents
background 7487 96.6 37374 96.7 7177 99.3 35596 99.3 14664 97.9 72970 97.9
<83.8 134 1.7 579 1.5 33 0.5 181 0.5 167 1.1 760 1.0
83.8-357 104 1.3 543 1.4 19 0.3 74 0.2 123 0.8 617 0.8
>357 26 0.3 146 0.4 2 0.0 12 0.0 28 0.2 158 0.2
a cut-points correspond to 50th and 90th percentile of exposure distribution among exposed cases/controls.
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Table 8. Distribution of occupational extremely low-frequency magnetic field (ELF-MF) exposure, electrical shock risk and electrical/electronic occupation 
among acute myeloid leukemia (AML) cases and controls.
Agent
Male Female Total
Cases Controls Cases Controls Cases Controls
n % n % n % n % n % n %
Total 2917 100 14585 100 2492 100 12460 100 5409 100 27045 100
Extrem ely low-frequency m agnetic fields
Ever exposed to
background levels 1475 50.6 7094 48.6 1398 56.1 6733 54.0 2873 53.1 13827 51.1
low levels 1090 37.4 5608 38.5 1075 43.1 5599 44.9 2165 40.0 11207 41.4
high levels 352 12.1 1883 12.9 19 0.8 128 1.0 371 6.9 2011 7.4
Cumulative exposure a
0 unit-years 1475 50.6 7094 48.6 1398 56.1 6733 54.0 2873 53.1 13827 51.1
1-16.2 unit-years 425 14.6 2235 15.3 566 22.7 2997 24.1 991 18.3 5232 19.3
16.2-29.9 unit-years 405 13.9 2003 13.7 366 14.7 1829 14.7 771 14.3 3832 14.2
29.9-159.9 unit-years 612 21.0 3253 22.3 162 6.5 901 7.2 774 14.3 4154 15.4
Electrical shocks
Ever exposed to
background levels 1571 53.9 7672 52.60 2055 82.5 10010 80.3 3626 67.0 17682 65.4
low levels 582 20.0 3008 20.6 398 16.0 2218 17.8 980 18.1 5226 19.3
high levels 764 26.2 3905 26.8 39 1.6 232 1.9 803 14.8 4137 15.3
Cumulative exposure a
0 unit-years 1571 53.9 7672 52.6 2055 82.5 10010 80.3 3626 67.0 17682 65.4
1-19.9 unit-years 321 11.0 1829 12.5 286 11.5 1649 13.2 607 11.20 3478 12.9
19.9-45.7 unit-years 424 14.5 2108 14.5 125 5.0 678 5.4 549 10.1 2786 10.3
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Agent
Male Female Total
Cases Controls Cases Controls Cases Controls
n % n % n % n % n % n %
45.7-159.9 unit-years 601 20.6 2976 20.4 26 1.0 123 1.0 627 11.6 3099 11.5
Electric/electronic
occupations
Ever exposed (yes vs. no) b 281 9.6 1404 9.6 37 1.5 185 1.5 318 5.9 1589 5.9
Ever exposed (yes vs. no) c 144 4.9 742 5.1 28 1.1 144 1.2 172 3.2 886 3.3
a cut-points correspond to tertiles of exposure distribution among exposed controls 
b classification based on Deapen & Henderson, 1986 
c classification based on Feychting et al, 2003
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5.2 Risk of adult leukemia by occupation
In Study I, statistically significantly increased incidences of AML were observed in 
drivers (observed cases [n]=555, SIR=1.16, 95% CI 1.07-1.26) and food workers 
(n=287, SIR=1.13, 95% CI 1.01-1.27) compared to the entire study population 
during follow-up from 1961 to 2005. The risk of CLL was elevated in clerical workers 
(n=1086, SIR=1.07, 95% CI 1.01-1.14) and farmers (n=1746, SIR=1.09, 95% CI 
1.04-1.14). The risk of ”Other leukemia” was statistically significantly increased in 
chemical process workers (SIR=1.18, 95% CI 1.01-1.38), other health workers 
(SIR=1.22, 95% CI 1.02-1.47), seamen (SIR=1.24, 95% CI 1.04-1.49) and sales 
agents (SIR=1.15, 95% CI 1.06-1.25).
In some occupational groups the risk of leukemia was significantly decreased. For 
example, the risk of AML among forestry workers (SIR=0.85, 95% CI 0.73-0.99) 
and seamen (SIR=0.79, 95% CI 0.64-0.97) was statistically significantly decreased. 
Among seamen, also the risk of CLL was decreased (SIR=0.79, 95% CI 0.65-0.96). 
The incidence of ”Other leukemia” among fishermen was significantly lower than 
the incidence in entire study population (SIR=0.68, 95% CI 0.53-0.85).
Analysis by year of first employment showed that excess risk of AML was 
restricted to drivers first hired before 1940 (SIR=1.15, 95% CI 1.00-1.33) and 
between 1940 and 1960 (SIR=1.21, 95% CI 1.08-1.35) (Table 9). AML risk was also 
restricted to sales agents (SIR=1.22, 95% CI 1.07-1.39), clerical workers (SIR=1.14, 
95% CI 1.03-1.27) and public safety workers (SIR=1.31, 95% CI 1.02-1.67) first 
hired before 1940, and to food workers (SIR=1.75, 95% CI 1.22-2.43) and building 
caretakers (SIR=1.31, 95% CI 1.04-1.63) first hired after 1960. The risk of AML risk 
significantly decreased by year of first employment for sales agents, clerical workers, 
and increasing trend for food workers and building caretakers. The risk of CLL was 
restricted to clerical workers (SIR=1.16, 95% CI 1.05-1.28), farmers (SIR=1.09, 95% 
CI 1.03-1.16) and engine operators (SIR=1.21, 95% CI 1.01-1.45) first hired before 
1940, and to teachers first hired after 1960 (SIR=1.20, 95% CI 1.01-1.43) (Table 9).
Analysis by duration of employment indicated statistically significantly increased 
AML risk among drivers (SIR=1.17, 95% CI 1.07-1.28), sales agents (SIR=1.12, 95% 
CI 1.02-1.23) and welders (SIR=1.27, 95% CI 1.01-1.59) employed for more than 30 
years (Table 10). Also excess risk of CLL among clerical workers (SIR=1.07, 95% 
CI 1.01-1.14) and farmers (SIR=1.09, 95% CI 1.04-1.14) were restricted to those 
with employment duration of more than 30 years (Table 10). The risk of AML
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among assistant nurses was restricted for duration less than 30 years with significant 
decreasing trend of the risk by duration of employment (Table 10).
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Table 9. Standardized incidence ratios (SIR) and 95% confidence intervals (95% CI) of acute myeloid leukemia (AML) and chronic
lymphocytic leukemia (CLL) by year of first employment in selected occupational categories (observed cases -  Obs; p-trend -  
p-value for Poisson trend test).
Occupation
-1940 1940-1960 1960- p-trend
Obs SIR 95% CI Obs SIR 95% CI Obs SIR 95% CI
AML
Religious workers 76 1.13 0.89-1.42 102 1.21 1.00-1.47 64 0.87 0.67-1.12 0.13
Clerical workers 353 1.14 1.03-1.27 571 1.03 0.95-1.12 203 0.95 0.83-1.09 0.04
Sales agents 234 1.22 1.07-1.39 210 1.02 0.89-1.17 66 0.93 0.72-1.18 0.02
Drivers 186 1.15 1.00-1.33 305 1.21 1.08-1.35 64 0.97 0.75-1.24 0.46
Public safety workers 67 1.31 1.02-1.67 59 0.97 0.74-1.25 22 1.04 0.65-1.58 0.17
Building caretakers 227 1.00 0.88-1.14 285 1.11 0.99-1.25 81 1.31 1.04-1.63 0.04
Food workers 104 0.95 0.78-1.15 148 1.11 0.99-1.25 35 1.75 1.22-2.43 <0.01
Textile workers 128 0.83 0.70-0.99 140 0.93 0.79-1.10 22 1.01 0.63-1.53 0.26
CLL
Clerical workers 407 1.16 1.05-1.28 505 1.03 0.94-1.12 174 1.03 0.89-1.19 0.09
Farmers 1095 1.09 1.03-1.16 589 1.07 0.99-1.16 62 1.17 0.90-1.50 0.99
Engine operators 115 1.21 1.01-1.45 116 0.87 0.73-1.04 48 1.25 0.92-1.66 0.49
Religious workers 84 0.95 0.76-1.17 120 1.20 1.00-1.44 84 1.16 0.92-1.43 0.19
Teachers 147 0.94 0.80-1.10 252 1.04 0.92-1.18 129 1.20 1.01-1.43 0.04
Plumbers 23 0.61 0.39-0.92 57 1.03 0.78-1.33 17 1.22 0.71-1.96 0.02
Seaman 44 0.80 0.58-1.08 45 0.72 0.53-0.96 14 1.11 0.61-1.86 0.60
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Table 10. Standardized incidence ratios (SIR) and 95% confidence intervals (95% CI) of acute myeloid leukemia (AML) and chronic
lymphocytic leukemia (CLL) by duration of employment in selected occupational categories (observed cases -  Obs; p-trend - 
p-value for Poisson trend test).
Occupation
<15  years 15-30 years >30 years p-trend
Obs SIR 95% CI Obs SIR 95% CI Obs SIR 95% CI
AML
Smelting workers 3 6.85 1.41-20.02 9 0.79 0.36-1.49 127 0.92 0.77-1.09 0.28
Assistant nurses 3 1.66 0.34-4.84 48 1.38 1.02-1.83 127 0.93 0.78-1.11 0.01
Clerical workers 6 0.86 0.32-1.88 147 0.93 0.79-1.09 974 1.07 1.00-1.14 0.11
Sales agents 2 1.01 0.12-3.63 44 0.84 0.61-1.13 464 1.12 1.02-1.23 0.09
Drivers 2 0.92 0.11-3.34 59 1.09 0.83-1.40 494 1.17 1.07-1.28 0.55
Welders 2 3.88 0.47-14.03 11 0.92 0.46-1.65 78 1.27 1.01-1.59 0.79
CLL
Clerical workers 1 2.10 0.05-11.70 66 1.13 0.87-1.44 1019 1.07 1.01-1.14 0.58
Farmers 0 0.00 0.00-27.48 36 1.18 0.83-1.64 1710 1.09 1.04-1.14 0.66
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5.3 Risk of adult leukemia and occupational exposure to 
solvents
There was no strong evidence for an increased risk of AML associated with 
occupational exposure to solvents in Study II. The largest risk was observed among 
workers in the highest decile of toluene exposure (1.35, 95% CI 0.74-2.46) in the 
main analysis with 10 year lag-time. The HR estimate for toluene remained elevated 
also in analyses with other lag-time assumptions, and the highest estimate was 
observed in analysis with no lag-time (1.86, 95% CI 1.06-3.28).
Among other solvents, ARHC (1.18, 95% CI 0.76-1.86) and trichloroethylene 
(1.12, 95% CI 0.83-1.49) had small non-significantly increased hazard ratios. The 
overall AML risk associated with benzene exposure was not elevated in Study II. 
However, there was some indication of increased risk among women (2.02, 95% CI 
0.58-7.04) and persons younger 50 years old (2.24, 95% CI 0.99-5.08) for the highest 
decile of benzene exposure.
In general, HR estimates were the highest in the analyses with short lag-time (e.g. 
3, 5 and 10 years) (Appendix 2) and tended to decrease towards null in the analyses 
with 15 or 20 year lag-time. Sex- and age-specific differences in HR estimates were 
observed for some solvents. However, none of sex- and age-specific association 
between solvent exposure and AML was statistically significant.
5.4 Risk of adult leukemia and occupational exposure to low- 
frequency magnetic field and electrical shock
There was no evidence for an association between occupational ELF-MF exposure, 
electrical shock and AML in Study III. The HR estimate for ever exposure to high 
levels of ELF-MF was 0.88 (95% CI 0.77-1.01), high risk of electrical shock was 0.94 
(95% CI 0.85-1.05).
The HR for “ever working in electrical/electronical occupation” based on 
Deapen and Henderson (1986) classification was 1.02 (95% CI 0.88-1.17) and based 
on Feychting et al. (2003) classification was 0.98 (95% CI 0.81-1.18).
The main results of this study were not sensitive to various lag-time assumptions 
(Appendix 3), exclusion of Iceland and economically inactive persons from the 
analyses or inclusion of subjects who started employment career before 1945.
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5.5 Agreement between NOCCA-JEM and individual dose 
measurements for estimation of occupational cosmic 
radiation exposure among Finnish airline personnel
A strong positive relationship between continuous STUK and NOCCA-JEM dose 
estimates was observed (Spearman correlation; rho=0.90; 95% CI 0.89-0.91) (Figure 
5). However, a normal curve fitted to the data was systematically different from the 
line o f equality. The latter shows where the normal curve would be if  two 
measurements would have perfectly matched. The ICC was low (0.37, 95% CI 0.01­
0.61). The Bland-Altman plot showed that mean difference between STUK and 
NOCCA-JEM was -9.3 mSv (95% CI [-9.6]-[-9.6]) and the negative sign of the 
estimate indicated underestimation. The upper limit of agreement was 10.1 (95% CI 
9.6-10.6) and the lower limit of agreement was -28.7 (95% CI [-29.1]-[-28.2]). 
NOCCA-JEM tended to underestimate individual dose estimates higher than about 
20 mSv and overestimate very small values.
Analyses of categorical data showed that PA was 64% (95% CI 62%-65%). The 
kappa statistics was 0.46 (95% CI 0.44-0.48) and weighted kappa was 0.43 (95% CI 
0.42-0.44). Figure 6 demonstrates ranking of measurements into low, medium and 
high categories by NOCCA-JEM and STUK. The shaded areas correspond to 
agreement and non-shaded to disagreement cells. There are many observations in 
disagreement cells (Figure 6).
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Figure 5. Scatter plot of ionizing radiation exposure estimates by the Nordic Occupational Cancer 
Studies Job-Exposure Matrix (No Cc A-JEM) and STUK-Radiation and Nuclear Safety 
Authority, Finland (mSv -  millisievert; p -  Spearman correlation coefficient).
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Figure 6. Distribution of ionizing radiation exposure by dose categories estimated by the Nordic 
Occupational Cancer Studies Job-Exposure Matrix (NOCCA-JEM) and STUK-Radiation 
and Nuclear Safety Authority, Finland (mSv -  millisievert; shaded areas correspond to 
agreement cells; dose categories are: <6 mSv, 6-12 mSv, >12 mSv).
96
6 Discussion
6.1 Summary of the ' "  " v
The findings from this study supports previous evidence that adult leukemia risk 
may be associated with specific occupational categories such as drivers, food 
workers, sales agents, clerical workers, welders, building caretakers, engine operators 
and farmers. It appeared that leukemia risk in some occupational categories was 
limited to particular years of the first employment and duration of employment.
Another finding of this study is a lack of association between occupational 
exposure to solvents, ELF-MF and electrical shock and working electric/electronic 
occupations and leukemia in workers. Surprisingly, this study did not demonstrate 
an elevated risk for occupational benzene exposure, which is a widely accepted risk 
factor of leukemia.
Accurate exposure estimation is a prerequisite for achievement of valid results in 
epidemiological studies. Therefore, assessment of reliability of NOCCA-JEM for 
occupational cosmic radiation exposure measurement was an essential complement 
to the current research study. Our findings indicated that NOCCA-JEM had 
substantial disagreement with individual dose measurements for estimation of 
cosmic radiation exposure among Finnish aircrew members.
6.2 Limitations of the study
In Study I, over 300 specific job titles were combined into broader 53 occupational 
categories and a group of economically inactive persons to allow for sufficient 
number of observed and expected cases. However, this approach could have reduced 
specificity of the study. In addition, occupations for each study participant were 
classified based on a single census (the first census during which subject was 30 years 
or older) ignoring potential change of job during employment career.
Despite advantages of NOCCA-JEM, its application is limited by potential 
exposure misclassification. Exposure misclassification is inherent to all JEMs
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because exposure prevalence is rarely 100% and there is usually an exposure variation 
in an occupation (Kauppinen et al., 2009). However, JEMs cannot account for such 
variation of exposure and assign a group average estimate to all persons within an 
occupational category (Siemiatycki, 1996; Teschke et al., 2002). Assigning group 
averages instead of true values to all workers may lead to Berkson error, which 
reduces the power of the study, but does not dilute the risk estimates (Armstrong, 
1998). Berkson error can make it more likely that true associations are not detected 
(Armstrong, 1998). The Study IV suggested that NOCCA-JEM is unlikely to 
introduce Berkson error for cosmic radiation because average estimate assigned by 
the NOCCA-JEM was different from true average estimates among cockpit and 
cabin crew members. However, analysis of categorical exposure in Study IV 
suggested that using NOCCA-JEM for deriving categorical cosmic radiation 
exposure may lead to exposure misclassification. In Studies II & III, misclassification 
of continuous cumulative exposures was not related to disease status of study 
participants because the same exposure measurement method (NOCCA-JEM) was 
applied to both cases and controls. This suggests that exposure misclassification of 
cumulative exposures in Studies II & III was likely to be non-differential. According 
to a commonly used overly simplistic approach that non-differential misclassification 
always leads to a bias towards the null, one would argue that the true risk estimates 
were likely to be stronger than those observed in Studies II & III. This could be true 
for dichotomous exposure variables. However, exposure variables in Studies II & 
III were multilevel ordinal variables created by categorizing continuous cumulative 
exposures. Non-differential misclassification of ordinal multilevel exposures does 
not necessarily attenuate positive risk estimates towards the null. The direction and 
magnitude of such bias depends on level of risk, exposure distribution, and 
misclassification rate (Birkett, 1992; Brenner, 1992; Correa-Villasenor, Stewart, 
Franco-Marina, & Seacat, 1995; Dosemeci, Wacholder, & Lubin, 1990; Rosner, 1996; 
Weinberg, Umbach, & Greenland, 1994). When exposure variables have three levels, 
non-differential exposure can bias risk estimates away from null only in the middle 
exposure category (Correa-Villasenor et al., 1995). The upward bias in the middle 
exposure level can occur when misclassification rate is small in the reference category 
(e.g. low level), and it is moderate to high in middle and high exposure categories, 
and the risk increases with true exposure. When misclassification rate is too high in 
non-adjacent exposure levels, a crossover bias can occur in middle and high exposure 
levels (Correa-Villasenor et al., 1995). In this circumstance, a detrimental risk 
(OR>1) will appear to be protective (OR<1), and conversely, a true protective risk 
will appear to be detrimental. Furthermore, depending on the shape o f exposure
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distribution, categorization of continuous exposures with non-differential 
measurement error into multilevel ordinal exposure variables can produce 
differential misclassification in ordinal exposure variables (Delpizzo & Borghesi, 
1995; Flegal, Keyl, & Nieto, 1991). Therefore, exposure misclassification of 
multilevel ordinal exposure variables in Studies II & III could even be differential.
Another potential source of exposure misclassification in this study is related to 
limited job history data. Job history of study participants was available only from 
1970, 1980 and 1990 censuses in Finland; 1981 census in Iceland; 1960, 1970 and 
1980 censuses in Norway; and 1960, 1970, 1980 and 1990 censuses in Sweden. 
Annual job histories for the entire employment career were imputed from these 
census records by assuming that subjects changed their occupation in the middle 
between two censuses. This assumption was probably the weakest for Iceland 
because annual job history data in this country was imputed from a single census 
record for the entire working career. However, the Icelandic part of the data 
constituted only a small proportion of all study participants (<1%). Therefore, 
inaccuracies in job histories from Iceland did not affect overall risk estimates. This 
was evident in sensitivity analysis in Study III, when the main results did not change 
after exclusion of Icelandic data from analysis. This assumption may not hold true 
also for persons with high occupational mobility. However, earlier studies indicated 
a low percentage of occupational mobility in Nordic countries. In a study analyzing 
occupational mobility in Finland, 85% of male and female employees worked in the 
same occupation in 1975 and 1980 (Kolari, 1989). The comparison was also made 
between 1980 and 1985 census records in the same study, and very stable labor 
market in Finland was demonstrated. Pukkala et al. (2009) estimated occupational 
stability proportion of subjects in the NOCCA cohort and observed higher stability 
among men than women, and in occupational categories where a long education was 
required. This evidence suggests that our results are unlikely to be biased by limited 
job history information.
A low prevalence of exposures in a study population was also a shortcoming in 
this study. Because most of the exposures of interest in the study population were 
very rare, it was impossible to define high exposure levels including only truly high 
exposures. Any attempt to do so resulted in very small number of exposed persons 
in the high category. Therefore, percentile-based cut-points were used for 
categorization to avoid small numbers. The main limitation of this approach is that 
the highest category included cumulative exposures with large differences in 
magnitude. Figure 7 shows a distribution of cumulative benzene and ionizing 
radiation exposures among exposed cases and controls in AML data with percentile-
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based categorization options. The distribution for both benzene and ionizing 
radiation is highly positively skewed with majority of exposed persons having small 
exposures. Vertical dashed-dot lines correspond to tertile cut-points, and dashed 
lines to 50th and 90th percentile cut-points o f exposure distribution among exposed 
subjects. When the second tertile is used as a cut-point for high exposure category, 
the values for benzene range from 7.3 ppm to 42.9 ppm, and for ionizing radiation 
from 4.9 mSv to 28.4 mSv in the highest category. A difference between minimum 
and maximum values included in the category is about 6-fold. When 90th percentile 
is used as a cut-point for high exposure category, the values for benzene range from 
13.6 ppm to 42.9 ppm, and for ionizing radiation from 12.5 mSv to 28.4 mSv. In this 
case, a difference is about 2-3 fold. Therefore, by using percentiles as cut-points for 
exposure levels, it is implicitly assumed that exposure values with such large 
differences have identical effects on leukemia risk (Bennette & Vickers, 2012).
Family history of leukemia, smoking and other life-style related factors could not 
be controlled for in Studies I through III, because there was no data on these factors. 
Although potential confounding effect of these factors on the risk estimates cannot 
be excluded, it is unlikely these are strong confounders.
Finally, reliability of NOCCA-JEM was assessed only for cosmic radiation 
because there were no individual estimates for other occupational exposures. In 
addition, radiation estimates were available only for the period 2001-2014 and not 
for entire working career o f study participants. This limits generalization o f 
agreement estimates found in Study IV.
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Figure 7. Distribution of cumulative benzene and ionizing radiation exposure among exposed acute 
myeloid leukemia (AML) cases and their matched controls (ppm -  parts per million; mSv -  
millisievert).
6.3 Strengths of the study
One of the main advantages that NOCCA studies offer is completeness and accuracy 
of cancer incidence data. Cancer registries in the Nordic countries are famous for 
their accurate cancer registration (Pukkala, 2009). Several studies indicated high- 
quality coverage of cancer incidence in Denmark since 1943. For example, 
comparison between hospital discharge and Danish Cancer Society data in 1977 
showed that 95% of cancer cases were registered in both sources (Osterlind & 
Jensen, 1985). Cancer incidence registration was moved from Danish Cancer Society 
to the National Board of Health in 1997. This was done to make cancer registration 
procedure electronically and part of other national registration. Eventually, this 
resulted in considerable delays of both cancer incidence and mortality registration 
and the newest available data in 2008 was a data from 2003. The impact of this
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change on accuracy of cancer registration in Denmark is unknown (Pukkala et al., 
2009).
A study comparing cancer registry data with Economic and Medical Information 
system conducted in 1976 showed 98% completeness of cancer registration in 
Norway (Lund, 1981). There was a small underreporting of cancer cases mainly for 
leukemia and multiple myeloma. 86.5% of all cancer cases registered in Norway since 
1953 are histologically verified and only 1.3% of cancer cases are based on death 
certificate alone (Larsen, Smastuen, Parkin, & Bray, 2007).
In a linkage study, a Finnish cancer registry data was compared to the national 
hospital discharge records for the period 1985-1988. This study demonstrated 99% 
completeness of the Finnish cancer registry and about 10% underreporting were for 
neoplasms of central nervous system, CLL and multiple myeloma (Teppo, Pukkala, 
& Lehtonen, 1994). The main reason for underreporting was a slow reporting of 
newly diagnosed cancer cases. Most of these cases were later reported via the normal 
registration procedure (Teppo et al., 1994). Slowness of reporting was also observed 
in other Nordic countries (Storm, Manders, Sporgel, Bang, & Jensen, 1990; 
Vidarsdottir, Stefansdottir, Jonsdottir, Jonasson, & Tryggvadottir, 2008).
A recent linkage o f hospital discharge information with Icelandic cancer registry 
indicated 99% completeness of cancer registry data in Iceland (Vidarsdottir et al., 
2008).
The difference between the Swedish cancer registry and registries o f other Nordic 
countries is that death certificates have not been used as a source of data in Sweden 
(Pukkala et al., 2009). Validation studies linking deaths certificates with Swedish 
cancer registry showed a maximum o f 4.5% underreporting mainly for prostate 
cancer, stomach cancer, myeloma and leukemia (Barlow, Westergen, Holmberg & 
Talback, 2009; Mattson, 1984). The small underreporting of leukemia cases in some 
Nordic cancer registries is unlikely to bias the results in the current study because 
this underreporting is not related to occupation (Pukkala et al., 2009). If 
underreporting was related to occupation, then selection bias could occur.
Another advantage o f the current study is that personal identity numbers were 
used to link information from various sources (census records, cancer registry, and 
population registry). This ensured complete ascertainment o f relevant events for 
each study participant (Pukkala et al., 2009). If needed, additional information from 
many other sources can also be obtained for study participants through linkage by 
using identity numbers.
Numeric exposure estimates for more than twenty chemical and non-chemical 
occupational factors was possible to generate by using NOCCA-JEM. This was an
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advantage over studies categorizing subjects merely into exposed and unexposed. In 
addition, NOCCA-JEM has an advantage over JEMs, which are based on 
questionnaire data. It is because exposure estimates in NOCCA-JEM are derived 
from individual measurement data, and NOCCA-JEM provides estimates for more 
than 300 specific occupations.
Finally, this study was the first to provide direct evidence for reliability of 
NOCCA-JEM through comparison with individual dose estimates from STUK. 
Individual dose estimates from STUK registry were estimated by using CARI-6 and 
EPCARD software, which are among the best available methods for calculation of 
effective dose. A validation study comparing CARI-6 effective dose estimates with 
in-flight dosimeter measurements of ambient dose equivalent demonstrated an 
excellent agreement between two methods (O’Brien et al., 2003). Another validation 
study showed better than ±20% agreement for EPCARD compared with measured 
doses (Lindborg et al., 2004).
6.4 Comparison with findings from previous studies
The occupational category of food workers in the Study I included cannery workers, 
butchers and sausage makers, dairy makers, processed food workers among others. 
Therefore, our results for food workers can be compared to results for meat industry 
workers from previous studies. Observed AML risk among food workers in this 
study is consistent with but considerably smaller than risk estimates observed in 
Bethwaite et al. (2001) and Fritschi et al. (2002). Our findings for drivers are 
consistent with but also smaller than findings from study of the Finnish workers 
exposed to diesel or gasoline engine exhaust (Guo et al., 2004), which were followed- 
up from 1971 to 1995. Guo et al. (2004) observed increased leukemia risk (SIR=1.29, 
1.02-1.60) for Finnish male truck drivers, but not for bus, taxi and motor 
vehicle/tram drivers. Observed excess CLL risk among farmers in this study is 
consistent with but considerably smaller than findings for farmers in Ireland 
(SIR=1.88, 1.34-2.56) (Kelleher et al., 1998) and animal breeding farmers (OR=3.05, 
1.12-8.32) in Italy (Amadori et al., 1995). Observed reduced leukemia risk among 
forestry workers, seamen and fishermen in this study is consistent with previous 
studies showing reduced risk for some specific occupational groups (Band et al., 
1996; Fu et al., 1996; Raabe et al., 1998). The literature review in this study did not 
yield an evidence in support of CLL risk among clerical workers. As opposed to 
previous studies (Band et al., 1996; Costantini et al., 2001; Robinson et al., 2015; 
Wong et al., 2010; Yoshinaga et al., 1999), this study did not show positive
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associations between adult leukemia and printers, painters, shoe and leather workers, 
electrical workers and mechanics, despite workers in these occupations maybe 
exposed to high benzene exposure levels. One explanation for the lack of association 
and observed smaller associations in the Study I is that relatively broad occupational 
categories were used, which probably included both exposed and unexposed 
persons. If the incidence rate among unexposed members of occupational category 
was lower than that in general population, and rates for exposed persons were higher, 
these rates would cancel each other out when averaged over the occupational 
category (Breslow & Day, 1987). Another potential explanation is that we cannot 
completely exclude the healthy worker effect because expected cases were derived 
from population which included large proportion (~26% in leukemia data) of 
economically inactive persons. Those who have been in active employment for many 
years were more likely to have a better health than economically inactive persons. 
Finally, observed increased risk restricted to particular period of first employment is 
consistent with a number of previous studies (Fu et al., 1996; Raabe et al., 1998; 
Straif et al., 1998).
The Study II did not demonstrate clear evidence for an association between 
occupational solvent exposure and AML. The highest risk estimate was observed for 
toluene exposure, which was statistically non-significant in the main analysis (10 year 
lag-time analysis). However, the risk for toluene was statistically significantly 
increased (HR=1.86, 95% CI 1.06-3.28) in a sensitivity analysis (no lag-time analysis). 
This finding is consistent with but smaller than the risk estimate for toluene 
(OR=2.6, 1.0-6.9) from a population-based case-control study in Shanghai (Adegoke 
et al., 2003). Our results did not indicate any evidence for benzene exposure. This is 
consistent with results from Italian multi-center case-control study (Constantini et 
al., 2008) and Australian, UK and Canadian petroleum workers study (Schnatter et 
al., 2012), but contrasts a strong positive relationship observed in previous individual 
studies and meta-analyses (Adegoke et al., 2003; Divine & Hartman, 2000; Guenel 
et al., 2002; Hayes et al., 1997; Vlaanderen et al., 2011; Vlaanderen et al., 2012).
Occupational exposure to ELF-MF, electrical shock and working in 
electric/electronic occupation was not associated with increased risk of AML in this 
study. In general, there is weak evidence for association between ELF-MF and AML. 
In a meta-analysis by Kheifets et al. (2008), a small increased meta-relative risk was 
observed for AML. This risk estimate was based on mainly older studies, while the 
recent studies demonstrated a marginal increase of AML risk. Koeman et al. (2014) 
observed a modest increased risk of AML in a prospective Netherlands Cohort 
Study. In that study, ELF-MF exposure was estimated using the same JEM  as was
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used in our Study III. To our knowledge, our study was the first to assess the 
association between electrical shock and AML.
The Study IV is consistent with previous studies assessing accuracy of JEM  in 
estimation of various occupational exposures. For example, in a study by Rybicki et 
al. (1997), low sensitivity (21% for copper, 0% for lead and 16% for iron) was 
observed for JEM  in estimation of exposure values of three metals. In addition, this 
study demonstrated a substantial bias (greater than 50% towards null) of true OR 
estimates by JEM  (Rybicki et al., 1997). Only a poor to fair agreement (kappa=0.07 
for formaldehyde, 0.33 for lead, 0.46 for insecticides, 0.12 for aromatic 
hydrocarbons, 0.28 for chlorinated hydrocarbons) was observed between FINJEM 
and industrial hygiene panel in an Australian community-based case-control study 
(Benke et al., 2001). In a retrospective Netherlands Cohort Study by Offermans et 
al. (2012), weighted kappa for estimation of asbestos exposure for asbestos JEM  was 
0.10 (95% CI 0.05-0.13), for DOMJEM was 0.29 (95% CI 0.23-0.32) and for 
FINJEM was 0.23 (95% CI 0.19-0.29). The highest weighted kappa (95% CI 0.70 
[0.65-0.74]) was observed for FINJEM for estimation of welding fumes (Offermans 
et al., 2012). There is however, indirect evidence for validity of FINJEM. In a study 
of occupational silica dust exposure, FINJEM was able to replicate a known 
association with dose-response relationship between silica dust and lung cancer 
(Pukkala et al., 2005).
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7 Summary and conclusions
In conclusion, this population-based epidemiological study showed that adult 
leukemia incidence in some occupational categories is statistically significantly higher 
than the incidence in general populations of Nordic countries. For some of these 
occupations, increased leukemia risk may be linked to specific occupational 
exposures. For example, food workers include wide range of specific occupations, 
which are potentially exposed to benzene, solvents and infectious agents from animal 
populations. Drivers are occupationally exposed to gasoline and diesel exhaust 
fumes. Increased risk of CLL among farmers might be related to either pesticides, 
which are commonly used in this occupational category, or infectious agents that can 
be transmitted to humans from animal populations. We are not aware of any 
occupational exposures as potential leukemia risk factors for categories of clerical 
workers and sales agents. Restriction of leukemia risk in particular time periods of 
first employment maybe related to higher exposure levels during that period.
This study did not provide clear evidence of an increased leukemia risk for 
occupational exposure to solvents, ELF-MF and electrical shocks and working in 
electric/electronic occupations. There was no increased risk also for benzene 
exposure, which is a widely accepted leukemia risk factor. Some explanations for the 
lack of association for benzene exposure are potential exposure misclassification by 
NOCCA-JEM, and low prevalence of high benzene exposures in the study 
population. There was some variation of risk estimates by sex and age. This may 
reflect either a true risk variation in these subgroups or maybe simply due to chance.
The reliability study of NOCCA-JEM for cosmic radiation exposure 
demonstrated substantial disagreement with individual level exposure data. This 
suggests that NOCCA-JEM may lead to substantial exposure measurement error 
and misclassification in studies of occupational cosmic radiation exposure. Studies 
conducted in Australia and Netherlands (Benke et al., 2001; Offermans et al., 2012) 
indicated poor to moderate validity of FINJEM for estimation of lead, asbestos, 
welding fumes, aromatic hydrocarbons, chlorinated hydrocarbons and insecticides. 
These results are apparently true also for NOCCA-JEM, because NOCCA-JEM 
estimates were mainly derived from FINJEM estimates (Kauppinen et al., 2009). 
However, generalization of these results to Nordic setting maybe limited because
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these studies were based on data from Australia and Netherlands (Benke et al., 2001; 
Offermans et al., 2012). There is also an indirect evidence of FINJEM validity 
suggesting that it is quite accurate in estimating some specific exposure agents. For 
example, FINJEM was able to replicate a known association and exposure-response 
relationship between silica dust exposure and lung cancer (Pukkala et al., 2005). 
Further studies based on the Nordic data are needed to assess reliability of NOCCA- 
JEM  for estimation of other specific occupational agents.
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10 Appendix 1. Imputation of missing job history data
A figure below is based on AML data used in Study III. It shows proportions of 
missing job history data during census years 1960, 1970, 1980 and 1990. The largest 
missing job history was observed for censuses in 1960 (24.4%) and in 1990 (27.1%), 
whereas it was less than 3% for the remaining censuses (Figure 8). Dark blue areas 
of bars indicate proportions of missing job history due to unavailable censuses. For 
example, 90.7% of missing job history during 1960 census was because the whole 
census was not available for Finland and Iceland in 1960, and 88.9% of missing job 
history in 1990 was because there were no census records at all for Norway and 
Iceland in 1990. In 1970, census records were not available only for Iceland.
30.0
25.0
20.0
15.0
10.0 
5.0 
0.0
ocode60 ocode70 ocode80 ocode90
■ unavailable census (%) ■ unknown data (%)
Figure 8. Missing job history in Study III (ocode60 -  occupational code in 1960 census; ocode70 -  
occupational code in 1970 census; ocode80 -  occupational code in 1980 census; ocode90 
-  occupational code in 1990 census; dark blue area corresponds to missing values due to 
unavailable census and light blue cells to missing values due to unknown data).
Occupational codes for missing years were imputed based on the nearest available 
census years by assuming that a person changed occupation in the middle between
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available census records. The earliest possible exposure start in the Study III was on 
01.01.1945 and the latest exposure end was on 31.12.2005. Therefore, all imputations 
of missing occupational codes were made between these dates. Imputations of job 
history data for each possible combination of missing occupational codes is 
presented in the table below. Cells with “plus” sign indicate available occupational 
code and “minus” sign unavailable code.
Occupational code
Imputation of missing codes
1960 1970 1980 1990
- - - + ocode90 1945-2005
+ - - + ocode60 1945-1974; ocode90 1975-2005
+ - - - ocode60 1945-2005
- + - - ocode70 1945-2005
- - + - ocode80 1945-2005
+ - + - ocode60 1945-1969; ocode80 1970-2005
- + + - ocode70 1945-1974; ocode80 1975-2005
+ + - - ocode60 1945-1964; ocode70 1965-2005
- - + + ocode80 1945-1984; ocode90 1985-2005
- + - + ocode70 1945-1979; ocode90 1980-2005
+ - + +
ocode60 1945-1969; ocode80 1970-1984; 
ocode90 1985-2005
+ + - +
ocode60 1945-1964; ocode70 1965-1979; 
ocode90 1980-2005
+ + + -
ocode60 1945-1964; ocode70 1965-1974; 
ocode80 1975-2005
- + + +
ocode70 1945-1974; ocode80 1975-1984; 
ocode90 1985-2015
+ + + +
ocode60 1945-1964; ocode70 1965-1974; 
ocode80 1975-1984; ocode90 1985-2005
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11 Appendix 2. Analyses with 0 and 5 years lag-time in Study II.
Table 11. Hazard ratios (HR) and 95% confidence intervals (95% CI) of acute myeloid leukemia associated with exposure to solvents and other co-factors. 
[ppm-parts per million]
Agent a (ppm/year)
0 years lag-time 5 years lag-time
Cases Controls HR 95% CI p for trend Cases Controls HR 95% CI p for trend
Aliphatic and alicyclic hydrocarbon 
solvents
<17.5 348 1739 0.89 0.70-1.15
0.75
364 1738 0.97 0.76-1.24
0.83
17.5-300 310 1522 0.98 0.75-1.27 293 1470 0.94 0.72-1.23
>300 65 430 0.56 0.33-0.93 60 402 0.57 0.34-0.97
Aromatic hydrocarbon so lventsb
<9.3 368 1711 1.12 0.95-1.30
0.53
371 1694 1.14 0.98-1.33
0.42
9.3-275 251 1391 0.89 0.74-1.09 256 1384 0.92 0.76-1.12
>275 94 457 1.13 0.78-1.63 81 406 1.20 0.81-1.78
Benzene
<3.7 453 2122 1.07 0.88-1.29
0.34
454 2077 1.03 0.85-1.25
0.47
3.7-13.6 316 1645 0.91 0.73-1.13 309 1634 0.86 0.69-1.07
>13.6 77 459 0.81 0.57-1.13 75 451 0.85 0.59-1.19
Toluene
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Agent a (ppm/year)
0 years lag-time 5 years lag-time
Cases Controls HR 95% CI p for trend Cases Controls HR 95% CI p for trend
<42.4 434 2055 1.11 0.90-1.37
0.49
439 2009 1.16 0.94-1.44
0.62
42.4-612 316 1669 1.06 0.83-1.35 309 1645 1.06 0.83-1.36
>612 86 433 1.86 1.05-3.26 80 423 1.53 0.84-2.77
Trichloroethylene
<16.2 310 1889 0.91 0.77-1.08
0.10
322 1839 0.99 0.84-1.17
0.17
16.2-121 293 1450 1.10 0.93-1.31 281 1408 1.10 0.93-1.31
>121 69 365 1.06 0.79-1.42 69 359 1.08 0.80-1.44
1,1,1-trichloroethane
<5.6 557 2886 0.92 0.79-1.08
0.59
580 2932 0.92 0.79-1.08
0.61
5.6-12.7 278 1636 0.79 0.66-0.96 264 1531 0.76 0.63-0.93
>12.7 138 697 0.91 0.71-1.15 111 592 0.84 0.65-1.08
Methylene chloride
<9.9 296 1430 1.20 0.97-1.48
0.47
301 1433 1.14 0.92-1.40
0.46
9.9-64.6 331 1692 1.09 0.88-1.35 313 1597 1.10 0.89-1.37
>64.6 63 362 0.88 0.49-1.57 62 349 1.08 0.58-1.99
Perchloroethylene
<12.1 85 514 0.90 0.69-1.17
0.39
86 501 0.89 0.69-1.16
0.35
12.1-106 76 381 0.98 0.74-1.30 75 380 0.97 0.73-1.29
>106 18 124 0.69 0.38-1.24 18 111 0.79 0.44-1.45
Other organic solvents
<83.8 158 774 0.99 0.81-1.19
0.51
163 765 1.06 0.87-1.28
0.5283.8-357 134 651 0.91 0.69-1.21 130 627 1.00 0.75-1.34
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Agent a (ppm/year)
0 years lag-time 5 years lag-time
Cases Controls HR 95% CI p for trend Cases Controls HR 95% CI p for trend
>357 37 212 0.95 0.57-1.57 31 198 0.87 0.51-1.49
a Occupationally unexposed individuals were used as a reference group in all analyses. 
b HR estimates for aromatic hydrocarbon solvents are from Model 2, all other HR are from Model 1.
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12 Appendix 3. Analyses with 5 and 10 years lag-time in Study III.
Table 12. Hazard ratios (HR) and 95% confidence intervals (95% CIs) of occupational exposure to low-frequency magnetic fields and acute myeloid 
leukemia.
Agent
5 years lag-time 10 years lag-time
Cases Controls HR 95% CI p for trend Cases Controls HR 95% CI p for trend
Extremely low-frequency magnetic fields
Ever exposed to
Background levels 2915 14380 1.00
0.58
3036 15043 1.00
0.85
Low levels 2125 10723 0.99 0.93-1.06 2017 10157 1.00 0.94-1.07
High levels 369 1942 0.95 0.83-1.09 356 1845 0.97 0.85-1.12
Duration of ever low/high 
exposed (HR/10 years) a
5409 27045 0.99 0.97-1.03 5409 27045 0.99 0.97-1.03
Duration of ever high 
exposed (HR/10 years) a
5409 27045 0.99 0.93-1.06 5409 27045 0.99 0.93-1.08
Cumulative exposure b
0.50 0.97
Background (0 unit-years) 2915 14380 1.00 3036 15043 1.00
1-16.2 unit-years 1153 5702 1.01 0.94-1.09 1240 6234 1.00 0.93-1.08
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Agent
5 years lag-time 10 years lag-time
Cases Controls HR 95% CI p for trend Cases Controls HR 95% CI p for trend
16.2-29.9 unit-years 690 3589 0.97 0.88-1.07 593 3016 0.99 0.90-1.11
>29.9 unit-years 651 3374 0.97 0.87-1.08 540 2752 0.99 0.89-1.12
a The risk associated with 10-year increase in duration of exposure. 
b Tertiles of exposure distribution among exposed controls used as cutoff points.
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O c c u p a t i o n  a n d  L e u k e m i a  in  N o r d i c  C o u n t r i e s
Madar Talibov, MSc, Susanna Kautiainen, PhD, Jan Ivar Martinsen, PhD, Kristina Kjaerheim, PhD, 
Elsebeth Lynge, PhD, Per Sparen, PhD, Laufey Tryggvadottir, PhD, Elisabete Weiderpass, PhD,
and Eero Pukkala, PhD
Objective: We studied occupational varia tion  o f  the risk  o f  acute m yeloid 
leukemia, chronic lym phocytic leukem ia, and other leu k em ia in N o rd ic  coun­
tries. Methods: T he study cohort com prised 15 m illion persons older than  30 
years who partic ipa ted  in  the population  censuses in 1 9 6 0 ,1970, 1980/1981, 
1990, or all o f  these years in five N ordic countries. Standardized incidence 
ra tios (SIRs) w ere estim ated for 53 occupations and one group o f  econom i­
cally inactive persons. Results: Significantly increased risks w ere observed 
for acute m yeloid leukem ia am ong drivers (SIR  =  1.16; 95%  confidence 
interval [CI], 1 .0 7 -1 .2 6 )an d fo o d w o rk ers  (SIR =  1.13; 95%  CI, 1 .01-1.27); 
for chronic lym phocytic leukem ia am ong farm ers (SIR =  1.09; 95%  CI, 1.04­
1.14) and  clerical workers (SIR =  1.07; 95%  CI, 1 .01-1.14); and  for other 
leukem ia am ong seam en (SIR  =  1.24; 95%  CI, 1 .04-1.49), “other health  
w orkers" (SIR =  1.22; 95%  CI, 1.02-1.47), chem ical process workers (SIR 
=  1.18; 95%  CI, 1 .01-1.38), a n d sa le s  agents (SIR  =  1.15; 95%  CI, 1.06­
1.25). Conclusion: O bserved m odest occupational variation ofleukem ia  risk  
m ight be associated w ith  occupational or lifestyle factors.
L eukemia is a heterogeneous group o f  malignancies. It is classi­fied as either lym phocytic or m yelogenous according to which  
kind o f  blood cell is affected. Both types have acute and chronic 
forms. Incidence ofleukem ia  among the elderly  in Nordic countries 
increased between the 1950s  and 1970s, when the increase began to 
level o f f  (Fig. 1 ) .1
Increased risk o f  leukemia may be associated w ith  a wide 
range o f  occupational agents such as ionizing radiation, electrom ag­
netic fields, benzene, ethylene oxide, styrene, butadiene, and pesti­
cides, among others. However, the evidence is not consistent.2 Pro­
posed m echanisms through which such agents act is complex. This 
study aimed to evaluate occupational variation o f  the risk o f  acute 
m yeloid leukemia (AM L), chronic lym phocytic leukemia (CLL),and  
all other leukemia combined (“other leukem ia”) inN ordic countries.
M ETH O D S
The Nordic Occupational Cancer (N O CCA) study cohort was 
based on populations in one or m ore censuses in Denmark, Finland, 
Iceland, N orway, and Sweden who participated in population cen­
suses from  1 9 6 0 ,1 9 7 0 ,1 9 8 0 / 1 9 8 1 ,1 9 9 0 ,  or all years and were 30  to 
64 years old at the beginning o f  follow -up and living in the country  
on January 1 after the census. Person-years were calculated until the
Fromthe School ofH ealth Sciences (Ms Talibov and Drs Kautiainen and Pukkala), 
University o f Tampere, Tampere, Finland; Cancer Registry o f Norway (Drs 
Martinsen, Kjaerheim, and Weiderpass), Oslo, Norway; Centre of Epidemiol­
ogy andScreening (DrLynge), Institute ofPublic Health, UniversityofCopen- 
hagen, Denmark; Department o f Epidemiology and Biostatistics (Drs Sparen 
and Weiderpass), Karolinska Institute, Stockholm, Sweden; Icelandic Can­
cer Registry (Dr Tryggvadottir), Reykjavik, Iceland; Finnish Cancer Registry 
(Dr Pukkala), Institute for Statistical and Epidemiological Cancer Research, 
Helsinki, Finland.
The NOCCA project was funded by the Nordic Cancer Union and the Scientific 
Council in Sweden. Madar Talibov was supported by postgraduate research 
grants fromthe Yij o Jahnsson Foundation andthe Finnish Cultural Foundation.
The authors declare no conflict o f interest.
Address correspondence to: M adar Talibov, MSc, School o f Health Sciences, 
University of Tampere, FI-33014, Tampere, Finland (Madar.Talibov@uta.fi.).
Copyright ©  2012 by American College o f Occupational and Environmental 
Medicine
DOI: 10.1097/JOM.0b013e3182664885
JOEM • Volume 54, Num ber 12, Decem ber 2012
date o f  emigration, death, or to December 3 1 o f  the following years: 
2003  in D enm ark andN orway, 2 004  in Iceland, and 2 005  in Finland  
and Sw eden. Inform ation about economic activity, occupation, and 
industry was recorded for each individual during the censuses, and 
questionnaires were centrally coded and computerized in the national 
statistical offices.3
In Finland, Norway, and Sw eden the occupations were coded  
to m ore than 300  categories according to national adaptations o f  
International Standard C lassification o f  Occupations from  1958 . In 
Iceland, the occupations were coded according to national adaptation 
o f  International Standard Classification o f  Occupations 196 8 , and 
a special national nomenclature was used for occupational coding 
in Denmark.3 Original national codes were converted to relatively  
specific but not too narrow  occupational titles w ith  53  categories 
(Table 1).
Information about cancer was obtained from  the cancer reg­
istries o f  the N ordic countries, which are fa irly  similar, on the basis o f  
notification from  clinical and pathologic departments, general practi­
tioners, private clinics, and death registries. In our data set, leukemia 
cases were classified as A M L , CLL, and other leukemia. For D en­
mark, the categories o f  C LL and other leukemia were not defined, 
and therefore subtype-specific results are presented only for A M L.
W e present our results as standardized incidence ratios (SIRs), 
which were computed as the ratio o f  the observed number o f  cases to 
the expected number o f  cases in strata defined according to 5 -year age 
category, 5-year period, sex, and country. To estimate the expected  
number o f  cases, incidence rates were m ultiplied by the respective 
numbers o f  person-years at risk. The 9 5 %  confidence intervals (CIs) 
for SIR estimates were calculated by assuming Poisson distribution  
for observed cases.
To evaluate the consistency and trends o f  SIR estimates, we 
combined the data to broader calendar periods ( 1 9 6 1 - 1 9 7 5 ,  197 6 ­
199 0 , and 1 9 9 1 -2 0 0 5 )  and age groups (3 0 -4 4 , 4 5 -5 9 ,  and > 60  
years). A  Poisson regression trend test4 was perform ed to assess 
the significance o fob se rved  trends o f  SIR estimates across age and 
calendar periods.
RESULTS
The cohort consisted o f  14 .9  m illion  individuals from  the 
five N ordic countries; 2 .0  m illion  from  Denmark, 3.4 m illion  from  
Finland, 10 0 ,0 00  from  Iceland, 2 .6  m illion  from  Norway, and 6.8  
m illion  from  Sweden. In total, 1 8 ,8 1 1  cases o fA M L , 2 0 ,46 2  cases o f  
CLL, and 15 ,57 0  cases o fotherleukem ia occurredduringthe follow- 
up from  1961  to 2005 . The number o f  person-years accumulated by  
the end o f  follow-up was 384 .4  m illion. For the analysis related  
to CLL and “other leukem ia,” excluding Denmark, the number o f  
person-years was 333 .5  m illion.
Table 1 shows the overall SIR  estimates for A M L , CLL, and 
other leukemia in 53 occupational categories and in the group o f  
econom ically inactive persons. During the follow -up, 555  cases o f  
A M L  occurred among drivers (SIR  =  1 .16 ; 95%  CI, 1 .0 7 -1 .2 6 )  
and 2 87  cases occurred among food w orkers (SIR  =  1 .13 ; 95%  CI, 
1 .0 1 -1 .2 7 ) .  The incidence o f  CLL was significantly higher than that 
o f  the population average in the occupational categories o f  farmers 
(SIR  =  1.09 ; 95%  CI, 1 .0 4 - 1 .1 4 )  and c lerical workers (SIR  =  1 .07; 
95%  CI, 1 .0 1 - 1 .1 4 ) .
1527
Copyright © 2012  Lippincott W illiam s & W ilk in s. Unauthorized reproduction of th is artic le  is prohibited.
Talibov et al______________________________________________________________________________________ JO EM  • Vo lum e 5 4 , N u m b er 12 , D ecem ber 2012
TA BLE 1. Observed Num ber and Standardized Incidence Ratios for AML, CLL, and Other Leukemia by Occupational 
Categories in Nordic Countries
Occupational Category
AML CLL Other Leukemia
Obs SIR 95%  CI Obs SIR 95%  CI Obs SIR 95%  CI
Technical workers, etc 662 0.98 0.91-1 .06 889 0.98 0.92-1 .05 616 0.98 0.91-1 .06
Laboratory assistants 36 1.23 0.86-1.71 17 0.75 0.44-1 .20 22 1.07 0.67-1.63
Physicians 65 1.22 0.94-1 .55 61 1.06 0.81-1 .37 36 0.83 0.58-1 .15
Dentists 27 1.07 0.70-1 .56 24 0.83 0.53-1 .24 29 1.35 0.91-1 .94
Nurses 130 0.96 0.81-1 .14 99 0.97 0.79-1 .18 84 0.91 0.73-1.13
A ssistant nurses 178 1.03 0.89-1 .19 156 1.00 0.85-1 .17 142 1.03 0.87-1.21
O ther health  workers 112 0.88 0.73-1 .06 100 0.91 0.75-1.11 113 1.22 1.02-1.47
Teachers 506 1.02 0.93-1.11 528 1.04 0.95-1.13 370 0.93 0.84-1 .03
R eligious workers, etc 242 1.08 0.95-1.23 288 1.10 0.98-1.23 206 0.96 0.84-1 .10
A rtistic  w orkers 57 0.91 0.69-1 .17 83 1.10 0.87-1 .36 58 1.03 0.78-1 .34
Journalists 33 1.17 0.81-1 .65 32 0.92 0.63-1 .30 28 1.06 0.70-1 .52
A dm inistrators 528 1.04 0.95-1.13 513 1.02 0.94-1.11 348 0.95 0.86-1 .06
C lerical workers 1127 1.05 0.99-1.11 1086 1.07 1 .0 1-1 .14 826 1.02 0.95-1 .09
Sales agents 510 1.09 1.00-1.19 697 1.04 0.97-1 .12 562 1.15 1.06-1.25
Shop workers 788 1.01 0.94-1 .08 611 1.01 0.93-1 .09 424 0.92 0.84-1.01
Farmers 1380 0.98 0.93-1.03 1746 1.09 1.04-1.14 1099 0.97 0.91-1.03
G ardeners 508 0.97 0.89-1 .06 637 0.98 0.91-1 .06 485 1.01 0.92-1 .10
Fisherm en 108 0.83 0.69-1 .00 111 0.83 0.69-1 .00 69 0.68 0.53-0.85
Forestry w orkers 160 0.85 0.73-0.99 287 0.95 0.85-1 .07 196 0.90 0.78-1 .04
M iners and quarry  workers 46 1.03 0.75-1 .37 68 0.97 0.75-1.23 56 1.11 0 .84-1 .45
Seam en 95 0.79 0.64-0.97 103 0.79 0.65-0.96 118 1.24 1.04-1.49
T ransport workers 179 1.03 0.89-1 .19 240 1.04 0.92-1 .18 146 0.97 0 .83-1 .14
Drivers 555 1.16 1.07-1.26 594 1.03 0.95-1 .12 395 0.97 0 .88-1 .07
Postal workers 200 1.01 0.88-1 .16 208 0.94 0.82-1 .08 157 0.91 0 .78-1 .06
Textile w orkers 290 0.89 0.79-1 .00 307 0.89 0.80-1 .00 250 0.93 0 .82-1 .05
Shoe and leather workers 48 0.92 0.68-1 .22 50 0.76 0.56-1 .00 61 1.19 0.91-1 .53
Sm elting w orkers 139 0.92 0.78-1 .09 167 0.92 0.79-1 .07 137 1.05 0 .89-1 .24
M echanics 658 0.97 0.90-1 .05 892 0.98 0.92-1 .05 635 1.00 0 .93-1 .08
Plum bers 74 0.98 0.77-1.23 97 0.91 0.74-1.11 72 0.97 0 .76-1 .22
W elders 91 1.23 0.99-1.51 117 0.99 0.83-1 .19 91 1.12 0 .90-1 .37
E lectrical w orkers 272 1.03 0.91-1 .16 349 1.00 0.90-1.11 254 1.03 0 .91-1 .17
W ood w orkers 539 0.97 0.89-1 .06 739 1.00 0.93-1 .07 491 0.92 0.84-1.01
Painters 128 0.97 0.82-1 .15 177 1.00 0.86-1 .16 109 0.86 0 .71-1 .04
O ther construction workers 298 0.98 0.87-1 .10 333 0.96 0.86-1 .07 246 0.99 0 .87-1 .12
B ricklayers 69 0.86 0.67-1 .09 75 0.89 0.70-1 .12 70 1.18 0 .92-1 .49
Printers 79 0.80 0.63-1 .00 119 1.05 0.88-1 .26 84 1.00 0.79-1 .23
C hem ical process w orkers 143 1.07 0.91-1 .26 171 1.01 0.87-1 .17 151 1.18 1 .01-1.38
Food w orkers 287 1.13 1 .01-1.27 213 0.92 0.80-1 .05 165 0.96 0 .82-1 .12
B everage workers 14 0.89 0.49-1 .49 4 1.15 0.57-2 .05 9 1.20 0 .55-2 .27
Tobacco w orkers 10 1.20 0.58-2.21 11 1.07 0.29-2 .75 3 1.01 0 .21-2 .94
G lass m akers, etc 145 0.88 0.75-1 .04 184 0.97 0.84-1 .12 151 1.07 0.91-1 .26
Packers 287 1.01 0.90-1.13 359 0.96 0.87-1 .06 293 1.03 0 .92-1 .16
Engine operators 200 1.04 0.91-1 .19 279 1.05 0.93-1 .18 182 0.95 0 .82-1 .10
Public safety w orkers 148 1.11 0.94-1 .30 182 1.09 0.94-1 .26 134 1.13 0 .95-1 .34
C ooks and stewards 121 1.02 0.85-1 .22 138 1.02 0.86-1.21 114 1.03 0 .86-1 .24
D om estic assistants 243 0.99 0.87-1 .12 222 1.03 0.90-1 .17 187 0.97 0.84-1 .12
W aiters 95 0.83 0.67-1 .02 113 0.99 0.82-1 .19 91 0.99 0 .80-1 .22
B uilding caretakers 593 1.08 1.00-1.17 440 0.96 0.87-1 .05 387 1.06 0 .96-1 .17
Chim ney sweeps 8 1.25 0.54-2 .45 11 1.19 0.59-2 .12 4 0.62 0 .17-1 .59
H airdressers 53 0.85 0.63-1.11 51 0.86 0.64-1.13 44 0.95 0.69-1 .27
Launderers 55 0.83 0.63-1 .08 61 0.99 0.75-1 .27 50 1.05 0 .78-1 .39
M ilitary personnel 88 1.20 0.96-1 .48 100 1.09 0.89-1.33 60 0.98 0.75-1 .26
O ther w orkers 521 0.98 0.90-1 .07 544 1.00 0.92-1 .09 406 0.97 0 .88-1 .07
E conom ically inactive 4883 0.99 0.96-1 .02 4779 0.99 0.96-1 .02 4054 1.02 0 .99-1 .05
AML, acute myeloid leukemia; CI, confidence interval; CLL, chronic lymphocytic leukemia; Obs, observed number of cases; SIR, standardized incidence ratio. 
The data given in bold indicates significant estimates.
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TA BLE 2. Observed Num ber and Standardized Incidence Ratio for AML, CLL, and Other Leukemia by Period and Selected* 
Occupational Categories in Nordic Countries
Type o f Leukemia Occupation
1961- 1975 1976- 1990 1991-2005
P-\Obs SIR 95%  CI Obs SIR 95%  CI Obs SIR 95%  CI
A M L Drivers 44 1.22 0.89-1 .64 224 1.12 0.98-1 .28 287 1.18 1.05-1.32 0.83
Foodw orkers 21 0.92 0.57-1 .40 113 1.03 0.86-1 .24 153 1.26 1.08-1.48 0.06
Seam en 13 0.87 0.46-1 .49 40 0.80 0.57-1 .09 42 0.76 0 .55-1.03 0.67
Forestry w orkers 11 0.59 0.30-1 .06 77 0.86 0.68-1 .08 72 0.90 0.71-1 .14 0.28
CLL Farmers 180 1.01 0.87-1 .17 851 1.13 1.06-1.21 715 1.07 0.99-1 .15 0.99
C lerical workers 92 1.61 1.30-1.97 331 1.00 0.90-1.11 663 1.06 0.98-1 .14 0.05
Seam en 15 1.10 0.62-1 .82 40 0.82 0.59-1 .12 48 0.71 0.53-0 .94 0.15
O ther leukem ia Seam en 29 1.17 0.79-1 .68 35 1.04 0.73-1 .45 54 1.46 1.09-1.90 0.25
O ther hea lth  workers 17 1.38 0.81-2 .22 36 1.24 0.87-1.71 60 1.17 0.89-1.51 0.55
C hem ical process w orkers 39 1.03 0.73-1.41 58 1.23 0.93-1 .59 54 1.26 0.95-1 .65 0.35
Sales agents 128 1.14 0.96-1 .36 192 1.11 0.96-1 .28 242 1.20 1.06-1.36 0.56
Fisherm en 26 0.74 0.48-1 .08 24 0.66 0.42-0 .98 19 0.63 0.38-0 .98 0.59
AML, acute myeloid leukemia; CI, confidence interval; CLL, chronic lymphocytic leukemia; Obs, observed number ofcases; SIR, standardizedincidence ratio. 
*Only occupations with significantly increased and decreased overall SIR estimates are shown. 
fPoisson trend test.
FIGU RE 1. Incidence rates (per 100,000 person-years) of 
leukemia in Nordic countries, among those aged 30 to 85 
years, adjusted to the world standard population. Tabulation 
is based on N ORDCAN data.1
Statistically significantly increased risk for other leukemia 
was observed among chemical process workers (SIR  =  1 .18 ; 95%  
CI, 1 .0 1 - 1 .3 8 ) ,  other health workers (SIR  =  1.22 ; 95%  CI, 1 .0 2 ­
1.47), seamen (SIR  =  1.24 ; 95%  CI, 1 .0 4 -1 .4 9 ) , and sales agents 
(SIR  =  1 .15 ; 95%  CI, 1 .0 6 -1 .2 5 ) . Significan tlydecreasedSIR sw ere  
observed among forestry w orkers and seamen for A M L ; seamen for 
CLL; and fishermen for other leukemia.
There was a tendency o f  increasing SIR over time for A M L  
among food workers (Table 2). The risk o f  CLL among clerical 
w orkers was only elevated in 1961  to 1975 . The other associations 
w ere quite stable over the periods.
Stratification b y  age (Table 3) showed that the SIR o f  A M L  
among food workers and SIR o f  other leukemia among other health  
w orkers w ere m ainly elevated in those younger than 60 years. There 
was some indication o f  increasing trend toward older ages for A M L  
among drivers and for other leukemia among seamen, but none 
o f  the trends were statistically significant. W e did not observe any
significant difference o f  the SIRs across sexes and countries (Tables 
4  and 5).
DISCUSSION
To our knowledge, this study is one o f  the largest to ex­
plore associations between occupational affiliation and leukemia. 
The strengths o f  this study include reliable ascertainment and high  
coverage ofleukem ia cases5-8 and the high accuracy o f  occupational 
coding in Nordic countries.3 The linkages between the census data, 
the m ortality and emigration data, and the cancer incidence data 
w ere based on the unique personal identity codes used in registries 
o f  all Nordic countries.
The inform ation about occupations was based on national 
censuses from  196 0  to 1990 . Occupations were classified on the 
basis o fth e  first census records for each person at the age o f3 0  years 
orolder. InFinland, occupation-specific standardizedm ortalityratios 
w ere calculated in two ways: first on the basis o f  one single census 
(198 0 ) and then restricted to persons w ho had stayed in the same 
occupation in subsequent censuses. The standardized m ortality ratio 
estimates were practically identical.9 We believe that these results, 
based on occupation in one census, give, in m ost instances, results 
sim ilar to those we would have obtained from  categorizations, based  
on occupational titles kept in several censuses. The follow-up in this 
study started w ith  the occupation held at the age o f 3 0  years or older 
to avoid m isclassification due to career development in the beginning 
o f  w ork life.
In general, there was quite little variation o f  the SIR estimates. 
We observed significantly elevated risk o f  A M L  among drivers and 
food workers. D rivers included car, taxi, van, bus, m otorcycle, and 
truck drivers. Som e o f  them are occupationally exposed to diesel 
exhaust, which is emitted as a result o f  combustion o f  diesel fuel. 
Some particles o f  diesel exhaust such as benzene, butadiene, ethy­
lene oxide, and styrene are carcinogenic to humans.10 There is ev i­
dence from  previous studies that exposure to benzene causes A M L  
in hum ans.11,12 Occupational exposure to butadiene, ethylene oxide, 
and styrene also has been linked to leukemia; however, the evidence 
is inconsistent.13-15 Age-specific pattern o f  the risk among drivers 
suggests that A M L  occurrence might depend on the duration o f  
exposure to benzene.
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TA BLE 3. Observed Num ber and Standardized Incidence Ratio for AML, CLL, and Other Leukemia by Age and Selected* 
Occupational Categories in Nordic Countries
30-44  45-59 >60
Type ofLeukemia Occupation Obs SIR 95%  CI Obs SIR 95%  CI Obs SIR 95%  CI P f
AM L Drivers 32 0.99 0.68-1 .40 119 1.11 0.93-1 .33 404 1.19 1.08-1.31 0.26
Food workers 14 1.26 0.69-2.11 63 1.40 1.08-1 .79 210 1.06 0.93-1.21 0.09
Seam en 0.37 0.08-1 .08 21 0.79 0.49-1 .21 71 0.83 0.65-1 .05 0.25
Forestry w orkers 10 1.32 0.63-2.43 20 0.67 0.41-1 .03 130 0.87 0.73-1.03 0.82
CLL Farmers 7 0.96 0 .39-1 .97 191 1.13 0.98-1 .30 1548 1.09 1.04-1.15 0.76
C lerical w orkers 16 0.84 0.48-1 .37 250 1.14 1.01-1 .29 820 1.06 0.99-1 .14 0.71
Seam en 0 0.00 0.00-2 .56 28 1.07 0.71-1 .55 75 0.73 0.58-0 .92 0.08
O ther leukem ia Seam en 8 1.00 0.43-1 .97 29 1.10 0.74-1 .58 81 1.33 1.05-1.65 0.29
O ther hea lth  workers 19 1.42 0.86-2 .22 45 1.46 1.07-1 .96 49 1.01 0.75-1.33 0.09
Chem ical process w orkers 9 1.16 0 .53-2 .20 33 1.14 0.78-1 .60 109 1.20 0.99-1 .45 0.82
Sales agents 47 1.19 0.88-1 .59 142 1.13 0.96-1 .33 373 1.16 1.05-1.28 0.98
Fisherm en 5 0.92 0.30-2 .14 17 0.80 0.46-1 .28 47 0.62 0.46-0.83 0.25
AML, acute myeloid leukemia; CI, confidence interval; CLL, chronic lymphocytic leukemia; Obs, observed number of cases; SIR, standardized incidence ratio. 
*Only occupations with significantly increased and decreased overall risk estimates are shown. 
fPoisson trend test.
TA BLE 4. Observed Num ber and Standardized Incidence Ratio for AML, CLL, and Other Leukemia by Sex and Selected* 
Occupational Categories in Nordic Countries
Type o f Leukemia Occupation
Male Female
Obs SIR 95%  CI Obs SIR 95%  CI
AM L Drivers 542 1.16 1.07-1.26 13 0.93 0.50-1 .60
Food workers 180 1.14 0.99-1 .32 107 1.11 0.92-1 .34
Seam en 94 0.79 0.64-0 .96 1 3.75 0.09-20.90
Forestry workers 157 0.85 0.73-0 .99 3 1.14 0.23-3 .32
CLL Farmers 1 553 1.09 1.03-1.14 193 1.13 0.98-1 .30
C lerical workers 461 1.09 0.99-1 .19 625 1.06 0.98-1 .15
Seam en 103 0.80 0.66-0 .96 0 0.00 0.00-17.16
O ther leukem ia Seam en 118 1.24 1.04-1.49 0 0.00 0.00-18.00
O ther health  workers 38 1.41 1.00-1.94 75 1.14 0.90-1.43
Chem ical process w orkers 136 1.18 1.00-1.40 15 1.19 0.67-1 .97
Sales agents 477 1.17 1.07-1.28 85 1.08 0.86-1 .34
Fisherm en 66 0.65 0.50-0.83 3 3.20 0.66-9 .36
AML, acute myeloid leukemia; CI, confidence interval; CLL, chronic lymphocytic leukemia; Obs, observed number of cases; SIR, standardized incidence ratio. 
*Only occupations with significantly increased and decreased overall risk estimates are shown.
Food workers included such occupations as cannery workers, 
butchers and sausage makers, dairy makers, and processed food 
workers, among others. Some o f  these occupational subgroups can be 
exposed to benzene in the workplace. For exam ple, benzene is used 
as a solvent in production o f  rubber cement, which is w id ely  used 
in the cannery industry. There was some indication o f  an increasing  
trend o f  SIR  among food workers over calendar periods. W e did 
not observe significant risk elevation among other benzene-exposed  
occupational groups such as shoe and leather workers and printing, 
painting, and rubber industry w orkers.
The incidence o f  C L L  was significantly higher in occupa­
tional categories o f  farmers and clerical w orkers than in the average 
population. Som e, but not all, epidemiological studies have found an 
association between farming and leukem ia.16-18 Two m ajor groups 
o f  risk factors were proposed as causes o f  hem atologic malignan­
cies among agricultural workers: The first group includes various 
chemicals such as pesticides, herbicides, and related substances. 
The second group includes various animal viruses.19 C lerical w ork­
ers included secretaries and clerical w orkers in banks and insurance 
companies, accounting and bookkeeping clerks, and other types o f  
office works. W e are not aware o f  any exposure in this occupational 
category that could put clerical workers at leukemia risk.
We found significantly increased SIR for other leukemia 
among chem ical process workers, seamen, sales agents and other 
healthw orkers. Chem icalprocess w orkers includeddistillers, cooks, 
and furnacemen, wood grinders, pulp m ill workers, paper and card­
board m ill w orkers, and other occupations related to chemical pro­
cessing. Chem ical process workers are exposed to a wide range 
o f  chemical agents including benzene, form aldehyde, toluene, and 
other solvents, which might explain the increased risk. We did not
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TABLE 5. Observed Number and Standardized Incidence Ratio for AML, CLL, and Other Leukemia by Country and Selected* Occupational Categories 
in Nordic Countries
Norway
Type o f Leukemia Occupation Obs S IR 95%  C I Obs S IR 95%  C I Obs S IR 95%  C I Obs S IR 95%  C I Obs S IR 95%  C I
A M L D rivers 122 1.08 0 .9 0 -1 .2 9 105 1.17 0 .9 7 -1 .4 2 3 1.11 0 .2 3 -3 .24 121 1.08 0 .9 0 -1 .2 9 204 1.26 1 .1 0 -1 .45
Food w orkers 86 1.02 0 .8 1 -1 .2 5 42 1.41 1 .02-1 .91 11 1.47 0 .7 3 -2 .63 81 1.14 0 .9 0 -1 .4 2 67 1.08 0 .8 4 -1 .3 7
Seam en 11 0.71 0 .3 5 -1 .2 7 14 1.48 0 .8 1 -2 .49 1 1.08 0 .0 3 -6 .0 2 57 0.75 0 .5 7 -0 .9 7 12 0.67 0 .3 4 -1 .1 6
Forestry w orkers 8 1.24 0 .5 4 -2 .4 5 42 0.95 0 .6 8 -1 .28 0 0 0 .0 0 -8 9 .1 3 43 0.75 0 .5 4 -1 .01 67 0.84 0 .6 5 -1 .0 7
C L L Farm ers - - - 549 1.05 0 .9 7 -1 .14 12 1.35 0 .7 0 -2 .3  6 503 1.22 1 .12 -1 .33 682 1.03 0 .9 6 -1 .11
C le r ic a l w orkers - - - 224 1.14 1 .0 0 -1 .30 11 1.23 0 .6 2 -2 .21 221 0.99 0 .8 7 -1 .13 630 1.08 1 .0 0 -1 .17
Seam en - - - 13 0.90 0 .4 8 -1 .54 0 0.00 0 .0 0 -4 .0 2 51 0.67 0 .5 0 -0 .8 8 39 1.02 0 .7 3 -1 .4 0
O ther leu kem ia Seam en - - - 11 1.10 0 .5 5 -1 .97 1 1.05 0 .0 3 -5 .83 69 1.19 0 .9 3 -1 .51 37 1.39 0 .9 8 -1 .9 2
O ther health  w orkers - - - 33 1.36 0 .9 3 -1 .90 0 0.00 0 .0 0 -9 .07 20 0.96 0 .5 9 -1 .4 8 60 1.27 0 .9 7 -1 .6 4
C h em ica l p rocess w orkers - - - 20 1.05 0 .6 4 -1 .6 2 0 0.00 0 .0 0 -1 1 .1 9 39 1.13 0 .8 1 -1 .5 5 92 1.24 1 .00 -1 .53
S a le s  agen ts - - - 87 1.11 0 .8 9 -1 .37 3 1.25 0 .2 6 -3 .67 134 1.32 1 .1 1 -1 .56 338 1.11 1 .00 -1 .23
F isherm en - - - 6 1.54 0 .5 7 -3 .36 2 0.51 0 .0 6 -1 .85 49 0.65 0 .4 8 -0 .8 6 12 0.64 0 .3 3 -1 .1 2
AM L, acute m yeloid leukemia; CI, confidence interval; C LL, chronic lym phocytic leukemia; O bs, observed num ber o f cases; SIR, standardized incidence ratio. 
*Only occupations w ith significantly increased and decreased overall risk estim ates are shown.
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observe risk elevation among other solvent-exposed occupational 
groups such as m echanics, smelting workers, building caretakers, 
painters, or printers. The cccupational category o f  “seamen” in­
cluded all kinds o f  seamen, from  deck crew to ship pilots. Am ong  
these occupational subgroups, only engine room  crew  is exposed to 
diesel exhaust, which might explain the increased risk. Professionals 
associated w ith  finance and sales , business service agents, and trade 
brokers were combined into the category o f  sales agents. “Other 
health workers” included veterinarians, pharmacists, and physio­
therapists, among others. It is possible that they are exposed to some 
carcinogenic agents at workplace, but w e cannot name any specific 
exposures.
Other occupational factors im plicated in the etiology  
o f  leukemia are ionizing radiation, electromagnetic fields, and 
form aldehyde.20-22 In our cohort, physicians and m iners were oc­
cupationally exposed to low doses o f  ionizing radiation; electrical 
workers were exposed to electromagnetic fields; and nurses, forestry  
workers, textile workers, shoe and leather workers, foundryw orkers, 
welders, and w ood workers were exposed to formaldehyde. W e did 
not observe significant elevation o f  leukemia risk in any o f  these 
occupational categories.
Am ong other suspected factors, cigarette smoking has been  
w eakly associated w ith  leukemia, especially the m yeloid type.23,24 
and the findings w ere highly controversial. However, being common  
and having a high variation between occupations, smoking is likely  
to a ffect our results to some extent; part o f  the excess A M L  risk seen 
among drivers and food w orkers is probably due to smoking.
Chrom osome aberrations such as Philadelphia chromosome, 
D own syndrom e, K linefelter syndrom e, ataxia telangiectasia, B loom  
syndrome, and Fanconi anemia also have been associated with  
leukemia.25 These conditions are rare and not clustered in certain  
occupations; therefore, we do not think that our results could be 
confounded by chrom osomal disorders.
It has been demonstrated that the use o f  broader occupa­
tional categories is not always an adequate surrogate for occupational 
factors.26 Some o f  the occupational categories in this study are het­
erogeneous and m ay therefore hide occupational risks.3 However, 
the aim o f  this study was to describe the variation in leukemia risk  
among occupations. I f  the aim was to study the effect o f  specific oc­
cupational factors on leukemia risk, w e should go for m ore specific 
occupational categories.
The magnitude o f  chance findings related to m ultiple com­
parisons is another issue to be considered in this type o f  study. 
Because w e had five independent, country-specific observations for 
each cancer-occupation combination, we could judge reasonably  
w ell which findings are due to chance and which are true ones. For 
example, variation o f  the SIRs by leukemia type among the seamen 
was quite uniform  in the country-specific analyses.
C O N CLU SION S
This study provides evidence that there is modest variation in 
the incidence o fleukem ia  between occupations. Som e o fth e  highest 
incidences could be at least partly attributed to occupational factors.
A C K N O W LE D G M E N TS
The au th o rs  thank th e  NOCCA p r o j e c t  team  m em b ers  w ho  
co n tr ib u ted  v a lu ab le  w ork  to  th is p r o je c t . The au th o rs  a ls o  thank  
P ro fe s so r  Tapio Nummi a n d  R aili Sa lm elin , PhD, f o r  s ta t is t i ca l input.
REFERENCES
1. NORDCAN: cancer incidence and mortality in the Nordic countries, Ver­
sion 3.0. Association of the Nordic Cancer Registries. http://www.ancr.nu. 
Published 2007. Accessed February 20, 2012.
2. Zeeb HBM. Adult leukaemia: what is the role o f currently 
known risk factors? Radiat Environ Biophys. 1998;36:217- 
228.
3. Pukkala E, Martinsen JI, Lynge E, et al. Occupation and cancer— follow- 
up o f 15 million people in  five Nordic countries. Acta Oncol. 2009;48:646- 
790.
4. Breslow NE, Day NE. Statistical methods in cancer research. Volume 
II—The design and analysis o f cohort studies. IARC  Sci Publ. 1987:1­
406.
5. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of 
a population-based cancer registry. Experience in Finland. Acta Oncol. 
1994;33:365-369.
6. Larsen IK, Smastuen M, Johannesen TB, et al. Data quality at the Cancer 
Registry o f Norway: an overview of comparability, completeness, validity 
and timeliness. Eur J  Cancer 2009;45:1218-1231.
7. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of 
the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 
2009;48:27-33.
8. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer 
Registry— history, content, quality and use. Dan M ed Bull. 1997;44:535- 
539.
9. Notkola V, Pajunen A, Leino-Arjas P. Occupational Mortality by Cause in 
Finland 1971-1991 and Occupational M obility. Helsinki, Finland: Statistics 
Finland; 1997. SVTH ealth ; vol 1.
10. IARC monographs on the evaluation o f carcinogenic risks to humans. Diesel 
and gasoline engine exhausts and some nitroarenes. International Agency for 
Research on Cancer. IARC  Monogr E val Carcinog Risks Hum. 1989;46:1- 
458.
11. Fu H, Demers PA, Costantini AS, et al. Cancer mortality among shoe manufac­
turing workers: ananalysis oftw o cohorts. Occup Environ Med. 1996;53:394- 
398.
12. Yin SN, Hayes RB, LinetM S, etal. A cohort study o f cancer among benzene- 
exposed workers in  China: overall results. Am J  Ind Med. 1996;29:227- 
235.
13. Hodgson JT, Jones RD. Mortality o f styrene production, polymerization and 
processing workers at a site in northwest England. Scand J  Work Environ 
Health. 1985;11:347-352.
14. Cole P, Delzell E, Acquavella J. Exposure to butadiene and lymphatic and 
hematopoietic cancer. Epidemiology. 1993;4:96-103.
15. Shore RE, Gardner MJ, Pannett B. Ethylene oxide: an assessment o f the 
epidemiological evidence on carcinogenicity. B r J  Ind Med. 1993;50:971- 
997.
16. Delzell E, Grufferman S. Mortality among white and nonwhite farm­
ers in North Carolina, 1976-1978. Am J  Epidemiol. 1985;121:391- 
402.
17. Kristensen P, Andersen A, Irgens LM, Laake P, Bye AS. Incidence and risk 
factors o f cancer among m en and women in  Norwegian agriculture. Scand J  
Work Environ Health. 1996;22:14-26.
18. Waterhouse D, Carman WJ, Schottenfeld D, Gridley G, McLean S. Cancer in­
cidence in the rural community o f Tecumseh, Michigan: a pattern o f increased 
lymphopoietic neoplasms. Cancer. 1996;77:763-770.
19. Pearce N, Reif JS. Epidemiologic studies o f cancer in agricultural workers. 
A m J In d M e d . 1990;18:133-148.
20. Hodgson JT, Jones RD. Mortality of a cohort o f tin miners 1941-86. B rJ In d  
Med. 1990;47:665-676.
21. Juutilainen J, Laara E, Pukkala E. Incidence o f leukaemia and brain tumours 
in  Finnish workers exposed to ELF magnetic fields. In t Arch Occup Environ 
Health. 1990;62:289-293.
22. Zhang L, Steinmaus C, Eastmond DA, Xin XK, Smith MT. Formaldehyde 
exposureandleukem ia:anew m eta-analysisandpotentialm echanism s.M utat 
Res. 2009;681:150-168.
23. Siegel M. Smoking and leukemia: evaluation o f a causal hypothesis. Am J  
Epidemiol. 1993;138:1-9.
24. Friedman GD. Cigarette smoking, leukemia, and multiple myeloma. Ann 
Epidemiol. 1993;3:425-428.
25. Linet MS, Cartwright RA. The leukaemias. In: Schottenfeld D, Fraumeni 
JF, eds. Cancer Epidemiology and Prevention. New York: Oxford University 
Press; 1996:841-892.
26. MacFarlane E, Glass D, Fritschi L. Is farm-related job title an adequate sur­
rogate for pesticide exposure in  occupational cancer epidemiology?. Occup 
Environ Med. 2009;66:497-501.
1532 ©  2012 A m erican  C o l le g e  o f  O ccu p a tion a l a n d  E nvironm en ta l M ed ic in e
Copyright © 2012 Lippincott W illiam s & W ilk in s. U nauthorized reproduction of th is a rtic le  is prohibited.
Original article
S c a n d  J  W o rk  E n v iro n  H e a lth . 2 0 1 4 ;4 0 (4 ) :4 2 0 -4 2 6 . d o i:1 0 .5 2 7 1 /s jw e h .3 4 3 6
Occupational exposure to solvents and acute myeloid leukemia: a 
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Objective The aim of the current study was to assess the relation between occupational exposure to solvents 
and the risk of acute myeloid leukemia (AML).
Methods Altogether, this study comprises 15 332 incident cases of AM L diagnosed in Finland, Norway, Swe­
den, and Iceland from 1961-2005 and 76 660 controls matched by year of birth, sex, and country. Occupational 
records were linked with Nordic Occupational Cancer Study job exposure matrix (JEM) to estimate quantitative 
va lues fo r  26  o c cu p a tio n a l exposu re  fac to rs . H aza rd  ra tio s  (H R )  w ith  9 5 %  con fide nce  in te rv a ls  (9 5 %  C I)  w ere  
estimated by using conditional logistic regression models.
Results W e d id  n o t observe s ta tis tic a lly  s ig n if ic a n tly  increased r is k  fo r  exposu re  to  any o f  the  so lven ts. H R  
estimates for high levels of toluene (HR 1.35, 95% CI 0.74-2.46), aromatic hydrocarbon solvents (ARHC) (HR
1.18, 9 5 %  C I 0 .7 6 -1 .8 6 ) , and m o d e ra te -to -h ig h  le ve ls  o f  tr ic h lo ro e th y le n e  w e re  s lig h t ly  b u t n o n -s ig n if ic a n tly  
elevated. We did not observe an association between benzene exposure and AM L in this study.
Conclusions This study did not provide clear evidence for an association between occupational solvent 
exposure and AM L. There was some indication for an excess risk in the groups of workers exposed to toluene, 
trichloroethylene, and ARHC.
Key terms aromatic hydrocarbon solvent; benzene; cancer; JEM; job exposure matrix; Nordic Occupational 
Cancer Study; toluene; trichloroethylene.
Acute myeloid leukemia (AML) is a cancer of blood and 
bone marrow. It accounts for approximately 25% of all 
leukemias among adults (1).
While the etiology of AML is poorly understood, 
it has been linked to genetic disorders, physical and 
chemical exposures, radiation exposure, chemotherapy, 
and viruses (2, 3).
There is a general consensus that benzene can cause 
AML in humans (4-8). Some previous studies suggested 
an association between exposure to solvents and AML 
(9-11).
The aim of this study was to assess the relation 
between occupational solvent exposure and AML.
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Methods
The current study employed a case-control design nested 
in the Nordic Occupational Cancer Study (NOCCA) 
cohort. The NOCCA cohort consists of 14.9 million 
individuals from Finland, Iceland, Norway, Denmark, 
and Sweden who participated in population censuses 
in 1960, 1970, 1980/1981, and/or 1990. As we had no 
access to the individual records from Denmark, their 
data were not included.
Occupational information was obtained from com­
puterized census records from 1960 and later censuses in 
Sweden and Norway and from 1970 and later censuses 
in Finland. In Iceland, the only computerized census 
record was available for 1981 census. Personal identity 
codes were used to link census records with the data 
from cancer registries and national population registries 
for information on cancer, death, and emigration. Each 
person was followed-up until the date of emigration, 
death or 31 December of the following years: 2005 
in Finland, 2004 in Iceland, 2003 in Norway, 2003 in 
Denmark, and 2005 in Sweden. A detailed account of the 
NOCCA cohort was given in Pukkala et al (12).
All incident AML cases diagnosed from 1961-2005 
were extracted from the NOCCA cohort. Five controls 
per case were randomly selected among persons who 
were alive and free from AML on the date of diagnosis 
of the case (hereafter the “index date” of the case-con­
trol set). Cases and controls could have a history of any 
cancer other than AML and were matched for the year 
of birth, sex, and country. Persons with minimum age of 
20 years at index date, and having occupational informa­
tion from at least one census record, were included in 
the present study.
For each case and control, the exposure to solvents 
and other occupational factors was estimated based 
on conversions of occupational codes to quantitative 
amounts of exposures with the NOCCA job exposure 
matrix (JEM). National experts from the Nordic coun­
tries developed the NOCCA JEM on the basis of the 
Finnish JEM (13). It covers more than 300 specific occu­
pations, 29 exposure agents and 4 periods: 1945-59, 
1960-74, 1975-84, and 1985-94. Exposure agents are 
characterized by the proportion of exposed (P) and the 
mean level of exposure among the exposed persons (L) 
in a specific occupation and time period. The NOCCA 
JEM was described in detail in Kauppinen et al (14).
We quantified exposure to benzene, toluene, per- 
chloroethylene, methylene chloride, trichloroethylene, 
and 1,1,1-trichloroethane as individual solvents; and 
aliphatic and alicyclic hydrocarbon solvents (ALHC), 
aromatic hydrocarbon solvents (ARHC), chlorinated 
hydrocarbon solvents (CHC), and other organic solvents 
(OSOL) as grouped solvents. In addition to this, we
Table 1. Individual/grouped solvents and co-factors with measure­
ment units. [PPM= parts per million of agent; mg/m3=milligram of 
agent in cubic of workroom air; f/cm3=fibers of asbestos in cubic 
centimeter of workroom air; gg/m3=microgram of agent in cubic 
meter of workroom air; gmol/l=micromoles of lead in liter of blood; 
mSv=annual equivalent radiation dose in millisieverts.]
A gent Unit
Solvent
A lip ha tic  and a licyc lic  hyd rocarbon  so lvents ppm
A rom a tic  hydrocarbon so lvents ppm
Benzene ppm
Toluene ppm
C hlorinated hydroca rbon  so lvents ppm
M ethylene ch lo ride ppm
Perchloroethy lene ppm
Trich lo roethylene ppm
1 ,1 ,1 -tr ich lo roe thane ppm
O ther o rgan ic  so lvents ppm
C o-factor
A n im al dust m g /m 3
A sbestos f/c m 3
Benzo(a)pyrene gg /m 3
B itum en fum es m g /m 3
C hrom ium gg /m 3
Diesel engine exhaust m g /m 3
Iron m g /m 3
Form aldehyde ppm
Gasoline ppm
Nickel gg /m 3
Lead gm ol/l
Q uartz dust m g /m 3
S u lph ur dioxide ppm
Ioniz ing radiation mSv
W ood dust m g /m 3
W eld ing fum es m g /m 3
quantified exposure to 16 other agents which were con­
sidered as potential co-factors in the analysis (table 1).
The procedure for quantifying cumulative expo­
sure was as follows. For each occupational code, a 
corresponding value of the product of proportion and 
level of exposure (PXL) from NOCCA JEM file was 
assigned. This value was then multiplied by employ­
ment period (T) in years during which the subject was 
in that occupation. The procedure was repeated for all 
exposure factors.
Employment period was assumed to start at the age 
of 20 and end at 65 years. If there were different occu­
pational codes in census records for a given person, the 
individual was assumed to have changed occupation in 
the middle of the known census years. In such a case, 
the exposure history of the persons consisted of more 
than one P*L*T value. Cumulative exposure for these 
individuals was estimated by summing up all of their 
P*L*T values over the entire working career. Assuming 
that AML develops over a number of years, and recent 
exposures are less relevant than those which took place 
in the past, we conducted main analyses in which all 
exposures that occurred during the last ten years before 
the index date were not counted.
S c a n d  J  W ork E nv iro n  H e a lth  2014 , v o l 40, n o  4  421
E x p o s u re  to s o lv e n ts  a n d  a c u te  m y e lo id  le u k e m ia
We estimated hazard ratios (HR) and 95% confi­
dence intervals (95% CI) for each solvent by conditional 
logistic regression. We selected values corresponding 
to the 50th and 90th percentiles of cumulative exposure 
distribution among all exposed case/control subjects as 
cut-off points for categorization. We defined exposure 
values of 0-50th percentile inclusive as “low”, 50-90th 
percentile inclusive as “moderate”, and >90th percentile 
of exposure distribution as “high”. Individuals with 0 
exposure were used as the reference group. Test for trend 
was performed for a dose-response relationship between 
exposure factors and AML.
Variable selection for the final main-effect models 
was based-on the “purposeful covariate selection” pro­
cedure (15). Benzene and toluene were highly correlated 
with ARHC. Therefore, we selected two alternative 
main-effect models. In Model 1, we included ben­
zene and toluene but not ARHC; and in Model 2, we 
included ARCH but neither benzene nor toluene. All 
other solvents were included in both models, and they 
were also adjusted for ionizing radiation and formalde­
hyde as co-factors. The results from both models were 
similar. Therefore, we present only the results of Model 
1, except for the ARHC results, which can only come 
from Model 2.
Analyses stratified by age and sex was conducted to 
explore potential age- and sex-specific interactions with 
exposure. Age at index was categorized into two broad 
levels: <50 and >50 years, because only a small propor­
tion of subjects (11-12%) were <50 years (table 2).
Finally, all analyses were done with different lag­
time assumptions (0, 3, 5, 7, 10, and 20 years).
Results
Altogether, 15 332 cases and 76 660 controls were identi­
fied during the study period (table 2). Of these, 350 cases 
(2.3%) and 2155 controls (2.8%) were excluded because 
they were either <20 years or had no occupational record. 
The proportion of male subjects was 52%, and 45% of 
the cases and controls were from Sweden. About 90% of 
case/controls were born before 1940, and the mean age at 
AML diagnosis was about 67 years (table 2).
We did not observe statistically significantly 
increased risk or dose-response relationship for any 
solvent exposure and AML (table 3). The highest risk 
estimate was observed for toluene levels >90th percentile 
of exposure distribution (HR 1.35, 95% CI 0.74-2.46). 
Risk estimates associated with exposure to high levels 
of ARHC and high and moderate levels of trichloroeth- 
ylene were slightly elevated. Similarly, a small increase 
in risk estimates for exposure to high levels of ionizing 
radiation and formaldehyde were also observed.
Table 2. Demographic characteristics of acute myeloid leukemia 
cases and controls.
C harac te ristic Cases C on tro ls
N % N %
Sex
Male 7751 51.7 38 642 51.9
Female 7231 48.3 35 863 48.1
C ountry
Finland 3484 23.3 17 419 23.4
Iceland 109 0.7 479 0.6
Norway 4606 30.7 22 928 30.8
Sweden 6783 45.3 33 679 45.2
Age at index date a
2 0 -2 9 139 0.9 690 0.9
3 0 -3 9 458 3.1 2271 3.1
4 0 -4 9 1163 7.8 5758 7.7
5 0 -5 9 1991 13.3 9881 13.3
6 0 -6 9 3558 23.8 17 687 23.7
7 0 -7 9 4836 32.3 24 089 32.3
>80 2837 18.9 14 129 18.9
Year o f b irth
<1910 3350 22.4 16 682 22.4
1 9 1 1 -1 9 2 0 4042 26.9 20 138 27.0
1 9 2 1 -1 9 3 0 3677 24.5 18 293 24.6
1 9 3 1 -1 9 4 0 2000 13.4 9926 13.3
1 9 4 1 -1 9 5 0 1406 9.4 6975 9.4
1 9 5 1 -1 9 6 0 507 3.4 2491 3.3
Total 14 982 100 74 505 100
a Index date is de fined as a date of d iagnoses fo r the case and a date of 
d iagnoses of the m atched case fo r the con tro l w ith in  each risk  set.
Sex-specific risk estimates associated with exposure 
to high levels of toluene were higher among men than 
women (table 4). In contrast, HR estimates for ARHC, 
benzene, methylene chloride, and trichloroethylene were 
more pronounced among women than men.
Analysis stratified on age showed that HR estimates 
of AML associated with exposure to some solvents might 
be higher in younger ages (table 5). For example, the 
risk of AML was more than two-fold among benzene- 
and methylene-chloride-exposed individuals <50 years, 
whereas it was close to one among those >50 years.
Analysis with different lag-time assumptions showed 
that HR estimates for toluene were 1.86 (95% CI 1.06­
3.28) with 0 lag-time and 1.62 (95% CI 0.89-2.96) 
with 20 year lag-time. HR for ARHC and trichloroeth- 
ylene remained elevated from 0-10-year-lag-time and 
decreased towards null with 20-year-lag-time (data not 
shown).
Discussion
The results from this study showed some suggestive 
evidence for an association between AML and solvent 
exposure but not consistently in both genders. There 
was non-significant excess risk for toluene, ARHC, and
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Table 3. Hazard ratios (HR) and 95% confidence intervals (95% 
CI) of acute myeloid leukemia associated with exposure to solvents 
and other co-factors. [Ppm=parts per million; mSv=millisieverts].
A gent a (ppm /year) Cases Contro ls HR 95%  CI P-value 
fo r  trend
Solvents
A lip ha tic  and a licyc lic 
hydrocarbon so lvents
<17.5 353 1743 1.01 0 .7 9 -1 .2 9
1 7 .5 -3 0 0 283 1393 1.08 0 .8 2 -1 .4 2
>300 54 366 0.64 0 .3 8 -1 .0 8 0.76
A rom a tic  hydrocarbon 
so lvents b
<9 .3 362 1661 1.10 0 .9 8 -1 .2 5
9 .3 -2 7 5 256 1362 0.99 0 .8 0 -1 .2 4
>275 63 342 1.18 0 .7 6 -1 .8 6 0.56
Benzene
<3 .7 430 1999 1.02 0 .8 4 -1 .2 4
3 .7 -1 3 .6 310 1633 0.88 0 .71 -1 .11
>13.6 68 418 0.80 0 .5 6 -1 .1 5 0.33
Toluene
<42.4 424 1954 1.17 0 .9 4 -1 .4 5
42 .4 -6 1 296 1602 1.01 0 .7 9 -1 .3 0
>612 76 400 1.35 0 .7 4 -2 .4 6 0.49
Trich lo roe thylene
<16.2 302 1760 0.93 0 .7 9 -1 .0 9
16 .2 -12 1 275 1373 1.12 0 .9 4 -1 .3 3
>121 68 345 1.12 0 .8 3 -1 .4 9 0.08
1,1 ,1 -tr ich lo ro e than e
<5 .6 566 2986 0.89 0 .7 6 -1 .0 4
5 .6 -1 2 .7 244 1317 0.86 0 .7 1 -1 .0 5
>12.7 86 482 0.81 0 .6 1 -1 .0 8 0.58
M ethylene ch lo ride
<9 .9 326 1638 1.01 0 .8 2 -1 .2 5
9 .9 -6 4 .6 249 1267 1.06 0 .8 4 -1 .3 4
>64.6 59 328 1.06 0 .5 8 -1 .9 4 0.43
P erchloroethy lene
<12.1 89 472 1.07 0 .8 3 -1 .3 8
1 2 .1 -1 0 6 67 381 0.83 0 .6 1 -1 .1 2
>106 16 96 0.72 0 .3 9 -1 .3 4 0.39
O ther o rgan ic  so lvents
<83 .8 167 760 1.09 0 .9 0 -1 .3 3
8 3 .8 -3 5 7 123 617 0.96 0 .7 1 -1 .3 0
>357 28 158 1.08 0 .6 1 -1 .9 0 0.48
C o-factor
Ion iz ing rad iation (m Sv/year) 
< 3 .6  27 159 0.84 0 .5 6 -1 .2 7
3 .6 -1 2 .5 27 121 1.09 0 .7 2 -1 .6 7
> 2.5 7 31 1.12 0 .4 9 -2 .5 5 0.89
Form aldehyde
<0.171 580 3241 0.89 0 .8 1 -0 .9 7
0 .1 7 1 -1 .6 485 2571 0.92 0 .8 3 -1 .0 3
>1.6 136 628 1.17 0 .91 -1 .51 0.07
a O ccupationa lly  unexposed ind iv idua ls  w ere used as a reference group 
in all analyses.
b HR es tim ates fo r a rom atic  hydrocarbon so lvents  are fro m  M odel 2, all 
o the r HR are fro m  M odel 1.
trichloroethylene. We did not observe an association 
between exposure to benzene and AML unlike many 
earlier studies (4-8).
The evidence for an increased risk of AML from 
exposure to organic solvents other than benzene is 
inconsistent. The recent studies by Kaufman et al (10) 
and Strom et al (11) suggested an increased risk of AML 
following solvent exposure. However, both studies had 
limitations with exposure assessment. In the former 
study, the authors combined benzene, gasoline, and 
other solvents into a single group due to a small number 
of exposed subjects. In the latter, exposure information 
was collected via personal interviews and was, there­
fore, subject to a recall bias. In an Italian multicenter 
case-control study no association between exposure to 
solvents and AML was found (16). Excess risk of AML 
from benzene exposure could be identifiable already at 
10 ppm/year exposure levels according to Vlaanderen 
et al (8). The estimated cumulative benzene exposure 
in our study exceeded 13.6 ppm/year for 68 cases and 
418 controls (table 3). These numbers are so high that 
our study is unlikely to lack power and miss an effect 
should one exist in our data.
Observed age and sex-specific variation in risk esti­
mates could result from effect of physiological differ­
ences by age and sex on pharmacokinetics (absorp­
tion, distribution, metabolism, elimination) of solvents 
(17-21). However, we cannot exclude the possibility of 
chance findings.
When interpreting our results, the following limita­
tions need to be considered. Because this study was based 
on general populations of the Nordic countries, only a 
small percentage of study population had considerable 
exposure to solvents. This constrained our choice of 
cumulative exposure categorization. Another potential 
limitation of the present study is exposure misclassifica- 
tion, which may arise from two sources. First, the generic 
JEM has a poor sensitivity and a failure to account for 
heterogeneity in exposure levels within jobs (22, 23). 
Work history data is a second factor likely to contribute 
to exposure misclassification. Individual work histories 
were based on census records that are a snapshot of a job 
held by individual at the time of the census. The data did 
not provide information on the changes of the job or tasks 
during the entire working career of an individual. In this 
study, we assumed that an individual held his/her occu­
pation until the mid-year between two censuses. Finally, 
we could not control for smoking and genetic factors that 
have previously been linked to AML (24-27). However, 
lung cancer risk was not elevated in the majority of occu­
pational groups with solvent exposure (12), suggesting 
that the smoking rate among solvent-exposed individuals 
was unlikely to be higher than the general population. 
In addition, genetic factors are very rare and unlikely to 
be related to solvent exposure. Therefore, smoking and
S c a n d  J  W ork E nv iro n  H e a lth  2014 , v o l 40, n o  4  423
E x p o s u re  to s o lv e n ts  a n d  a c u te  m y e lo id  le u k e m ia
Table 4. Sex-specific hazard ratios (HR) and 95% confidence intervals (95 % CI) of acute myeloid leukemia associated with exposure to 
solvents with sex-specific variation of HR estimates. [ppm=parts per million].
A gen t a (ppm /year) Males Females
Cases Contro ls HR 95%  CI P-value 
fo r  trend
Cases C on tro ls HR 95%  CI P-value 
fo r  trend
A ro m a tic  hyd rocarbon  so lvents  b
<9 .3 265 1182 1.14 0 .9 9 -1 .3 2 97 479 1.04 0 .8 1 -1 .3 2
9 .3 -2 7 5 197 1000 1.02 0 .7 9 -1 .3 0 59 362 1.13 0 .6 2 -2 .0 3
>275 52 296 1.17 0 .6 7 -2 .0 2 0.49 11 46 1.67 0 .7 1 -3 .9 6  0.72
Benzene
<3.7 350 1515 1.12 0 .8 7 -1 .4 4 81 486 0.86 0 .6 0 -1 .2 2
3 .7 -1 3 .6 264 1414 0.89 0 .6 9 -1 .1 8 45 213 1.10 0 .6 9 -1 .7 4
>13.6 63 405 0.76 0 .5 1 -1 .1 3 0.18 5 17 2.02 0 .5 8 -7 .0 4  0.59
Toluene
<42.4 366 1647 1.17 0 .90 -1 .51 58 301 0.87 0 .5 4 -1 .4 2
42 .4 -6 1 277 1483 1.02 0 .7 7 -1 .3 6 19 125 0.63 0 .29 -1 .31
>612 71 383 1.41 0 .7 3 -2 .7 5 0.32 5 17 0.85 0 .1 7 -4 .3 5  0.35
T rich lo roe thy lene
<16.2 239 1400 0.92 0 .7 7 -1 .0 9 63 360 1.15 0 .7 1 -1 .8 5
16 .2 -121 225 1117 1.09 0 .9 1 -1 .3 2 50 258 1.41 0 .8 5 -2 .3 6
>121 49 242 1.10 0 .7 9 -1 .5 4 0.08 19 101 1.52 0 .7 1 -3 .2 6  0.61
M ethylene ch lo ride
<9 .9 255 1301 0.99 0 .7 6 -1 .2 8 41 201 1.24 0 .7 9 -1 .9 6
9 .9 -6 4 .6 258 1251 1.12 0 .8 6 -1 .4 7 21 152 0.78 0 .4 5 -1 .3 7
>64.6 58 326 1.14 0 .5 9 -2 .1 9 0.23 1 2 1.66 0 .1 0 -2 8 .8  0.58
a O ccupationa lly  unexposed ind iv idua ls  w ere used as a reference g roup  in all analyses. 
b HR es tim ates fo r  a rom a tic  hyd roca rbon  so lvents  are fro m  M odel 2, all o the r HR are fro m  M odel 1
Table 5. Age-specific hazard ratios (HR) and 95% confidence intervals (95% CI) of acute myeloid leukemia associated with exposure to 
solvents with age-specific variation of HR estimates. [ppm=parts per million].
A gent a (ppm /year) <50 years >50 years
Cases C on tro ls HR 95%  CI P-value 
fo r  trend
Cases C on tro ls HR 95%  CI P-value 
fo r trend
A rom a tic  hydrocarbon so lvents  b
<3 .3 39 197 1.03 0 .7 2 -1 .4 9 199 806 1.25 1 .0 6 -1 .4 7
3 .3 -1 1 0 25 163 0.67 0 .3 3 -1 .3 3 256 1389 0.95 0 .80 -1 .11
>110 10 37 1.75 0 .6 2 -4 .9 5 0.94 152 773 1.05 0 .7 2 -1 .5 4  0.53
Benzene
<1 .34 55 255 1.07 0 .66 -1 .71 173 836 1.05 0 .8 2 -1 .3 6
1 .3 4 -5 29 219 0.69 0 .3 6 -1 .2 9 222 1033 0.97 0 .7 6 -1 .2 4
>5 18 44 2.24 0 .9 9 -5 .0 8 0.65 311 1663 0.82 0 .6 3 -1 .0 7  0.25
Toluene
<16.9 47 252 0.96 0 .4 9 -1 .8 8 213 1019 1.13 0 .8 8 -1 .4 4
1 6 .9 -2 2 0 40 197 1.39 0 .62 -3 .11 336 1601 1.33 1 .0 1 -1 .7 5
>220 11 49 1.27 0 .3 0 -5 .3 8 0.63 149 838 0.78 0 .5 3 -1 .1 5  0.51
Trich lo roe thylene
<5 .62 38 229 0.84 0 .5 3 -1 .3 5 88 562 0.87 0 .6 6 -1 .1 4
5 .6 2 -2 4 .9 35 178 1.03 0 .6 5 -1 .6 4 194 1043 1.07 0 .87 -1 .31
>24.9 11 43 1.28 0 .6 2 -2 .6 3 0.40 279 1423 1.08 0 .9 0 -1 .2 9  0.13
M ethylene ch lo ride
<5 .58 50 220 1.12 0 .6 4 -1 .9 7 164 875 0.93 0 .7 2 -1 .2 0
5 .5 8 -1 7 .5 29 187 0.75 0 .37 -1 .51 217 1067 1.05 0 .8 1 -1 .3 6
>17.5 11 43 2.31 0 .83 -6 .41 0.76 163 841 1.15 0 .8 4 -1 .5 7  0.48
O ther o rgan ic  so lvents
<33 .6 21 98 1.15 0 .6 7 -1 .9 8 82 346 1.19 0 .9 2 -1 .5 6
3 3 .6 -1 4 4 18 77 1.48 0 .6 5 -3 .4 0 80 434 0.95 0 .7 3 -1 .2 4
>144 3 21 0.88 0 .1 8 -4 .2 5 0.56 114 559 1.81 1 .13 -2 .91  0.58
a O ccupationa lly  unexposed ind iv idua ls  w ere used as a re ference g roup  in all analyses. 
b HR es tim ates fo r a rom a tic  hydrocarbon so lvents are fro m  M odel 2, all o the r HR are fro m  M odel 1.
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genetic factors could have only a little, if any, confound­
ing effect on our estimates.
To our knowledge this was the largest study to 
assess the relationship between occupational exposure 
to solvents and AML, which covered the general popula­
tions of four Nordic countries. By linking occupational 
records to the NOCCA JEM, we were able to generate 
quantitative exposure estimates for 26 work-related 
agents. It enabled us to explore exposure-response 
relations beyond the analysis of crude categorization 
(“exposed” versus “non-exposed”) or analysis by occu­
pational groups. In addition, we were able to control for 
exposure to multiple agents and variation of exposure 
levels over time.
In conclusion, this study did not provide a clear evi­
dence for an association between occupational solvent 
exposure and AML. There was some indication for an 
excess risk among those exposed to toluene, trichloro- 
ethylene, ARHC.
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